KR20150133097A - An electroluminescent compound and an electroluminescent device comprising the same - Google Patents
An electroluminescent compound and an electroluminescent device comprising the same Download PDFInfo
- Publication number
- KR20150133097A KR20150133097A KR1020140059983A KR20140059983A KR20150133097A KR 20150133097 A KR20150133097 A KR 20150133097A KR 1020140059983 A KR1020140059983 A KR 1020140059983A KR 20140059983 A KR20140059983 A KR 20140059983A KR 20150133097 A KR20150133097 A KR 20150133097A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- carbon atoms
- substituted
- mol
- unsubstituted
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 249
- 239000000126 substance Substances 0.000 claims abstract description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 158
- 238000000034 method Methods 0.000 claims description 57
- 125000003118 aryl group Chemical group 0.000 claims description 41
- 125000001424 substituent group Chemical group 0.000 claims description 40
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 28
- 239000011368 organic material Substances 0.000 claims description 24
- 125000000217 alkyl group Chemical group 0.000 claims description 21
- 125000001072 heteroaryl group Chemical group 0.000 claims description 20
- 230000005525 hole transport Effects 0.000 claims description 20
- 125000003367 polycyclic group Chemical group 0.000 claims description 20
- 125000002723 alicyclic group Chemical group 0.000 claims description 15
- 125000003545 alkoxy group Chemical group 0.000 claims description 14
- 125000005549 heteroarylene group Chemical group 0.000 claims description 13
- 238000002347 injection Methods 0.000 claims description 13
- 239000007924 injection Substances 0.000 claims description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims description 12
- 125000003342 alkenyl group Chemical group 0.000 claims description 10
- 125000004104 aryloxy group Chemical group 0.000 claims description 10
- 125000002950 monocyclic group Chemical group 0.000 claims description 10
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims description 9
- 125000003282 alkyl amino group Chemical group 0.000 claims description 9
- 229910052805 deuterium Inorganic materials 0.000 claims description 9
- 125000005241 heteroarylamino group Chemical group 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 229910052717 sulfur Inorganic materials 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 8
- 125000005264 aryl amine group Chemical group 0.000 claims description 7
- 125000005103 alkyl silyl group Chemical group 0.000 claims description 6
- 125000002947 alkylene group Chemical group 0.000 claims description 6
- 125000000304 alkynyl group Chemical group 0.000 claims description 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 6
- 125000001769 aryl amino group Chemical group 0.000 claims description 6
- 125000005104 aryl silyl group Chemical group 0.000 claims description 6
- 125000000732 arylene group Chemical group 0.000 claims description 6
- 239000002019 doping agent Substances 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 125000004404 heteroalkyl group Chemical group 0.000 claims description 6
- 125000005842 heteroatom Chemical group 0.000 claims description 5
- 125000004419 alkynylene group Chemical group 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 4
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 claims description 4
- 125000004414 alkyl thio group Chemical group 0.000 claims description 3
- 125000003277 amino group Chemical group 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- 125000005110 aryl thio group Chemical group 0.000 claims description 2
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 2
- 150000001721 carbon Chemical group 0.000 claims 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 239000010410 layer Substances 0.000 abstract description 141
- 239000002346 layers by function Substances 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 description 434
- 238000003786 synthesis reaction Methods 0.000 description 434
- 238000004519 manufacturing process Methods 0.000 description 286
- 238000005160 1H NMR spectroscopy Methods 0.000 description 83
- -1 2-pentyl group Chemical group 0.000 description 55
- 239000000463 material Substances 0.000 description 53
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 45
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 18
- SWJPEBQEEAHIGZ-UHFFFAOYSA-N 1,4-dibromobenzene Chemical compound BrC1=CC=C(Br)C=C1 SWJPEBQEEAHIGZ-UHFFFAOYSA-N 0.000 description 16
- 239000000758 substrate Substances 0.000 description 16
- 229940125782 compound 2 Drugs 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000011541 reaction mixture Substances 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- IWHJPYXAFGKABF-UHFFFAOYSA-N 1,1-dibromoethene Chemical compound BrC(Br)=C IWHJPYXAFGKABF-UHFFFAOYSA-N 0.000 description 10
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 10
- 238000000151 deposition Methods 0.000 description 10
- PQXKHYXIUOZZFA-UHFFFAOYSA-M lithium fluoride Chemical compound [Li+].[F-] PQXKHYXIUOZZFA-UHFFFAOYSA-M 0.000 description 10
- 230000032258 transport Effects 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 7
- 230000008021 deposition Effects 0.000 description 7
- AOUCAPVHEWYHDZ-UHFFFAOYSA-N 9,9-dimethyl-1-(4-phenylphenyl)fluoren-2-amine Chemical compound C1(=CC=C(C=C1)C1=C(C=CC=2C3=CC=CC=C3C(C12)(C)C)N)C1=CC=CC=C1 AOUCAPVHEWYHDZ-UHFFFAOYSA-N 0.000 description 6
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 6
- 229940125904 compound 1 Drugs 0.000 description 6
- 125000000623 heterocyclic group Chemical group 0.000 description 6
- 239000012044 organic layer Substances 0.000 description 6
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 5
- VQGHOUODWALEFC-UHFFFAOYSA-N 2-phenylpyridine Chemical compound C1=CC=CC=C1C1=CC=CC=N1 VQGHOUODWALEFC-UHFFFAOYSA-N 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 5
- SWGQITQOBPXVRC-UHFFFAOYSA-N methyl 2-bromobenzoate Chemical compound COC(=O)C1=CC=CC=C1Br SWGQITQOBPXVRC-UHFFFAOYSA-N 0.000 description 5
- BXXLTVBTDZXPTN-UHFFFAOYSA-N methyl 2-iodobenzoate Chemical compound COC(=O)C1=CC=CC=C1I BXXLTVBTDZXPTN-UHFFFAOYSA-N 0.000 description 5
- UWTUEMKLYAGTNQ-OWOJBTEDSA-N (e)-1,2-dibromoethene Chemical compound Br\C=C\Br UWTUEMKLYAGTNQ-OWOJBTEDSA-N 0.000 description 4
- GMVJKSNPLYBFSO-UHFFFAOYSA-N 1,2,3-tribromobenzene Chemical compound BrC1=CC=CC(Br)=C1Br GMVJKSNPLYBFSO-UHFFFAOYSA-N 0.000 description 4
- YWDUZLFWHVQCHY-UHFFFAOYSA-N 1,3,5-tribromobenzene Chemical compound BrC1=CC(Br)=CC(Br)=C1 YWDUZLFWHVQCHY-UHFFFAOYSA-N 0.000 description 4
- PTPGZCQGDXUUAH-UHFFFAOYSA-N 2-bromo-4,6-diphenyl-1,3,5-triazine Chemical compound N=1C(Br)=NC(C=2C=CC=CC=2)=NC=1C1=CC=CC=C1 PTPGZCQGDXUUAH-UHFFFAOYSA-N 0.000 description 4
- FIHILUSWISKVSR-UHFFFAOYSA-N 3,6-dibromo-9h-carbazole Chemical compound C1=C(Br)C=C2C3=CC(Br)=CC=C3NC2=C1 FIHILUSWISKVSR-UHFFFAOYSA-N 0.000 description 4
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical group C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 4
- DMVOXQPQNTYEKQ-UHFFFAOYSA-N biphenyl-4-amine Chemical compound C1=CC(N)=CC=C1C1=CC=CC=C1 DMVOXQPQNTYEKQ-UHFFFAOYSA-N 0.000 description 4
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- PXFBSZZEOWJJNL-UHFFFAOYSA-N triphenylen-2-ylboronic acid Chemical compound C1=CC=C2C3=CC(B(O)O)=CC=C3C3=CC=CC=C3C2=C1 PXFBSZZEOWJJNL-UHFFFAOYSA-N 0.000 description 4
- NHDIQVFFNDKAQU-UHFFFAOYSA-N tripropan-2-yl borate Chemical compound CC(C)OB(OC(C)C)OC(C)C NHDIQVFFNDKAQU-UHFFFAOYSA-N 0.000 description 4
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 description 3
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 3
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 3
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 3
- WQONPSCCEXUXTQ-UHFFFAOYSA-N 1,2-dibromobenzene Chemical compound BrC1=CC=CC=C1Br WQONPSCCEXUXTQ-UHFFFAOYSA-N 0.000 description 3
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 3
- LPLLWKZDMKTEMV-UHFFFAOYSA-N 1-bromo-3-(3-bromophenyl)benzene Chemical group BrC1=CC=CC(C=2C=C(Br)C=CC=2)=C1 LPLLWKZDMKTEMV-UHFFFAOYSA-N 0.000 description 3
- KBVDUUXRXJTAJC-UHFFFAOYSA-N 2,5-dibromothiophene Chemical compound BrC1=CC=C(Br)S1 KBVDUUXRXJTAJC-UHFFFAOYSA-N 0.000 description 3
- MDFXJBQEWLCGHP-MFOYZWKCSA-N 2-[2-[(z)-(pyridine-4-carbonylhydrazinylidene)methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=CC=C1\C=N/NC(=O)C1=CC=NC=C1 MDFXJBQEWLCGHP-MFOYZWKCSA-N 0.000 description 3
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 description 3
- LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 description 3
- DWYHDSLIWMUSOO-UHFFFAOYSA-N 2-phenyl-1h-benzimidazole Chemical compound C1=CC=CC=C1C1=NC2=CC=CC=C2N1 DWYHDSLIWMUSOO-UHFFFAOYSA-N 0.000 description 3
- DFRAKBCRUYUFNT-UHFFFAOYSA-N 3,8-dicyclohexyl-2,4,7,9-tetrahydro-[1,3]oxazino[5,6-h][1,3]benzoxazine Chemical compound C1CCCCC1N1CC(C=CC2=C3OCN(C2)C2CCCCC2)=C3OC1 DFRAKBCRUYUFNT-UHFFFAOYSA-N 0.000 description 3
- DLGZLIXYVSQGOX-UHFFFAOYSA-N 4-[8-[4-(4-tert-butylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]furan-2-carboxamide Chemical compound C1CN(C(C)(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=COC(C(N)=O)=C1 DLGZLIXYVSQGOX-UHFFFAOYSA-N 0.000 description 3
- 229940127007 Compound 39 Drugs 0.000 description 3
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 3
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 239000010406 cathode material Substances 0.000 description 3
- 229940125797 compound 12 Drugs 0.000 description 3
- 229940125844 compound 46 Drugs 0.000 description 3
- 229920001940 conductive polymer Polymers 0.000 description 3
- 238000005401 electroluminescence Methods 0.000 description 3
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 3
- 238000004770 highest occupied molecular orbital Methods 0.000 description 3
- 229910044991 metal oxide Inorganic materials 0.000 description 3
- 150000004706 metal oxides Chemical class 0.000 description 3
- XBRJXFYZADAIRU-UHFFFAOYSA-N methyl 2,6-dibromobenzoate Chemical compound COC(=O)C1=C(Br)C=CC=C1Br XBRJXFYZADAIRU-UHFFFAOYSA-N 0.000 description 3
- LPOIGVZLNWEGJG-UHFFFAOYSA-N n-benzyl-5-(4-methylpiperazin-1-yl)-2-nitroaniline Chemical compound C1CN(C)CCN1C1=CC=C([N+]([O-])=O)C(NCC=2C=CC=CC=2)=C1 LPOIGVZLNWEGJG-UHFFFAOYSA-N 0.000 description 3
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 2
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 2
- JWJQEUDGBZMPAX-UHFFFAOYSA-N (9-phenylcarbazol-3-yl)boronic acid Chemical compound C12=CC=CC=C2C2=CC(B(O)O)=CC=C2N1C1=CC=CC=C1 JWJQEUDGBZMPAX-UHFFFAOYSA-N 0.000 description 2
- OCZZOCFKNXICNU-UHFFFAOYSA-N 1,2,3-tribromo-4-chlorobenzene Chemical compound ClC1=CC=C(Br)C(Br)=C1Br OCZZOCFKNXICNU-UHFFFAOYSA-N 0.000 description 2
- 125000000355 1,3-benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 2
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical group C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 2
- PTTHBZMGHRDZCV-UHFFFAOYSA-N 1h-indol-3-ylboronic acid Chemical compound C1=CC=C2C(B(O)O)=CNC2=C1 PTTHBZMGHRDZCV-UHFFFAOYSA-N 0.000 description 2
- LACYYWKMIJOHLU-UHFFFAOYSA-N 2,5-dibromofuran Chemical compound BrC1=CC=C(Br)O1 LACYYWKMIJOHLU-UHFFFAOYSA-N 0.000 description 2
- AYHGAQGOMUQMTR-UHFFFAOYSA-N 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine Chemical compound C1=CC(Br)=CC=C1C1=NC(C=2C=CC=CC=2)=NC(C=2C=CC=CC=2)=N1 AYHGAQGOMUQMTR-UHFFFAOYSA-N 0.000 description 2
- ZROZRIKRPGMZBK-UHFFFAOYSA-N 2-iodo-1h-benzimidazole Chemical compound C1=CC=C2NC(I)=NC2=C1 ZROZRIKRPGMZBK-UHFFFAOYSA-N 0.000 description 2
- 125000005979 2-naphthyloxy group Chemical group 0.000 description 2
- QENGPZGAWFQWCZ-UHFFFAOYSA-N 3-Methylthiophene Chemical compound CC=1C=CSC=1 QENGPZGAWFQWCZ-UHFFFAOYSA-N 0.000 description 2
- LTBWKAYPXIIVPC-UHFFFAOYSA-N 3-bromo-9h-carbazole Chemical compound C1=CC=C2C3=CC(Br)=CC=C3NC2=C1 LTBWKAYPXIIVPC-UHFFFAOYSA-N 0.000 description 2
- NYPYPOZNGOXYSU-UHFFFAOYSA-N 3-bromopyridine Chemical compound BrC1=CC=CN=C1 NYPYPOZNGOXYSU-UHFFFAOYSA-N 0.000 description 2
- FQVDXLYJTMHMCG-UHFFFAOYSA-N 3-iodo-1h-indole Chemical compound C1=CC=C2C(I)=CNC2=C1 FQVDXLYJTMHMCG-UHFFFAOYSA-N 0.000 description 2
- ONKCIMOQGCARHN-UHFFFAOYSA-N 3-methyl-n-[4-[4-(3-methylanilino)phenyl]phenyl]aniline Chemical compound CC1=CC=CC(NC=2C=CC(=CC=2)C=2C=CC(NC=3C=C(C)C=CC=3)=CC=2)=C1 ONKCIMOQGCARHN-UHFFFAOYSA-N 0.000 description 2
- XWQVQSXLXAXOPJ-QNGMFEMESA-N 4-[[[6-[5-chloro-2-[[4-[[(2r)-1-methoxypropan-2-yl]amino]cyclohexyl]amino]pyridin-4-yl]pyridin-2-yl]amino]methyl]oxane-4-carbonitrile Chemical compound C1CC(N[C@H](C)COC)CCC1NC1=CC(C=2N=C(NCC3(CCOCC3)C#N)C=CC=2)=C(Cl)C=N1 XWQVQSXLXAXOPJ-QNGMFEMESA-N 0.000 description 2
- NUKYPUAOHBNCPY-UHFFFAOYSA-N 4-aminopyridine Chemical compound NC1=CC=NC=C1 NUKYPUAOHBNCPY-UHFFFAOYSA-N 0.000 description 2
- GJXAVNQWIVUQOD-UHFFFAOYSA-N 4-bromodibenzothiophene Chemical compound S1C2=CC=CC=C2C2=C1C(Br)=CC=C2 GJXAVNQWIVUQOD-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 0 C*(C)c1nc2ccccc2[n]1 Chemical compound C*(C)c1nc2ccccc2[n]1 0.000 description 2
- IPWKHHSGDUIRAH-UHFFFAOYSA-N CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C Chemical compound CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 2
- VUOPQUOIXQHHRR-UHFFFAOYSA-N CC1(C)OB(c(c(C2(C)C)c3N(C4c5ccccc5)c5c2cccc5)cc(C2(C)C)c3N4c3c2cccc3)OC1(C)C Chemical compound CC1(C)OB(c(c(C2(C)C)c3N(C4c5ccccc5)c5c2cccc5)cc(C2(C)C)c3N4c3c2cccc3)OC1(C)C VUOPQUOIXQHHRR-UHFFFAOYSA-N 0.000 description 2
- GATVIKZLVQHOMN-UHFFFAOYSA-N Chlorodibromomethane Chemical compound ClC(Br)Br GATVIKZLVQHOMN-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical group C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 2
- 125000005332 alkyl sulfoxy group Chemical group 0.000 description 2
- 239000010405 anode material Substances 0.000 description 2
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 2
- 150000003974 aralkylamines Chemical group 0.000 description 2
- 150000004982 aromatic amines Chemical class 0.000 description 2
- 125000005165 aryl thioxy group Chemical group 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 125000006267 biphenyl group Chemical group 0.000 description 2
- UFVXQDWNSAGPHN-UHFFFAOYSA-K bis[(2-methylquinolin-8-yl)oxy]-(4-phenylphenoxy)alumane Chemical compound [Al+3].C1=CC=C([O-])C2=NC(C)=CC=C21.C1=CC=C([O-])C2=NC(C)=CC=C21.C1=CC([O-])=CC=C1C1=CC=CC=C1 UFVXQDWNSAGPHN-UHFFFAOYSA-K 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- GOXNHPQCCUVWRO-UHFFFAOYSA-N dibenzothiophen-4-ylboronic acid Chemical compound C12=CC=CC=C2SC2=C1C=CC=C2B(O)O GOXNHPQCCUVWRO-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229960004979 fampridine Drugs 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- LCSMGMWMTSWXDD-UHFFFAOYSA-N n-(9,9-dimethylfluoren-2-yl)-9,9-dimethylfluoren-2-amine Chemical compound C1=CC=C2C(C)(C)C3=CC(NC4=CC=C5C6=CC=CC=C6C(C5=C4)(C)C)=CC=C3C2=C1 LCSMGMWMTSWXDD-UHFFFAOYSA-N 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 239000007773 negative electrode material Substances 0.000 description 2
- 125000002971 oxazolyl group Chemical group 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 238000005240 physical vapour deposition Methods 0.000 description 2
- 229920000553 poly(phenylenevinylene) Polymers 0.000 description 2
- 229920000767 polyaniline Polymers 0.000 description 2
- 229920000137 polyphosphoric acid Polymers 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000001725 pyrenyl group Chemical group 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- UWTUEMKLYAGTNQ-UHFFFAOYSA-N 1,2-dibromoethene Chemical compound BrC=CBr UWTUEMKLYAGTNQ-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- QENIALCDPFDFHX-UHFFFAOYSA-N 1,4-dibromo-2,5-dimethylbenzene Chemical compound CC1=CC(Br)=C(C)C=C1Br QENIALCDPFDFHX-UHFFFAOYSA-N 0.000 description 1
- IBGUDZMIAZLJNY-UHFFFAOYSA-N 1,4-dibromonaphthalene Chemical compound C1=CC=C2C(Br)=CC=C(Br)C2=C1 IBGUDZMIAZLJNY-UHFFFAOYSA-N 0.000 description 1
- KEURHSDOWCBXFX-UHFFFAOYSA-N 1-(2-bromophenyl)-2-nitrobenzene Chemical group [O-][N+](=O)C1=CC=CC=C1C1=CC=CC=C1Br KEURHSDOWCBXFX-UHFFFAOYSA-N 0.000 description 1
- ZSKXYSCQDWAUCM-UHFFFAOYSA-N 1-(chloromethyl)-2-dodecylbenzene Chemical compound CCCCCCCCCCCCC1=CC=CC=C1CCl ZSKXYSCQDWAUCM-UHFFFAOYSA-N 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical group C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 1
- DSMRKVAAKZIVQL-UHFFFAOYSA-N 1-bromo-2-tert-butylbenzene Chemical compound CC(C)(C)C1=CC=CC=C1Br DSMRKVAAKZIVQL-UHFFFAOYSA-N 0.000 description 1
- PKJBWOWQJHHAHG-UHFFFAOYSA-N 1-bromo-4-phenylbenzene Chemical group C1=CC(Br)=CC=C1C1=CC=CC=C1 PKJBWOWQJHHAHG-UHFFFAOYSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 1
- 125000006023 1-pentenyl group Chemical group 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- MYKQKWIPLZEVOW-UHFFFAOYSA-N 11h-benzo[a]carbazole Chemical group C1=CC2=CC=CC=C2C2=C1C1=CC=CC=C1N2 MYKQKWIPLZEVOW-UHFFFAOYSA-N 0.000 description 1
- GVBHCMNXRKOJRH-UHFFFAOYSA-N 2,4,5,6-tetrachloropyrimidine Chemical compound ClC1=NC(Cl)=C(Cl)C(Cl)=N1 GVBHCMNXRKOJRH-UHFFFAOYSA-N 0.000 description 1
- PJZDEYKZSZWFPX-UHFFFAOYSA-N 2,6-dibromonaphthalene Chemical compound C1=C(Br)C=CC2=CC(Br)=CC=C21 PJZDEYKZSZWFPX-UHFFFAOYSA-N 0.000 description 1
- LONBOJIXBFUBKQ-UHFFFAOYSA-N 2,7-dibromo-9,9-dimethylfluorene Chemical compound C1=C(Br)C=C2C(C)(C)C3=CC(Br)=CC=C3C2=C1 LONBOJIXBFUBKQ-UHFFFAOYSA-N 0.000 description 1
- TYRZAGMAVZESQX-UHFFFAOYSA-N 2-amino-5-chlorobenzenethiol Chemical compound NC1=CC=C(Cl)C=C1S TYRZAGMAVZESQX-UHFFFAOYSA-N 0.000 description 1
- FZCQMIRJCGWWCL-UHFFFAOYSA-N 2-amino-5-chlorophenol Chemical compound NC1=CC=C(Cl)C=C1O FZCQMIRJCGWWCL-UHFFFAOYSA-N 0.000 description 1
- VRVRGVPWCUEOGV-UHFFFAOYSA-N 2-aminothiophenol Chemical compound NC1=CC=CC=C1S VRVRGVPWCUEOGV-UHFFFAOYSA-N 0.000 description 1
- BCMGOTDNNMLUBS-UHFFFAOYSA-N 2-bromo-1,8-naphthyridine Chemical compound C1=CC=NC2=NC(Br)=CC=C21 BCMGOTDNNMLUBS-UHFFFAOYSA-N 0.000 description 1
- VECCYQZDQOPISO-UHFFFAOYSA-N 2-bromo-3-chloro-1h-indole Chemical compound C1=CC=C2C(Cl)=C(Br)NC2=C1 VECCYQZDQOPISO-UHFFFAOYSA-N 0.000 description 1
- IAEGJEFWTVJXPB-UHFFFAOYSA-N 2-bromo-6-chloro-1h-benzimidazole Chemical compound ClC1=CC=C2N=C(Br)NC2=C1 IAEGJEFWTVJXPB-UHFFFAOYSA-N 0.000 description 1
- BIMSFWCFKDVSNO-UHFFFAOYSA-N 2-bromo-6-chloroaniline Chemical compound NC1=C(Cl)C=CC=C1Br BIMSFWCFKDVSNO-UHFFFAOYSA-N 0.000 description 1
- MBHPOBSZPYEADG-UHFFFAOYSA-N 2-bromo-9,9-dimethylfluorene Chemical compound C1=C(Br)C=C2C(C)(C)C3=CC=CC=C3C2=C1 MBHPOBSZPYEADG-UHFFFAOYSA-N 0.000 description 1
- PJRGCJBBXGNEGD-UHFFFAOYSA-N 2-bromo-9h-carbazole Chemical compound C1=CC=C2C3=CC=C(Br)C=C3NC2=C1 PJRGCJBBXGNEGD-UHFFFAOYSA-N 0.000 description 1
- WGFCNCNTGOFBBF-UHFFFAOYSA-N 2-bromopyrazine Chemical compound BrC1=CN=CC=N1 WGFCNCNTGOFBBF-UHFFFAOYSA-N 0.000 description 1
- GEDOYYDMCZUHNW-UHFFFAOYSA-N 2-bromotriphenylene Chemical group C1=CC=C2C3=CC(Br)=CC=C3C3=CC=CC=C3C2=C1 GEDOYYDMCZUHNW-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- DDGPPAMADXTGTN-UHFFFAOYSA-N 2-chloro-4,6-diphenyl-1,3,5-triazine Chemical compound N=1C(Cl)=NC(C=2C=CC=CC=2)=NC=1C1=CC=CC=C1 DDGPPAMADXTGTN-UHFFFAOYSA-N 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- WDYBHPQXZGAVMW-UHFFFAOYSA-N 2-iodo-3H-indole Chemical compound C1=CC=CC2=C1CC(=N2)I WDYBHPQXZGAVMW-UHFFFAOYSA-N 0.000 description 1
- WONYVCKUEUULQN-UHFFFAOYSA-N 2-methyl-n-(2-methylphenyl)aniline Chemical group CC1=CC=CC=C1NC1=CC=CC=C1C WONYVCKUEUULQN-UHFFFAOYSA-N 0.000 description 1
- JTMODJXOTWYBOZ-UHFFFAOYSA-N 2-methyl-n-phenylaniline Chemical group CC1=CC=CC=C1NC1=CC=CC=C1 JTMODJXOTWYBOZ-UHFFFAOYSA-N 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- DPJCXCZTLWNFOH-UHFFFAOYSA-N 2-nitroaniline Chemical compound NC1=CC=CC=C1[N+]([O-])=O DPJCXCZTLWNFOH-UHFFFAOYSA-N 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- LGBWTIGIAGCRKW-UHFFFAOYSA-N 2-phosphanylaniline Chemical compound NC1=CC=CC=C1P LGBWTIGIAGCRKW-UHFFFAOYSA-N 0.000 description 1
- 125000006607 3,3-dimethylbutyloxy group Chemical group 0.000 description 1
- DMEVMYSQZPJFOK-UHFFFAOYSA-N 3,4,5,6,9,10-hexazatetracyclo[12.4.0.02,7.08,13]octadeca-1(18),2(7),3,5,8(13),9,11,14,16-nonaene Chemical group N1=NN=C2C3=CC=CC=C3C3=CC=NN=C3C2=N1 DMEVMYSQZPJFOK-UHFFFAOYSA-N 0.000 description 1
- VPMJBJSLTPBZLR-UHFFFAOYSA-N 3,6-dibromobenzene-1,2-diamine Chemical compound NC1=C(N)C(Br)=CC=C1Br VPMJBJSLTPBZLR-UHFFFAOYSA-N 0.000 description 1
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 description 1
- DYTMTLPTFUWUSO-UHFFFAOYSA-N 3-bromo-5-chloro-1h-indole Chemical compound ClC1=CC=C2NC=C(Br)C2=C1 DYTMTLPTFUWUSO-UHFFFAOYSA-N 0.000 description 1
- KUBSCXXKQGDPPD-UHFFFAOYSA-N 3-bromo-9-phenylcarbazole Chemical compound C12=CC=CC=C2C2=CC(Br)=CC=C2N1C1=CC=CC=C1 KUBSCXXKQGDPPD-UHFFFAOYSA-N 0.000 description 1
- VWYTZNPMXYCBPK-UHFFFAOYSA-N 3-bromobenzene-1,2-diamine Chemical compound NC1=CC=CC(Br)=C1N VWYTZNPMXYCBPK-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- JJYPMNFTHPTTDI-UHFFFAOYSA-N 3-methylaniline Chemical group CC1=CC=CC(N)=C1 JJYPMNFTHPTTDI-UHFFFAOYSA-N 0.000 description 1
- BXIXXXYDDJVHDL-UHFFFAOYSA-N 4-Chloro-ortho-phenylenediamine Chemical compound NC1=CC=C(Cl)C=C1N BXIXXXYDDJVHDL-UHFFFAOYSA-N 0.000 description 1
- AVESHYKDJMFQGJ-UHFFFAOYSA-N 4-bromo-2,6-diphenylpyridine Chemical compound C=1C(Br)=CC(C=2C=CC=CC=2)=NC=1C1=CC=CC=C1 AVESHYKDJMFQGJ-UHFFFAOYSA-N 0.000 description 1
- SXSXZCWQJDWRST-UHFFFAOYSA-N 4-bromo-3-ethenylpyridine Chemical compound BrC1=C(C=NC=C1)C=C SXSXZCWQJDWRST-UHFFFAOYSA-N 0.000 description 1
- SQTLUXJWUCHKMT-UHFFFAOYSA-N 4-bromo-n,n-diphenylaniline Chemical compound C1=CC(Br)=CC=C1N(C=1C=CC=CC=1)C1=CC=CC=C1 SQTLUXJWUCHKMT-UHFFFAOYSA-N 0.000 description 1
- MQFYUZCANYLWEI-UHFFFAOYSA-N 4-methylnaphthalen-1-amine Chemical group C1=CC=C2C(C)=CC=C(N)C2=C1 MQFYUZCANYLWEI-UHFFFAOYSA-N 0.000 description 1
- JAUCIDPGGHZXRP-UHFFFAOYSA-N 4-phenyl-n-(4-phenylphenyl)aniline Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1NC(C=C1)=CC=C1C1=CC=CC=C1 JAUCIDPGGHZXRP-UHFFFAOYSA-N 0.000 description 1
- DUXSBFIFHQSVDY-UHFFFAOYSA-N 4-pyridin-2-yl-1H-pyrimidin-4-amine Chemical compound C=1C=CC=NC=1C1(N)NC=NC=C1 DUXSBFIFHQSVDY-UHFFFAOYSA-N 0.000 description 1
- RMIFLIVHJLREFJ-UHFFFAOYSA-N 5-bromo-2-nitroaniline Chemical compound NC1=CC(Br)=CC=C1[N+]([O-])=O RMIFLIVHJLREFJ-UHFFFAOYSA-N 0.000 description 1
- MCGDFFHOFXZDDV-UHFFFAOYSA-N 5-bromobenzene-1,3-diamine Chemical compound NC1=CC(N)=CC(Br)=C1 MCGDFFHOFXZDDV-UHFFFAOYSA-N 0.000 description 1
- XDPXAVRAVFDBAA-UHFFFAOYSA-N 6-chloro-2-iodo-1h-benzimidazole Chemical compound ClC1=CC=C2NC(I)=NC2=C1 XDPXAVRAVFDBAA-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- RDNNQPYPXUYANO-UHFFFAOYSA-N 8-iodo-7h-purine Chemical compound C1=NC=C2NC(I)=NC2=N1 RDNNQPYPXUYANO-UHFFFAOYSA-N 0.000 description 1
- GUTJITRKAMCHSD-UHFFFAOYSA-N 9,9-dimethylfluoren-2-amine Chemical compound C1=C(N)C=C2C(C)(C)C3=CC=CC=C3C2=C1 GUTJITRKAMCHSD-UHFFFAOYSA-N 0.000 description 1
- GZSUIHUAFPHZSU-UHFFFAOYSA-N 9-ethyl-2,3-dihydro-1h-carbazol-4-one Chemical compound C12=CC=CC=C2N(CC)C2=C1C(=O)CCC2 GZSUIHUAFPHZSU-UHFFFAOYSA-N 0.000 description 1
- QXDWMAODKPOTKK-UHFFFAOYSA-N 9-methylanthracen-1-amine Chemical group C1=CC(N)=C2C(C)=C(C=CC=C3)C3=CC2=C1 QXDWMAODKPOTKK-UHFFFAOYSA-N 0.000 description 1
- WGUUKVJNVYAFFI-UHFFFAOYSA-N 9h-carbazol-3-ylboronic acid Chemical compound C1=CC=C2C3=CC(B(O)O)=CC=C3NC2=C1 WGUUKVJNVYAFFI-UHFFFAOYSA-N 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- NOPRBDOJUXEQCY-UHFFFAOYSA-N Brc1c2Nc3ccccc3Oc2ccc1 Chemical compound Brc1c2Nc3ccccc3Oc2ccc1 NOPRBDOJUXEQCY-UHFFFAOYSA-N 0.000 description 1
- MDASWRVQPNUUNC-UHFFFAOYSA-N Brc1ccc(-c2nc(cccc3)c3[nH]2)[o]1 Chemical compound Brc1ccc(-c2nc(cccc3)c3[nH]2)[o]1 MDASWRVQPNUUNC-UHFFFAOYSA-N 0.000 description 1
- DQSOWILWHRUEQL-UHFFFAOYSA-N Brc1ccc(-c2nc(cccc3)c3[nH]2)[s]1 Chemical compound Brc1ccc(-c2nc(cccc3)c3[nH]2)[s]1 DQSOWILWHRUEQL-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- DEECXVJGRIENES-UHFFFAOYSA-N C1(=CC=C(C=C1)C1=C(C=CC(=C1)NC1=CC=C(C=C1)Br)C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound C1(=CC=C(C=C1)C1=C(C=CC(=C1)NC1=CC=C(C=C1)Br)C1=CC=CC=C1)C1=CC=CC=C1 DEECXVJGRIENES-UHFFFAOYSA-N 0.000 description 1
- DMQCFEKTOLSHSB-UHFFFAOYSA-N CC(C)(c(cccc1)c1-[n]1c2ccccc2c(-c2ccccc2)c1)O Chemical compound CC(C)(c(cccc1)c1-[n]1c2ccccc2c(-c2ccccc2)c1)O DMQCFEKTOLSHSB-UHFFFAOYSA-N 0.000 description 1
- AMSKNMRHAIMIJS-UHFFFAOYSA-N CC(C)(c(cccc1c(-c2ccccc2)c2)c1[n]2-c1ccc2)c1c2-c1c(-c2ccccc2)nc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)nc1-c1ccccc1 Chemical compound CC(C)(c(cccc1c(-c2ccccc2)c2)c1[n]2-c1ccc2)c1c2-c1c(-c2ccccc2)nc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)nc1-c1ccccc1 AMSKNMRHAIMIJS-UHFFFAOYSA-N 0.000 description 1
- YZZJAGCBCWANGU-UHFFFAOYSA-N CC(C)(c(cccc1c(-c2ccccc2)c2)c1[n]2-c1ccc2)c1c2Br Chemical compound CC(C)(c(cccc1c(-c2ccccc2)c2)c1[n]2-c1ccc2)c1c2Br YZZJAGCBCWANGU-UHFFFAOYSA-N 0.000 description 1
- GJNQXABWEFCGHJ-UHFFFAOYSA-N CC(C)(c1cc(Cl)c2)c(cccc3)c3-[n]3c1c2c(Br)c3 Chemical compound CC(C)(c1cc(Cl)c2)c(cccc3)c3-[n]3c1c2c(Br)c3 GJNQXABWEFCGHJ-UHFFFAOYSA-N 0.000 description 1
- MVSUKQOTOUOCIY-UHFFFAOYSA-N CC(C)(c1ccccc1-[n]1c(-c2ccccc2)nc2c1cccc2Cl)O Chemical compound CC(C)(c1ccccc1-[n]1c(-c2ccccc2)nc2c1cccc2Cl)O MVSUKQOTOUOCIY-UHFFFAOYSA-N 0.000 description 1
- DHIIVKNGUHAQND-UHFFFAOYSA-N CC(C)(c1ccccc1-[n]1c(ccc(Cl)c2)c2c(Br)c1)O Chemical compound CC(C)(c1ccccc1-[n]1c(ccc(Cl)c2)c2c(Br)c1)O DHIIVKNGUHAQND-UHFFFAOYSA-N 0.000 description 1
- PTZCBFYGOIQUFA-UHFFFAOYSA-N CC(C)(c1nc(F)ccc1-[n]1c(-c2ccccc2)nc2c1cccc2)O Chemical compound CC(C)(c1nc(F)ccc1-[n]1c(-c2ccccc2)nc2c1cccc2)O PTZCBFYGOIQUFA-UHFFFAOYSA-N 0.000 description 1
- XCHNLCGZJBAXAU-UHFFFAOYSA-N CC(c1nc(F)ccc1-[n]1c(-c2ccccc2)nc2ccccc12)=O Chemical compound CC(c1nc(F)ccc1-[n]1c(-c2ccccc2)nc2ccccc12)=O XCHNLCGZJBAXAU-UHFFFAOYSA-N 0.000 description 1
- AIYLNDJDCBJMMY-UHFFFAOYSA-N CC1(C)OB(c(cc2)ccc2-c(cc2c3ccccc33)ccc2[n]3-c2ccccc2)OC1(C)C Chemical compound CC1(C)OB(c(cc2)ccc2-c(cc2c3ccccc33)ccc2[n]3-c2ccccc2)OC1(C)C AIYLNDJDCBJMMY-UHFFFAOYSA-N 0.000 description 1
- XMZMTTCXLBQOOW-UHFFFAOYSA-N CC1(C)OB(c(cc2c(-c3ccccc3)c3)cc4c2[n]3-c2ccccc2C4(C)C)OC1(C)C Chemical compound CC1(C)OB(c(cc2c(-c3ccccc3)c3)cc4c2[n]3-c2ccccc2C4(C)C)OC1(C)C XMZMTTCXLBQOOW-UHFFFAOYSA-N 0.000 description 1
- DINYICIEKQRGLZ-UHFFFAOYSA-N CC1(C)OB(c2c(-c3ccccc3)nc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)nc2-c2ccccc2)OC1(C)C Chemical compound CC1(C)OB(c2c(-c3ccccc3)nc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)nc2-c2ccccc2)OC1(C)C DINYICIEKQRGLZ-UHFFFAOYSA-N 0.000 description 1
- XPLKTSMDKJUHAP-UHFFFAOYSA-N CC1(C)OB(c2cc(nc3-c4ccccc4)c4[n]3-c3ccccc3C(C)(C)c4c2)OC1(C)C Chemical compound CC1(C)OB(c2cc(nc3-c4ccccc4)c4[n]3-c3ccccc3C(C)(C)c4c2)OC1(C)C XPLKTSMDKJUHAP-UHFFFAOYSA-N 0.000 description 1
- HIGJBIVBPHAUNA-UHFFFAOYSA-N CC1(C)OB(c2nc(-c3ccccc3)nc(-c3ccccc3)n2)OC1(C)C Chemical compound CC1(C)OB(c2nc(-c3ccccc3)nc(-c3ccccc3)n2)OC1(C)C HIGJBIVBPHAUNA-UHFFFAOYSA-N 0.000 description 1
- SHUNGZZFZAVWBS-UHFFFAOYSA-N CC1(C)c(c(-c(cc2)ccc2-c2cc(-[n]3c(-c4ccccc4)nc4c3cccc4)cc(-[n]3c(-c4ccccc4)nc4ccccc34)c2)ccc2)c2-[n]2c3c1cccc3c(-c1ccccc1)c2 Chemical compound CC1(C)c(c(-c(cc2)ccc2-c2cc(-[n]3c(-c4ccccc4)nc4c3cccc4)cc(-[n]3c(-c4ccccc4)nc4ccccc34)c2)ccc2)c2-[n]2c3c1cccc3c(-c1ccccc1)c2 SHUNGZZFZAVWBS-UHFFFAOYSA-N 0.000 description 1
- YBOMLFZMOGPCGP-UHFFFAOYSA-N CC1(C)c(c(-c(cc2)ccc2-c2cc(Br)cc(Br)c2)ccc2)c2-[n]2c3c1cccc3c(-c1ccccc1)c2 Chemical compound CC1(C)c(c(-c(cc2)ccc2-c2cc(Br)cc(Br)c2)ccc2)c2-[n]2c3c1cccc3c(-c1ccccc1)c2 YBOMLFZMOGPCGP-UHFFFAOYSA-N 0.000 description 1
- UBFNSSMSQQVODF-UHFFFAOYSA-N CC1(C)c2cc(N(c(cc3)ccc3-c(c3ccccc33)c[n]3-c(cccc3)c3C(OC)=O)c(cc3)ccc3-c3ccccc3)ccc2-c2c1cccc2 Chemical compound CC1(C)c2cc(N(c(cc3)ccc3-c(c3ccccc33)c[n]3-c(cccc3)c3C(OC)=O)c(cc3)ccc3-c3ccccc3)ccc2-c2c1cccc2 UBFNSSMSQQVODF-UHFFFAOYSA-N 0.000 description 1
- GUDUSYIEGJDUOC-UHFFFAOYSA-N CC1(C)c2ccccc2-[n]2c(-c3ccccc3)nc3cc(Cl)cc1c23 Chemical compound CC1(C)c2ccccc2-[n]2c(-c3ccccc3)nc3cc(Cl)cc1c23 GUDUSYIEGJDUOC-UHFFFAOYSA-N 0.000 description 1
- PMSTVIVCTDSVQD-UHFFFAOYSA-N CC1(C)c2ccccc2N(C(c2ccccc2)N(c2c3C4(C)C)c5c4cccc5)c2c1cc3-c(cc1)ccc1Br Chemical compound CC1(C)c2ccccc2N(C(c2ccccc2)N(c2c3C4(C)C)c5c4cccc5)c2c1cc3-c(cc1)ccc1Br PMSTVIVCTDSVQD-UHFFFAOYSA-N 0.000 description 1
- URWAUNVCSOGWIF-UHFFFAOYSA-N CC1(C)c2ccccc2N(C(c2ccccc2)N(c2c3C4(C)C)c5c4cccc5)c2c1cc3-c1ccc2[nH]c(cccc3)c3c2c1 Chemical compound CC1(C)c2ccccc2N(C(c2ccccc2)N(c2c3C4(C)C)c5c4cccc5)c2c1cc3-c1ccc2[nH]c(cccc3)c3c2c1 URWAUNVCSOGWIF-UHFFFAOYSA-N 0.000 description 1
- OTQNREYUMAOFOM-UHFFFAOYSA-N CC1(C)c2ccccc2N(C(c2ccccc2)N(c2c3C4(C)C)c5c4cccc5)c2c1cc3Br Chemical compound CC1(C)c2ccccc2N(C(c2ccccc2)N(c2c3C4(C)C)c5c4cccc5)c2c1cc3Br OTQNREYUMAOFOM-UHFFFAOYSA-N 0.000 description 1
- UCLWLHJTSPRLCK-UHFFFAOYSA-N CC1(C)c2nc(-c(cc3)ccc3-c(cc3)cc(c4ccccc44)c3[n]4-c3ccccc3)ncc2-[n]2c3c1cccc3cc2-c1ccccc1 Chemical compound CC1(C)c2nc(-c(cc3)ccc3-c(cc3)cc(c4ccccc44)c3[n]4-c3ccccc3)ncc2-[n]2c3c1cccc3cc2-c1ccccc1 UCLWLHJTSPRLCK-UHFFFAOYSA-N 0.000 description 1
- DIBNXBOBMLZXCT-UHFFFAOYSA-N CC1(C)c2nc(Br)ncc2-[n]2c3c1cccc3cc2-c1ccccc1 Chemical compound CC1(C)c2nc(Br)ncc2-[n]2c3c1cccc3cc2-c1ccccc1 DIBNXBOBMLZXCT-UHFFFAOYSA-N 0.000 description 1
- SCSSNGUCRQNUTE-UHFFFAOYSA-N COC(c(c(-[n]1c(-c2ccccc2)nc2c1cncn2)ccc1)c1Br)=O Chemical compound COC(c(c(-[n]1c(-c2ccccc2)nc2c1cncn2)ccc1)c1Br)=O SCSSNGUCRQNUTE-UHFFFAOYSA-N 0.000 description 1
- DCDURNOJHWOXQQ-UHFFFAOYSA-N COC(c(cccc1)c1-[n](c1ccc2)c(-c3ccccc3)nc1c2Cl)=O Chemical compound COC(c(cccc1)c1-[n](c1ccc2)c(-c3ccccc3)nc1c2Cl)=O DCDURNOJHWOXQQ-UHFFFAOYSA-N 0.000 description 1
- VEKQVXSBDFNQSD-UHFFFAOYSA-N COC(c(cccc1)c1-[n](c1ccccc11)c(-c2ccccc2)c1-c(cc1)ccc1N(c(cc1)ccc1-c1ccccc1)c(cc1)ccc1-c1ccccc1)O Chemical compound COC(c(cccc1)c1-[n](c1ccccc11)c(-c2ccccc2)c1-c(cc1)ccc1N(c(cc1)ccc1-c1ccccc1)c(cc1)ccc1-c1ccccc1)O VEKQVXSBDFNQSD-UHFFFAOYSA-N 0.000 description 1
- OLYAJRMBQUJXFD-UHFFFAOYSA-N C[BrH]c(cccc1Br)c1Br Chemical compound C[BrH]c(cccc1Br)c1Br OLYAJRMBQUJXFD-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- QPMBDFPAFFKDLN-UHFFFAOYSA-N Clc(cc1)cc(O2)c1-[n]1c(Br)nc3cccc2c13 Chemical compound Clc(cc1)cc(O2)c1-[n]1c(Br)nc3cccc2c13 QPMBDFPAFFKDLN-UHFFFAOYSA-N 0.000 description 1
- YAOOQROAADDEIJ-UHFFFAOYSA-N Clc(cc1)cc(Oc2ccc3)c1Nc2c3Br Chemical compound Clc(cc1)cc(Oc2ccc3)c1Nc2c3Br YAOOQROAADDEIJ-UHFFFAOYSA-N 0.000 description 1
- QCPLGVDMLXCVCP-UHFFFAOYSA-N Clc1cccc2c1nc(-c1ccccc1)[nH]2 Chemical compound Clc1cccc2c1nc(-c1ccccc1)[nH]2 QCPLGVDMLXCVCP-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- XQVWYOYUZDUNRW-UHFFFAOYSA-N N-Phenyl-1-naphthylamine Chemical group C=1C=CC2=CC=CC=C2C=1NC1=CC=CC=C1 XQVWYOYUZDUNRW-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- QHHIOQVDGHKVLD-UHFFFAOYSA-N Nc(cc1)ccc1-c1cc2c(cccc3)c3c(cccc3)c3c2cc1 Chemical compound Nc(cc1)ccc1-c1cc2c(cccc3)c3c(cccc3)c3c2cc1 QHHIOQVDGHKVLD-UHFFFAOYSA-N 0.000 description 1
- 101150003085 Pdcl gene Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- NRCMAYZCPIVABH-UHFFFAOYSA-N Quinacridone Chemical compound N1C2=CC=CC=C2C(=O)C2=C1C=C1C(=O)C3=CC=CC=C3NC1=C2 NRCMAYZCPIVABH-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910006404 SnO 2 Inorganic materials 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WXOQGOXTUJOXCA-UHFFFAOYSA-N [I].[Cu] Chemical compound [I].[Cu] WXOQGOXTUJOXCA-UHFFFAOYSA-N 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- YUENFNPLGJCNRB-UHFFFAOYSA-N anthracen-1-amine Chemical group C1=CC=C2C=C3C(N)=CC=CC3=CC2=C1 YUENFNPLGJCNRB-UHFFFAOYSA-N 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- YCOXTKKNXUZSKD-UHFFFAOYSA-N as-o-xylenol Natural products CC1=CC=C(O)C=C1C YCOXTKKNXUZSKD-UHFFFAOYSA-N 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- WZJYKHNJTSNBHV-UHFFFAOYSA-N benzo[h]quinoline Chemical group C1=CN=C2C3=CC=CC=C3C=CC2=C1 WZJYKHNJTSNBHV-UHFFFAOYSA-N 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 125000006616 biphenylamine group Chemical group 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ULWZFKSDBAAHEI-UHFFFAOYSA-N c(cc1)ccc1-c1nc(ncnc2)c2[nH]1 Chemical compound c(cc1)ccc1-c1nc(ncnc2)c2[nH]1 ULWZFKSDBAAHEI-UHFFFAOYSA-N 0.000 description 1
- PQUIJQZCMPYFMV-UHFFFAOYSA-N c1c(-c2nc3ccccc3[nH]2)[o]c(-c(cc2)cc3c2c(cccc2)c2c2c3cccc2)c1 Chemical compound c1c(-c2nc3ccccc3[nH]2)[o]c(-c(cc2)cc3c2c(cccc2)c2c2c3cccc2)c1 PQUIJQZCMPYFMV-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- XCJYREBRNVKWGJ-UHFFFAOYSA-N copper(II) phthalocyanine Chemical compound [Cu+2].C12=CC=CC=C2C(N=C2[N-]C(C3=CC=CC=C32)=N2)=NC1=NC([C]1C=CC=CC1=1)=NC=1N=C1[C]3C=CC=CC3=C2[N-]1 XCJYREBRNVKWGJ-UHFFFAOYSA-N 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000005266 diarylamine group Chemical group 0.000 description 1
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical group C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 1
- UZVGSSNIUNSOFA-UHFFFAOYSA-N dibenzofuran-1-carboxylic acid Chemical compound O1C2=CC=CC=C2C2=C1C=CC=C2C(=O)O UZVGSSNIUNSOFA-UHFFFAOYSA-N 0.000 description 1
- IYYZUPMFVPLQIF-ALWQSETLSA-N dibenzothiophene Chemical group C1=CC=CC=2[34S]C3=C(C=21)C=CC=C3 IYYZUPMFVPLQIF-ALWQSETLSA-N 0.000 description 1
- 125000005509 dibenzothiophenyl group Chemical group 0.000 description 1
- HARXPQAGQNXGGI-UHFFFAOYSA-N dibromomethanimine Chemical compound BrC(Br)=N HARXPQAGQNXGGI-UHFFFAOYSA-N 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical group C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- RBTKNAXYKSUFRK-UHFFFAOYSA-N heliogen blue Chemical compound [Cu].[N-]1C2=C(C=CC=C3)C3=C1N=C([N-]1)C3=CC=CC=C3C1=NC([N-]1)=C(C=CC=C3)C3=C1N=C([N-]1)C3=CC=CC=C3C1=N2 RBTKNAXYKSUFRK-UHFFFAOYSA-N 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- 229910003437 indium oxide Inorganic materials 0.000 description 1
- PJXISJQVUVHSOJ-UHFFFAOYSA-N indium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[In+3].[In+3] PJXISJQVUVHSOJ-UHFFFAOYSA-N 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000005921 isopentoxy group Chemical group 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VXWPONVCMVLXBW-UHFFFAOYSA-M magnesium;carbanide;iodide Chemical compound [CH3-].[Mg+2].[I-] VXWPONVCMVLXBW-UHFFFAOYSA-M 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- FGSIUBWPZRBMOC-UHFFFAOYSA-N methyl 2-amino-3-bromobenzoate Chemical compound COC(=O)C1=CC=CC(Br)=C1N FGSIUBWPZRBMOC-UHFFFAOYSA-N 0.000 description 1
- DJBLAZOEXVMLNX-UHFFFAOYSA-N methyl 3-bromo-6-fluoropyridine-2-carboxylate Chemical compound COC(=O)C1=NC(F)=CC=C1Br DJBLAZOEXVMLNX-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- RDSXVQDXXSPFHG-UHFFFAOYSA-N n-(4-bromophenyl)-4-phenylaniline Chemical compound C1=CC(Br)=CC=C1NC1=CC=C(C=2C=CC=CC=2)C=C1 RDSXVQDXXSPFHG-UHFFFAOYSA-N 0.000 description 1
- AMHSSMRZIPHUIJ-UHFFFAOYSA-N n-(4-bromophenyl)-9,9-dimethylfluoren-2-amine Chemical compound C1=C2C(C)(C)C3=CC=CC=C3C2=CC=C1NC1=CC=C(Br)C=C1 AMHSSMRZIPHUIJ-UHFFFAOYSA-N 0.000 description 1
- IBHBKWKFFTZAHE-UHFFFAOYSA-N n-[4-[4-(n-naphthalen-1-ylanilino)phenyl]phenyl]-n-phenylnaphthalen-1-amine Chemical group C1=CC=CC=C1N(C=1C2=CC=CC=C2C=CC=1)C1=CC=C(C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C3=CC=CC=C3C=CC=2)C=C1 IBHBKWKFFTZAHE-UHFFFAOYSA-N 0.000 description 1
- 125000006606 n-butoxy group Chemical group 0.000 description 1
- 125000001298 n-hexoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000006608 n-octyloxy group Chemical group 0.000 description 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005184 naphthylamino group Chemical group C1(=CC=CC2=CC=CC=C12)N* 0.000 description 1
- 125000005484 neopentoxy group Chemical group 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical group C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 229920002098 polyfluorene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920000128 polypyrrole Polymers 0.000 description 1
- 229920000123 polythiophene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- YYMBJDOZVAITBP-UHFFFAOYSA-N rubrene Chemical compound C1=CC=CC=C1C(C1=C(C=2C=CC=CC=2)C2=CC=CC=C2C(C=2C=CC=CC=2)=C11)=C(C=CC=C2)C2=C1C1=CC=CC=C1 YYMBJDOZVAITBP-UHFFFAOYSA-N 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 150000003413 spiro compounds Chemical class 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical group C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 125000003011 styrenyl group Chemical group [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 125000005649 substituted arylene group Chemical group 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 238000010345 tape casting Methods 0.000 description 1
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001935 tetracenyl group Chemical group C1(=CC=CC2=CC3=CC4=CC=CC=C4C=C3C=C12)* 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- TVIVIEFSHFOWTE-UHFFFAOYSA-K tri(quinolin-8-yloxy)alumane Chemical compound [Al+3].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 TVIVIEFSHFOWTE-UHFFFAOYSA-K 0.000 description 1
- 125000005259 triarylamine group Chemical group 0.000 description 1
- 150000003852 triazoles Chemical group 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000006617 triphenylamine group Chemical group 0.000 description 1
- 125000005580 triphenylene group Chemical group 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- YVTHLONGBIQYBO-UHFFFAOYSA-N zinc indium(3+) oxygen(2-) Chemical compound [O--].[Zn++].[In+3] YVTHLONGBIQYBO-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
- H05B33/00—Electroluminescent light sources
- H05B33/12—Light sources with substantially two-dimensional radiating surfaces
- H05B33/14—Light sources with substantially two-dimensional radiating surfaces characterised by the chemical or physical composition or the arrangement of the electroluminescent material, or by the simultaneous addition of the electroluminescent material in or onto the light source
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02B—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO BUILDINGS, e.g. HOUSING, HOUSE APPLIANCES OR RELATED END-USER APPLICATIONS
- Y02B20/00—Energy efficient lighting technologies, e.g. halogen lamps or gas discharge lamps
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Electroluminescent Light Sources (AREA)
Abstract
Description
본 발명은 유기발광 화합물에 관한 것으로서, 보다 구체적으로는 유기전계발광소자의 발광층 호스트 화합물 또는 정공수송 재료로 채용되는 유기발광 화합물 및 이를 채용하여 장수명 및 발광 효율이 현저히 향상된 유기전계발광소자에 관한 것이다.BACKGROUND OF THE
유기전계발광소자는 투명 기판 위에도 소자를 형성할 수 있을 뿐 아니라, 플라즈마 디스플레이 패널(Plasma Display Panel)이나 무기 전계 발광(EL) 디스플레이에 비해 10 V 이하의 저전압 구동이 가능하고, 전력 소모가 비교적 적으며, 색감이 뛰어나다는 장점이 있고, 녹색, 청색, 적색의 3가지 색을 나타낼 수가 있어 최근에 차세대 디스플레이 소자로 많은 관심의 대상이 되고 있다.The organic electroluminescent device can not only form an element on a transparent substrate but also can operate at a low voltage of 10 V or less as compared with a plasma display panel (Plasma Display Panel) or an inorganic electroluminescence (EL) display, It has the advantage of excellent color and has three colors of green, blue, and red. It has recently become a subject of interest as a next generation display device.
다만, 이러한 유기전계발광소자가 상기와 같은 특징으로 발휘하기 위해서는 소자 내 유기층을 이루는 물질인 정공주입 물질, 정공수송 물질, 발광 물질, 전자수송 물질, 전자주입 물질 등이 안정하고 효율적인 재료에 의하여 뒷받침되는 것이 선행되어야 하나, 아직까지는 안정하고 효율적인 유기 전계발광 소자자용 유기물층 재료의 개발이 충분히 이루어지지 않은 상태이다. 따라서, 저전압 구동, 고효율 및 장수명을 갖는 새로운 재료의 개발이 계속 요구되고 있는 실정이다.However, in order for such an organic electroluminescent device to exhibit such characteristics, a hole injecting material, a hole transporting material, a light emitting material, an electron transporting material, and an electron injecting material, which are materials forming an organic layer in a device, However, until now, stable and efficient development of an organic layer material for an organic electroluminescence element has not been sufficiently developed yet. Therefore, there is a continuing demand for development of new materials having low-voltage driving, high efficiency and long life.
특히, 종래 정공수송 재료로 구리 프탈로시아닌(CuPc), MTDATA, 4,4'-비스[N-(1-나프틸)-N-페닐아미노]바이페닐(NPB), N,N'-다이페닐-N,N'-비스(3-메틸페닐)-(1,1'-바이페닐)-4,4'-다이아민(TPD) 등이 알려져 있으나, 이를 소자에 채용시 효율 및 수명이 저하되는 문제가 있고, 이를 개량하기 위하여 다양한 치환기를 갖는 아릴아민계 화합물에 대해서 개발되고 있으나, 여전히 효율과 장수명을 동시에 충족시키기에는 충분하지 않은 문제점을 갖고 있다.In particular, conventional hole transport materials include copper phthalocyanine (CuPc), MTDATA, 4,4'-bis [N- (1-naphthyl) -N- phenylamino] biphenyl (NPB), N, N, N'-bis (3-methylphenyl) - (1,1'-biphenyl) -4,4'-diamine (TPD) has been known. However, Based compound having various substituents in order to improve it, but it still has a problem that it is not enough to satisfy efficiency and long life at the same time.
또한, 유기 발광 소자에서 발광효율을 결정하는 가장 중요한 요인은 발광 재료이다. 발광 재료로는 현재 형광 재료가 널리 사용되고 있으나, 발광 메커니즘 상 인광 재료의 개발이 이론적으로 발광 효율을 보다 개선시킬 수 있는 방법 중의 하나이고, 이에 따라 현재까지 다양한 인광 재료에 대해서 개발이 이루어지고 있으며, 특히 인광 발광 호스트 재료로는 현재까지 CBP가 가장 널리 알려져 있고, BALq 유도체를 호스트로 이용한 유기 발광 소자가 공지되어 있다.Further, the most important factor for determining the luminous efficiency in an organic light emitting device is a light emitting material. However, the development of a phosphorescent material on a light-emitting mechanism is one of the ways that the luminous efficiency can be improved more theoretically. Accordingly, a variety of phosphorescent materials have been developed to date, In particular, CBP is the most widely known phosphorescent host material, and an organic light emitting device using a BALq derivative as a host is known.
그러나, 인광 발광 재료를 사용한 유기 발광 소자는 형광 발광 재료를 사용한 소자에 비해 전류 효율이 상당히 높으나, 인광 발광 재료의 호스트로 BAlq, CBP 등의 재료를 사용할 경우, 형광재료를 사용한 소자에 비해 구동 전압이 높아서 전력 효율면에서 큰 이점이 없고, 또한, 소자의 수명 측면에서도 만족할만한 수준이 되질 못하여 더욱 안정적이고, 고성능의 호스트 재료의 개발이 요구되고 있다.However, in the case of using a material such as BAlq or CBP as a host of a phosphorescent material, the organic electroluminescent device using the phosphorescent material has a higher current efficiency than the device using the fluorescent material, There is no great advantage in terms of power efficiency, and the life of the device can not be satisfactory. Thus, development of a more stable and high-performance host material is required.
본 발명은 유기전계발광소자의 발광층 또는 정공주입층 내지 정공수송층에 채용되어 우수한 발광 특성을 구현할 수 있는 신규한 유기발광 화합물 및 이를 포함하는 유기전계발광소자를 제공하고자 한다.The present invention provides a novel organic electroluminescent compound which can be used for a light emitting layer, a hole injecting layer, and a hole transporting layer of an organic electroluminescent device to realize excellent luminescent characteristics, and an organic electroluminescent device including the same.
본 발명은 상기 과제를 해결하기 위하여, 하기 [화학식 1]로 표시되는 코어 골격에 하기 [구조식 1] 또는 [구조식 2]를 치환체로 갖는 것을 특징으로 하는 유기발광 화합물 및 이를 포함하는 유기전계발광소자를 제공한다.In order to solve the above problems, the present invention provides an organic electroluminescent compound having as a substituent the following
[화학식 1][Chemical Formula 1]
[구조식 1][Structural formula 1]
[구조식 2][Structural formula 2]
상기 [화학식 1] 및 [구조식 1] 내지 [구조식 2]에 따른 유기발광 화합물의 구체적인 구조 및 치환기에 대해서는 후술한다.The specific structures and substituents of the organic luminescent compounds according to the above formulas (1) and (1) to (2) will be described later.
본 발명에 따른 유기발광 화합물은 구조 평판도가 우수하고, 높은 삼중항(triplet) 상태를 가져서 종래 인광 호스트 화합물이나 정공수송 화합물에 비하여 보다 향상된 발광 효율과 장수명 특성의 구현이 가능하여 이를 채용한 유기전계발광소자는 다양한 디스플레이 소자에 유용하여 사용될 수 있다.The organic luminescent compound according to the present invention has an excellent structure flatness and a high triplet state, which enables to realize a luminescent efficiency and a longevity characteristic which are higher than those of conventional phosphorescent host compounds and hole transport compounds, The light emitting device can be used for various display devices.
도 1 내지 5는 본 발명의 일 실시예에 따른 유기전계발광소자의 구조를 예시한 단면도이다.1 to 5 are cross-sectional views illustrating the structure of an organic electroluminescent device according to an embodiment of the present invention.
이하, 본 발명을 보다 구체적으로 설명한다.Hereinafter, the present invention will be described more specifically.
본 발명은 하기 [화학식 1]로 표시되는 신규한 유기발광 화합물에 관한 것이다.The present invention relates to a novel organic luminescent compound represented by the following formula (1).
[화학식 1][Chemical Formula 1]
상기 [화학식 1]에서, X1 내지 X10은 각각 독립적으로 N 또는 CR1이고, X11은 단일결합이거나, CR2R3, CR4, NR5, PR6, SiR7R8, O 및 S 중에서 선택되는 것을 특징으로 한다.Wherein X 1 to X 10 are each independently N or CR 1 and X 11 is a single bond or CR 2 R 3 , CR 4 , NR 5 , PR 6 , SiR 7 R 8 , O and S, < / RTI >
상기 R1 내지 R8은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 비치환된 탄소수 2 내지 30의 알케닐기, 치환 또는 비치환된 탄소수 2 내지 30의 알키닐기, 치환 또는 비치환된 탄소수 3 내지30의 시클로알킬기, 치환 또는 비치환된 탄소수 2 내지 30의 헤테로시클로알킬기, 치환 또는 비치환된 탄소수 5 내지 30의 시클로알케닐기, 치환 또는 비치환된 탄소수 1 내지 30의 알콕시기, 치환 또는 비치환된 탄소수 6 내지 30의 아릴옥시기, 치환 또는 비치환된 탄소수 1 내지 30의 알킬티옥시기, 치환 또는 비치환된 탄소수 5 내지 30의 아릴티옥시기, 치환 또는 비치환된 탄소수 1 내지 30의 알킬아민기, 치환 또는 비치환된 탄소수 5 내지 30의 아릴아민기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환된 탄소수 3 내지 50의 헤테로아릴기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기, 치환 또는 비치환된 실릴기, 아미노기, 싸이올기, 시아노기, 히드록시기, 니트로기 및 할로겐기로 이루어진 군에서 선택된다.Each of R 1 to R 8 is independently selected from the group consisting of hydrogen, deuterium, a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 30 carbon atoms, a substituted or unsubstituted alkoxy group having 2 to 30 carbon atoms A substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms, a substituted or unsubstituted heterocycloalkyl group having 2 to 30 carbon atoms, a substituted or unsubstituted cycloalkenyl group having 5 to 30 carbon atoms, a substituted or unsubstituted C1- A substituted or unsubstituted C1 to C30 alkoxy group, a substituted or unsubstituted C6 to C30 aryloxy group, a substituted or unsubstituted C1 to C30 alkylthio group, a substituted or unsubstituted C1 to C30 arylthio group, An unsubstituted alkylamine group having 1 to 30 carbon atoms, a substituted or unsubstituted arylamine group having 5 to 30 carbon atoms, a substituted or unsubstituted aryl group having 5 to 50 carbon atoms, A substituted or unsubstituted aryl group having 5 to 50 carbon atoms, a substituted or unsubstituted C3 to C30 cycloalkyl having 3 to 30 carbon atoms, a substituted or unsubstituted C3 to C30 heteroaryl group, a substituted or unsubstituted C3 to C30 cycloalkyl, A substituted or unsubstituted heteroaryl group having 2 to 50 carbon atoms, a substituted or unsubstituted silyl group, an amino group, a thiol group, a cyano group, a hydroxyl group, a nitro group and a halogen group.
또한, 상기 R1 내지 R8 중 인접한 치환기는 서로 연결되어 지환족, 방향족의 단일환 또는 다환 고리를 형성할 수 있으며, 상기 형성된 지환족, 방향족의 단일환 또는 다환 고리의 탄소원자는 N, S 및 O 중에서 선택되는 어느 하나 이상의 헤테로원자로 치환될 수 있다.The adjacent substituents of R 1 to R 8 may be connected with each other to form a monocyclic or polycyclic ring of an alicyclic or aromatic group and the carbon atom of the monocyclic or aromatic monocyclic or polycyclic ring formed may be N, Lt; / RTI > may be substituted with any one or more heteroatoms selected from < RTI ID = 0.0 >
또한, 상기 R1 내지 R8은 각각 1종 이상의 치환기로 더 치환될 수 있고, 상기 1종 이상의 치환기는 중수소, 시아노기, 할로겐기, 히드록시기, 니트로기, 탄소수 1 내지 24의 알킬기, 탄소수 1 내지 24의 할로겐화된 알킬기, 탄소수 1 내지 24의 알케닐기, 탄소수 1 내지 24의 알키닐기, 탄소수 1 내지 24의 헤테로알킬기, 탄소수 6 내지 24의 아릴기, 탄소수 6 내지 24의 아릴알킬기, 탄소수 2 내지 24의 헤테로아릴기, 또는 탄소수 2 내지 24의 헤테로아릴알킬기, 탄소수 1 내기 24의 알콕시기, 탄소수 1 내지 24의 알킬아미노기, 탄소수 1 내지 24의 아릴아미노기, 탄소수 1 내지 24의 헤테로아릴아미노기, 탄소수 1 내지 24의 알킬실릴기, 탄소수 1 내지 24의 아릴실릴기 및 탄소수 1 내지 24의 아릴옥시기로 이루어진 군에서 선택된다.
Each of R 1 to R 8 may further be substituted with at least one substituent, and the at least one substituent may be substituted with at least one substituent selected from the group consisting of deuterium, cyano group, halogen group, hydroxyl group, nitro group, An alkyl group having 1 to 24 carbon atoms, an alkenyl group having 1 to 24 carbon atoms, an alkynyl group having 1 to 24 carbon atoms, a heteroalkyl group having 1 to 24 carbon atoms, an aryl group having 6 to 24 carbon atoms, an arylalkyl group having 6 to 24 carbon atoms, A heteroaryl group having 2 to 24 carbon atoms, an alkoxy group having 1 to 24 carbon atoms, an alkylamino group having 1 to 24 carbon atoms, an arylamino group having 1 to 24 carbon atoms, a heteroarylamino group having 1 to 24 carbon atoms, a heteroarylamino group having 1 to 24 carbon atoms, An alkylsilyl group having 1 to 24 carbon atoms, an arylsilyl group having 1 to 24 carbon atoms, and an aryloxy group having 1 to 24 carbon atoms.
본 발명에 따른 [화학식 1]의 유기발광 화합물은 하기 [화학식 2] 내지 [화학식 17] 중에서 선택되는 어느 하나일 수 있다.The organic electroluminescent compound of Formula 1 according to the present invention may be any one selected from the following
상기 [화학식 2] 내지 [화학식 17]에서, X1 내지 X11의 정의는 상기 [화학식 1]에서의 정의와 동일하다.In the above formulas (2) to (17), the definitions of X 1 to X 11 are as defined in the above formula (1).
또한, 상기 X1 내지 X11의 각 치환기는 인접한 치환기와 서로 연결되어 지환족, 방향족의 단일환 또는 다환 고리를 형성할 수 있으며, 상기 형성된 지환족, 방향족의 단일환 또는 다환 고리의 탄소원자는 N, S 및 O 중에서 선택되는 어느 하나 이상의 헤테로원자로 치환될 수 있다.
Each of the substituents of X 1 to X 11 may be connected to adjacent substituents to form a monocyclic or polycyclic ring of an alicyclic or aromatic group, and the carbon atom of the formed alicyclic or aromatic monocyclic or polycyclic ring may be N , S and < RTI ID = 0.0 > O, < / RTI >
또한, 본 발명은 상기 [화학식 2] 내지 [화학식 17]에서 보는 바와 같은 코어 골격에 특징적인 치환체를 갖는 것을 특징으로 한다.In addition, the present invention is characterized by having a substituent characteristic of the core skeleton as shown in the above formulas (2) to (17).
먼저, [화학식 1] 내지 [화학식 17]에서, 상기 X2 내지 X6 중 적어도 하나 이상은 CR3이고, 상기 *-R3는 하기 [구조식 1]인 것을 특징으로 하고, 상기와 같은 코어 골격에 하기 [구조식 1]의 치환기를 적어도 하나 이상 포함하여 분자 구조 평판도가 매우 우수하고 삼중항 에너지가 높아 특히, 정공수송 재료로 활용될 수 있다.At least one of X 2 to X 6 in the formulas (1) to (17) is CR 3 , and * -R 3 is represented by the following structural formula (1) Has at least one substituent of the following
[구조식 1][Structural formula 1]
[구조식 1]에서,In the
L1은 치환 또는 비치환된 탄소수 1 내지 30의 알킬렌기, 치환 또는 비치환된 탄소수 2 내지 30의 알케닐렌기, 치환 또는 비치환된 탄소수 2 내지 30의 알키닐렌기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬렌기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴렌기, 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴렌기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 5 내지 50의 아릴렌기 및 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴렌기 중에서 선택된다.L 1 is a substituted or unsubstituted alkylene group having 1 to 30 carbon atoms, a substituted or unsubstituted aliphatic hydrocarbon group having 2 to 30 carbon atoms A substituted or unsubstituted C2-C30 alkynylene group, a substituted or unsubstituted C3-C30 A substituted or unsubstituted C2 to C30 heteroarylene group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C50 arylene group, a substituted or unsubstituted C2 to C30 heteroarylene group, A substituted or unsubstituted heteroarylene group having 2 to 50 carbon atoms in which at least one unsubstituted or substituted unsubstituted arylene group having 5 to 50 carbon atoms and a substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms is fused.
n은 0 내지 4의 정수이고, n이 2 이상인 경우, 복수 개의 L1은 서로 동일하거나 상이할 수 있다.n is an integer of 0 to 4, and when n is 2 or more, a plurality of L 1 may be the same or different from each other.
Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 5 내지 50의 아릴기 및 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기 중에서 선택된다.Ar 1 and Ar 2 are the same or different and each independently represents a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms, a substituted or unsubstituted group having 5 to 50 carbon atoms A substituted or unsubstituted aryl group, a substituted or unsubstituted C2 to C50 heteroaryl group, a substituted or unsubstituted C3 to C30 cycloalkyl substituted or unsubstituted aryl group having 5 to 50 carbon atoms, And a substituted or unsubstituted C2 to C50 heteroaryl group in which one or more ring-opened cycloalkyl having 3 to 30 carbon atoms is fused.
또한, 상기 Ar1 및 Ar2는 서로 결합하거나 인접한 치환기와 연결되어 지환족, 방향족의 단일환 또는 다환 고리를 형성할 수 있으며, 상기 형성된 지환족, 방향족의 단일환 또는 다환 고리의 탄소원자는 N, S 및 O 중에서 선택되는 어느 하나 이상의 헤테로원자로 치환될 수 있다.Ar 1 and Ar 2 may be bonded to each other or may be connected to adjacent substituents to form a monocyclic or polycyclic ring of an alicyclic or aromatic group. The carbon atom of the formed alicyclic or aromatic monocyclic or polycyclic ring may be N, S and < RTI ID = 0.0 > O, < / RTI >
p는 0 내지 3이 정수이고, 상기 p가 2 이상인 경우 복수의 *-( )는 서로 동일하거나 상이할 수 있다.p is an integer of 0 to 3, and when p is 2 or more, a plurality of * - () may be the same or different from each other.
또한, 상기 L1, Ar1 및 Ar2는 각각 1종 이상의 치환기로 더 치환될 수 있고, 상기 1종 이상의 치환기는 중수소, 시아노기, 할로겐기, 히드록시기, 니트로기, 탄소수 1 내지 24의 알킬기, 탄소수 1 내지 24의 할로겐화된 알킬기, 탄소수 1 내지 24의 알케닐기, 탄소수 1 내지 24의 알키닐기, 탄소수 1 내지 24의 헤테로알킬기, 탄소수 6 내지 24의 아릴기, 탄소수 6 내지 24의 아릴알킬기, 탄소수 2 내지 24의 헤테로아릴기, 또는 탄소수 2 내지 24의 헤테로아릴알킬기, 탄소수 1 내기 24의 알콕시기, 탄소수 1 내지 24의 알킬아미노기, 탄소수 1 내지 24의 아릴아미노기, 탄소수 1 내지 24의 헤테로아릴아미노기, 탄소수 1 내지 24의 알킬실릴기, 탄소수 1 내지 24의 아릴실릴기 및 탄소수 1 내지 24의 아릴옥시기로 이루어진 군에서 선택된다.
Further, L 1, Ar 1 and Ar 2 each may be further substituted with one or more substituents, the one or more substituents are deuterium, a cyano group, an alkyl group, a halogen group, a hydroxyl group, a nitro group, having 1 to 24 carbon atoms, A halogenated alkyl group having 1 to 24 carbon atoms, an alkenyl group having 1 to 24 carbon atoms, an alkynyl group having 1 to 24 carbon atoms, a heteroalkyl group having 1 to 24 carbon atoms, an aryl group having 6 to 24 carbon atoms, an arylalkyl group having 6 to 24 carbon atoms, A heteroaryl group having 2 to 24 carbon atoms, a heteroarylalkyl group having 2 to 24 carbon atoms, an alkoxy group having 24 carbon atoms, an alkylamino group having 1 to 24 carbon atoms, an arylamino group having 1 to 24 carbon atoms, a heteroarylamino group having 1 to 24 carbon atoms , An alkylsilyl group having 1 to 24 carbon atoms, an arylsilyl group having 1 to 24 carbon atoms, and an aryloxy group having 1 to 24 carbon atoms.
다음으로, [화학식 1] 내지 [화학식 17]에서, 상기 X2 내지 X10 중 하나 이상은 CR3이고, 상기 *-R3는 하기 [구조식 2]인 것을 특징으로 하고, 상기와 같은 코어 골격에 하기 [구조식 2]의 치환기를 적어도 하나 이상 포함하여 분자 구조 평판도가 매우 우수하고 삼중항 에너지가 높아 특히, 발광층의 인광 호스트 화합물로 활용될 수 있다.In the formulas (1) to (17), at least one of X 2 to X 10 is CR 3 , and * -R 3 is [Structural Formula 2] Has at least one substituent of the following formula [2] and has a very high molecular structure flatness and a high triplet energy, so that it can be used as a phosphorescent host compound in a light emitting layer.
[구조식 2][Structural formula 2]
상기 [구조식 2]에서,In the
L2는 치환 또는 비치환된 탄소수 1 내지 30의 알킬렌기, 치환 또는 비치환된 탄소수 2 내지 30의 알케닐렌기, 치환 또는 비치환된 탄소수 2 내지 30의 알키닐렌기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬렌기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴렌기, 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴렌기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 5 내지 50의 아릴렌기 및 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴렌기 중에서 선택된다.L 2 is a substituted or unsubstituted alkylene group having 1 to 30 carbon atoms, a substituted or unsubstituted alkylene group having 2 to 30 carbon atoms A substituted or unsubstituted C2-C30 alkynylene group, a substituted or unsubstituted C3-C30 A substituted or unsubstituted C2 to C30 heteroarylene group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C50 arylene group, a substituted or unsubstituted C2 to C30 heteroarylene group, A substituted or unsubstituted heteroarylene group having 2 to 50 carbon atoms in which at least one unsubstituted or substituted unsubstituted arylene group having 5 to 50 carbon atoms and a substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms is fused.
m은 0 내지 4의 정수이고, m이 2 이상인 경우, 복수 개의 L2는 서로 동일하거나 상이할 수 있다.m is an integer of 0 to 4, and when m is 2 or more, a plurality of L 2 may be the same or different from each other.
Ar3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 5 내지 50의 아릴기 및 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기 중에서 선택된다.And Ar 3 are the same or different and each independently represents a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms, a substituted or unsubstituted aryl group having 5 to 50 carbon atoms, A substituted or unsubstituted C2 to C50 heteroaryl group, a substituted or unsubstituted C3 to C30 heteroaryl group, a substituted or unsubstituted C6 to C30 heteroaryl group, a substituted or unsubstituted C3 to C30 cycloalkyl, And a substituted or unsubstituted C2 to C50 heteroaryl group in which at least one of 3 to 30 cycloalkyls is fused.
또한, q는 0 내지 3이 정수이고, 상기 q가 2 이상인 경우 복수의 Ar3는 서로 동일하거나 상이할 수 있고, 상기 복수의 Ar3 및 이의 치환기는 인접한 치환기와 연결되어 지환족, 방향족의 단일환 또는 다환 고리를 형성할 수 있으며, 상기 형성된 지환족, 방향족의 단일환 또는 다환 고리의 탄소원자는 N, S 및 O 중에서 선택되는 어느 하나 이상의 헤테로원자로 치환될 수 있다.And q is an integer of 0 to 3, and when q is 2 or more, a plurality of Ar 3 may be the same or different from each other, and the plurality of Ar 3 and the substituent thereof may be linked to adjacent substituents to form alicyclic or aromatic groups And a carbon atom of the formed alicyclic or aromatic monocyclic or polycyclic ring may be substituted with any one or more heteroatoms selected from N, S and O.
또한, 상기 L2 및 Ar3는 각각 1종 이상의 치환기로 더 치환될 수 있고, 상기 1종 이상의 치환기는 중수소, 시아노기, 할로겐기, 히드록시기, 니트로기, 탄소수 1 내지 24의 알킬기, 탄소수 1 내지 24의 할로겐화된 알킬기, 탄소수 1 내지 24의 알케닐기, 탄소수 1 내지 24의 알키닐기, 탄소수 1 내지 24의 헤테로알킬기, 탄소수 6 내지 24의 아릴기, 탄소수 6 내지 24의 아릴알킬기, 탄소수 2 내지 24의 헤테로아릴기, 또는 탄소수 2 내지 24의 헤테로아릴알킬기, 탄소수 1 내기 24의 알콕시기, 탄소수 1 내지 24의 알킬아미노기, 탄소수 1 내지 24의 아릴아미노기, 탄소수 1 내지 24의 헤테로아릴아미노기, 탄소수 1 내지 24의 알킬실릴기, 탄소수 1 내지 24의 아릴실릴기 및 탄소수 1 내지 24의 아릴옥시기로 이루어진 군에서 선택된다.
Each of L 2 and Ar 3 may be further substituted with one or more substituents. The substituent may be one or more substituents selected from the group consisting of deuterium, cyano, halogen, hydroxy, nitro, alkyl having 1 to 24 carbon atoms, An alkyl group having 1 to 24 carbon atoms, an alkenyl group having 1 to 24 carbon atoms, an alkynyl group having 1 to 24 carbon atoms, a heteroalkyl group having 1 to 24 carbon atoms, an aryl group having 6 to 24 carbon atoms, an arylalkyl group having 6 to 24 carbon atoms, A heteroaryl group having 2 to 24 carbon atoms, an alkoxy group having 1 to 24 carbon atoms, an alkylamino group having 1 to 24 carbon atoms, an arylamino group having 1 to 24 carbon atoms, a heteroarylamino group having 1 to 24 carbon atoms, a heteroarylamino group having 1 to 24 carbon atoms, An alkylsilyl group having 1 to 24 carbon atoms, an arylsilyl group having 1 to 24 carbon atoms, and an aryloxy group having 1 to 24 carbon atoms.
본 발명에 있어서, 상기 치환기들의 예시들에 대해서 아래에서 구체적으로 설명하나, 이에 한정되는 것은 아니다.In the present invention, examples of the substituents will be specifically described below, but the present invention is not limited thereto.
본 발명에 있어서, 상기 알킬기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나 1 내지 50인 것이 바람직하다. 구체적인 예로는 메틸기, 에틸기, 프로필기, n-프로필기, 이소프로필기, 부틸기, n-부틸기, 이소부틸기, tert-부틸기, sec-부틸기, 1-메틸-부틸기, 1-에틸-부틸기, 펜틸기, n-펜틸기, 이소펜틸기, 네오펜틸기, tert-펜틸기, 헥실기, n-헥실기, 1-메틸펜틸기, 2-메틸펜틸기, 4-메틸-2-펜틸기, 3,3-디메틸부틸기, 2-에틸부틸기, 헵틸기, n-헵틸기, 1-메틸헥실기, 시클로펜틸메틸기, 시클로헥틸메틸기, 옥틸기, n-옥틸기, tert-옥틸기, 1-메틸헵틸기, 2-에틸헥실기, 2-프로필펜틸기, n-노닐기, 2,2-디메틸헵틸기, 1-에틸-프로필기, 1,1-디메틸-프로필기, 이소헥실기, 2-메틸펜틸기, 4-메틸헥실기, 5-메틸헥실기 등이 있으나, 이들에 한정되지 않는다.In the present invention, the alkyl group may be linear or branched, and the number of carbon atoms is not particularly limited, but is preferably 1 to 50. Specific examples include methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, Ethyl, propyl, isopropyl, n-butyl, isobutyl, isobutyl, isobutyl, A tert-butyl group, a tert-butyl group, a 2-pentyl group, a 3,3-dimethylbutyl group, a 2-ethylbutyl group, a heptyl group, Ethylhexyl group, 2-propylpentyl group, n-nonyl group, 2,2-dimethylheptyl group, 1-ethyl-propyl group, 1,1-dimethyl-propyl group , Isohexyl group, 2-methylpentyl group, 4-methylhexyl group, 5-methylhexyl group and the like, but are not limited thereto.
본 발명에 있어서, 알콕시기는 직쇄 또는 분지쇄일 수 있다. 알콕시기의 탄소수는 특별히 한정되지 않으나, 입체적 방해를 주지 않는 범위인 1 내지 30개인 것이 바람직하다. 구체적으로, 메톡시기, 에톡시기, n-프로폭시기, 이소프로폭시기, i-프로필옥시기, n-부톡시기, 이소부톡시기, tert-부톡시기, sec-부톡시기, n-펜틸옥시기, 네오펜틸옥시기, 이소펜틸옥시기, n-헥실옥시기, 3,3-디메틸부틸옥시기, 2-에틸부틸옥시기, n-옥틸옥시기, n-노닐옥시기, n-데실옥시기, 벤질옥시기, p-메틸벤질옥시기 등이 될 수 있으나, 이에 한정되는 것은 아니다.In the present invention, the alkoxy group may be linear or branched. The number of carbon atoms of the alkoxy group is not particularly limited, but is preferably in the range of 1 to 30, which does not cause steric hindrance. Specific examples thereof include a methoxy group, an ethoxy group, an n-propoxy group, an isopropoxy group, an i-propyloxy group, a n-butoxy group, an isobutoxy group, a tert- , Neopentyloxy group, isopentyloxy group, n-hexyloxy group, 3,3-dimethylbutyloxy group, 2-ethylbutyloxy group, n-octyloxy group, n- , A benzyloxy group, a p-methylbenzyloxy group, and the like, but are not limited thereto.
본 발명에 있어서, 상기 알케닐기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나, 2 내지 40인 것이 바람직하다. 구체적인 예로는 비닐기, 1-프로페닐기, 이소프로페닐기, 1-부테닐기, 2-부테닐기, 3-부테닐기, 1-펜테닐기, 2-펜테닐기, 3-펜테닐기, 3-메틸-1-부테닐기, 1,3-부타디에닐기, 알릴기, 1-페닐비닐-1-일기, 2-페닐비닐-1-일기, 2,2-디페닐비닐-1-일기, 2-페닐-2-(나프틸-1-일)비닐-1-일기, 2,2-비스(디페닐-1-일)비닐-1-일기, 스틸베닐기, 스티레닐기 등이 있으나 이들에 한정되지 않는다.In the present invention, the alkenyl group may be straight-chain or branched, and the number of carbon atoms is not particularly limited, but is preferably 2 to 40. Specific examples include a vinyl group, a 1-propenyl group, an isopropenyl group, a 1-butenyl group, a 2-butenyl group, a 3-butenyl group, a 1-pentenyl group, a 2-pentenyl group, a 3-pentenyl group, 2-phenylvinyl-1-yl group, 2,2-diphenylvinyl-1-yl group, 2-phenyl-2-yl group, But are not limited to, - (naphthyl-1-yl) vinyl-1-yl group, 2,2-bis (diphenyl-1-yl) vinyl-1-yl group, stilbenyl group, styrenyl group and the like.
본 발명에 있어서, 아릴기는 단환식 또는 다환식일 수 있고, 탄소수는 특별히 한정되지 않으나 6 내지 60인 것이 바람직하다. 단환식 아릴기의 예로는 페닐기, 비페닐기, 터페닐기, 스틸벤기 등이 있고, 다환식 아릴기의 예로는 나프틸기, 안트라세닐기, 페난트레닐기, 파이레닐기, 페릴레닐기, 테트라세닐기, 크라이세닐기, 플루오레닐기, 아세나프타센닐기, 트리페닐렌기, 플루오안트렌(fluoranthrene)기 등이 있으나, 본 발명의 범위가 이들 예로만 한정되는 것은 아니다.In the present invention, the aryl group may be monocyclic or polycyclic, and the number of carbon atoms is not particularly limited, but is preferably 6 to 60. [ Examples of the monocyclic aryl group include a phenyl group, a biphenyl group, a terphenyl group and a stilbene group. Examples of the polycyclic aryl group include a naphthyl group, an anthracenyl group, a phenanthrenyl group, a pyrenyl group, a perylenyl group, , A chlorenyl group, a fluorenyl group, an acenaphthacenyl group, a triphenylene group, and a fluororanthrene group, but the scope of the present invention is not limited to these examples.
본 발명에 있어서, 헤테로고리기는 이종원자로 O, N 또는 S를 포함하는 헤테로고리기로서, 탄소수는 특별히 한정되지 않으나 탄소수 2 내지 60인 것이 바람직하다. 헤테로고리기의 예로는 티오펜기, 퓨란기, 피롤기, 이미다졸기, 티아졸기, 옥사졸기, 옥사디아졸기, 트리아졸기, 피리딜기, 비피리딜기, 피리미딜기, 트리아진기, 트리아졸기, 아크리딜기, 피리다진기, 피라지닐기, 퀴놀리닐기, 퀴나졸린기, 퀴녹살리닐기, 프탈라지닐기, 피리도 피리미디닐기, 피리도 피라지닐기, 피라지노 피라지닐기, 이소퀴놀린기, 인돌기, 카바졸기, 벤조옥사졸기, 벤조이미다졸기, 벤조티아졸기, 벤조카바졸기, 벤조티오펜기, 디벤조티오펜기, 벤조퓨라닐기, 디벤조퓨라닐기, 페난트롤린기, 티아졸릴기, 이소옥사졸릴기, 옥사디아졸릴기, 티아디아졸릴기, 벤조티아졸릴기, 페노티아지닐기 등이 있으나, 이들에만 한정되는 것은 아니다.In the present invention, the heterocyclic group is a heterocyclic group containing O, N or S as a heteroatom, and the number of carbon atoms is not particularly limited, but is preferably 2 to 60 carbon atoms. Examples of the heterocyclic group include a thiophene group, a furane group, a furyl group, an imidazole group, a thiazole group, an oxazole group, an oxadiazole group, a triazole group, a pyridyl group, a bipyridyl group, a pyrimidyl group, A pyridazinyl group, a pyrazinopyrazinyl group, an isoquinoline group, an isoquinolinyl group, an isoquinolinyl group, an isoquinolinyl group, an isoquinolinyl group, an isoquinolyl group, , An indole group, a carbazole group, a benzoxazole group, a benzoimidazole group, a benzothiazole group, a benzocarbazole group, a benzothiophene group, a dibenzothiophene group, a benzofuranyl group, a dibenzofurancyl group, a phenanthroline group, An isothiazolyl group, an isoxazolyl group, an oxadiazolyl group, a thiadiazolyl group, a benzothiazolyl group, a phenothiazinyl group and the like, but is not limited thereto.
본 발명에 있어서, 아릴옥시기, 아릴티옥시기, 아릴술폭시기 및 아랄킬아민기 중의 아릴기는 전술한 아릴기의 예시와 같다. 구체적으로 아릴옥시기로는 페녹시기, p-토릴옥시기, m-토릴옥시기, 3,5-디메틸-페녹시기, 2,4,6-트리메틸페녹시기, ptert-부틸페녹시기, 3-비페닐옥시기, 4-비페닐옥시기, 1-나프틸옥시기, 2-나프틸옥시기, 4-메틸-1-나프틸옥시기, 5-메틸-2-나프틸옥시기, 1-안트릴옥시기, 2-안트릴옥시기, 9-안트릴옥시기, 1-페난트릴옥시기, 3-페난트릴옥시기, 9-페난트릴옥시기 등이 있고, 아릴티옥시기로는 페닐티옥시기기, 2-메틸페닐티옥시기, 4-tert-부틸페닐티옥시기 등이 있으며, 아릴술폭시기로는 벤젠술폭시기, p-톨루엔술폭시기 등이 있으나, 이에 한정되지 않는다.In the present invention, the aryl group in the aryloxy group, arylthioxy group, arylsulfoxy group and aralkylamine group is the same as the aforementioned aryl group. Specific examples of the aryloxy group include a phenoxy group, a p-tolyloxy group, an m-tolyloxy group, a 3,5-dimethyl-phenoxy group, a 2,4,6-trimethylphenoxy group, a ptert- Anthryloxy group, 2-naphthyloxy group, 2-naphthyloxy group, 4-methyl-1-naphthyloxy group, Anthryloxy group, 9-anthryloxy group, 1-phenanthryloxy group, 3-phenanthryloxy group, 9-phenanthryloxy group and the like. Examples of the arylthioxy group include phenylthioxy group, 2- A 4-tert-butylphenyloxy group, and the like. Examples of the arylsulfoxy group include benzene sulfoxy group and p-toluenesulfoxy group. However, the present invention is not limited thereto.
본 발명에 있어서, 시클로알킬기는 특별히 한정되지 않으나, 탄소수 3 내지 60인 것이 바람직하며, 구체적으로 시클로프로필기 시클로부틸기 시클로펜틸기 3-메틸시클로펜틸기 2,3-디메틸시클로펜틸기, 시클로헥실기, 3-메틸시클로헥실기, 4-메틸시클로헥실기, 2,3-디메틸시클로헥실기, 3,4,5-트리메틸시클로헥실기, 4-tert-부틸시클로헥실기, 시클로헵틸기, 시클로옥틸기 등이 있으나, 이에 한정되지 않는다.In the present invention, the cycloalkyl group is not particularly limited, but preferably has 3 to 60 carbon atoms, and specifically includes cyclopropyl group, cyclobutyl group, cyclopentyl group, 3-methylcyclopentyl group, 2,3-dimethylcyclopentyl group, Methylcyclohexyl group, 2,3-dimethylcyclohexyl group, 3,4,5-trimethylcyclohexyl group, 4-tert-butylcyclohexyl group, cycloheptyl group, cyclo An octyl group, and the like, but are not limited thereto.
본 발명에 있어서, 할로겐기의 예로는 불소, 염소, 브롬 또는 요오드가 있다.In the present invention, examples of the halogen group include fluorine, chlorine, bromine or iodine.
본 발명에 있어서, 아릴아민기의 예로는 치환 또는 비치환된 모노아릴아민기, 치환 또는 비치환된 디아릴아민기, 또는 치환 또는 비치환된 트리아릴아민기가 있다. 상기 아릴아민기 중의 아릴기는 단환식 아릴기일 수 있고, 다환식 아릴기일 수 있다. 상기 아릴기가 2 이상을 포함하는 아릴아민기는 단환식 아릴기, 다환식 아릴기, 또는 단환식아릴기와 다환식 아릴기를 동시에 포함할 수 있다.In the present invention, examples of the arylamine group include a substituted or unsubstituted monoarylamine group, a substituted or unsubstituted diarylamine group, or a substituted or unsubstituted triarylamine group. The aryl group in the arylamine group may be a monocyclic aryl group or a polycyclic aryl group. The arylamine group having at least two aryl groups may contain a monocyclic aryl group, a polycyclic aryl group, or a monocyclic aryl group and a polycyclic aryl group at the same time.
상기 아릴아민기의 구체적인 예로는 페닐아민기, 나프틸아민기, 비페닐아민기, 안트라세닐아민기, 3-메틸-페닐아민기, 4-메틸-나프틸아민기, 2-메틸-비페닐아민기, 9-메틸-안트라세닐아민기, 디페닐 아민기, 페닐 나프틸 아민기, 디톨릴 아민기, 페닐 톨릴 아민기, 카바졸기 및 트리페닐 아민기 등이 있으나, 이에 한정되는 것은 아니다.Specific examples of the arylamine group include a phenylamine group, a naphthylamine group, a biphenylamine group, an anthracenylamine group, a 3-methylphenylamine group, a 4-methylnaphthylamine group, But are not limited to, an amine group, a 9-methyl-anthracenylamine group, a diphenylamine group, a phenylnaphthylamine group, a ditolylamine group, a phenyltolylamine group, a carbazole group and a triphenylamine group.
본 발명에 있어서, 실릴기는 구체적으로 트리메틸실릴기, 트리에틸실릴기, t-부틸디메틸실릴기, 비닐디메틸실릴기, 프로필디메틸실릴기, 트리페닐실릴기, 디페닐실릴기, 페닐실릴기 등이 있으나 이에 한정되지 않는다.In the present invention, the silyl group is specifically exemplified by trimethylsilyl, triethylsilyl, t-butyldimethylsilyl, vinyldimethylsilyl, propyldimethylsilyl, triphenylsilyl, diphenylsilyl, But are not limited thereto.
본 발명에 있어서, 헤테로아릴아민기 중의 헤테로 아릴기는 전술한 헤테로고리기의 예시 중에서 선택될 수 있다.In the present invention, the heteroaryl group in the heteroarylamine group can be selected from the examples of the above-mentioned heterocyclic group.
본 발명에 있어서, 알킬티옥시기, 알킬술폭시기 중의 알킬기는 전술한 알킬기의 예시와 같다. 구체적으로 알킬티옥시기로는 메틸티옥시기, 에틸티옥시기, tert-부틸티옥시기, 헥실티옥시기, 옥틸티옥시기 등이 있고, 알킬술폭시기로는 메실, 에틸술폭시기, 프로필술폭시기, 부틸술폭시기 등이 있으나, 이에 한정되지 않는다.In the present invention, the alkyloxy group in the alkylthio group and the alkyl group in the alkylsulfoxy group are the same as the aforementioned alkyl groups. Specific examples of the alkyloxy group include a methylthio group, an ethylthio group, a tert-butylthio group, a hexylthio group and an octylthio group. Examples of the alkylsulfoxy group include a mesyl group, an ethylsulfoxy group, a propylsulfoxy group, But are not limited thereto.
본 발명에 있어서, "치환 또는 비치환된"이란, 중수소, 할로겐기, 니트릴기, 니트로기, 히드록시기, 알킬기, 시클로알킬기, 알콕시기, 아릴옥시기, 알킬티옥시기, 아릴티옥시기, 알킬술폭시기, 아릴술폭시기, 알케닐기, 실릴기, 붕소기, 알킬아민기, 아랄킬아민기, 아릴아민기, 아릴기, 플루오레닐기, 카바졸기 및 N, O 및 S 원자 중 1개 이상을 포함하는 헤테로고리기 중 적어도 하나의 치환기로 치환 또는 비치환된 것을 의미한다.In the present invention, the "substituted or unsubstituted" means a group selected from the group consisting of deuterium, halogen, nitrile, nitro, hydroxy, alkyl, cycloalkyl, , An arylsulfoxy group, an alkenyl group, a silyl group, a boron group, an alkylamine group, an aralkylamine group, an arylamine group, an aryl group, a fluorenyl group, a carbazole group and at least one of N, O and S atoms Substituted or unsubstituted with at least one substituent in the heterocyclic group.
본 발명에 있어서, 치환된 아릴렌기라 함은, 페닐기, 비페닐기, 나프탈렌기, 플루오레닐기, 파이레닐기, 페난트레닐기, 페릴렌기, 테트라세닐기. 안트라센닐기 등이 다른 치환기로 치환된 것을 의미한다.In the present invention, the substituted arylene group means a phenyl group, a biphenyl group, a naphthalene group, a fluorenyl group, a pyrenyl group, a phenanthrenyl group, a perylene group, a tetracenyl group. Anthracenyl group and the like are substituted with other substituents.
본 발명에 있어서, 치환된 헤테로아릴렌기라 함은, 피리딜기, 티오페닐기, 트리아진기, 퀴놀린기, 페난트롤린기, 이미다졸기, 티아졸기, 옥사졸기, 카바졸기 및 이들의 축합헤테로고리기, 예컨대 벤즈퀴놀린기, 벤즈이미다졸기, 벤즈옥사졸기, 벤즈티아졸기, 벤즈카바졸기, 디벤조티오페닐기, 디벤조퓨란기 등이 다른 치환기로 치환된 것을 의미한다.
In the present invention, the substituted heteroarylene group includes a pyridyl group, a thiophenyl group, a triazine group, a quinoline group, a phenanthroline group, an imidazole group, a thiazole group, an oxazole group, a carbazole group and condensed heterocyclic groups, Such as a benzoquinoline group, a benzimidazole group, a benzoxazole group, a benzothiazole group, a benzzcarbazole group, a dibenzothiophenyl group, a dibenzofurane group and the like are substituted with other substituents.
상기 [화학식 1]로 표시되는 본 발명에 따른 유기발광 화합물은 그 구조적 특이성으로 인하여 유기전계발광소자의 유기물층으로 사용될 수 있고, 보다 구체적으로 유기물층 내의 정공수송층 내지 정공주입층에 정공수송물질로 사용될 수 있다.The organic luminescent compound according to the present invention represented by
본 발명에 따른 [화학식 1]로 표시되는 정공수송물질로 채용될 수 있는 유기발광 화합물의 구체적인 예로는 하기 화합물들이 있으나, 이들에만 한정되는 것은 아니다.Specific examples of the organic luminescent compound that can be employed as the hole transporting material represented by
상기 [화학식 1]로 표시되는 본 발명에 따른 유기발광 화합물은 그 구조적 특이성으로 인하여 유기전계발광소자의 유기물층으로 사용될 수 있고, 보다 구체적으로 발광층의 인광 호스트 화합물로 사용될 수 있다.The organic luminescent compound according to the present invention represented by
본 발명에 따른 [화학식 1]로 표시되는 발광층의 인광 호스트 화합물로 채용될 수 있는 유기발광 화합물의 구체적인 예로는 하기 화합물들이 있으나, 이들에만 한정되는 것은 아니다.Specific examples of the organic luminescent compound that can be employed as the phosphorescent host compound of the luminescent layer represented by
상기와 같은 구조의 코어 구조에 다양한 치환기를 도입함으로써 도입된 치환기의 고유 특성을 갖는 유기발광 화합물을 합성할 수 있다. 예컨대, 유기전계발광소자의 제조시 사용되는 정공 주입층 물질, 정공 수송층 물질, 발광층 물질, 및 전자 수송층 물질에 사용되는 치환기를 상기 구조에 도입함으로써 각 유기물층에서 요구하는 조건들을 충족시키는 물질을 제조할 수 있다.An organic luminescent compound having the intrinsic characteristics of the substituent introduced by introducing various substituents into the core structure having the above structure can be synthesized. For example, by introducing a substituent used in a hole injecting layer material, a hole transporting layer material, a light emitting layer material, and an electron transporting layer material used in manufacturing an organic electroluminescent device into the structure, a material meeting the requirements of each organic material layer is manufactured .
특히, 본 발명에 따른 [화학식 1]로 표시되는 유기발광 화합물은 상기에서 살펴본 바와 같이, 특징적 코어 구조체에 치환기를 도입한 결과 평판 구조도가 우수하고, 높은 삼중항(triplet) 상태를 가짐을 확인하였는 바, 이를 유기전계발광소자의 유기물층에 채용시 효율, 구동전압, 수명 등에서 우수한 특성을 나타내는 유기전계발광소자의 구현이 가능하다.In particular, as described above, the organic luminescent compound represented by
본 발명의 화합물은 유기전계발광소자의 통상의 제조방법에 따라 소자에 적용할 수 있다.The compound of the present invention can be applied to a device according to a conventional method of manufacturing an organic electroluminescent device.
본 발명의 하나의 실시예에 따른 유기전계발광소자는 제1 전극과 제2 전극 및 이 사이에 배치된 유기물층을 포함하는 구조로 이루어질 수 있으며, 본 발명에 따른 유기발광 화합물을 소자의 유기물층에 사용한다는 것을 제외하고는 통상의 소자의 제조 방법 및 재료를 사용하여 제조될 수 있다.The organic electroluminescent device according to one embodiment of the present invention may have a structure including a first electrode, a second electrode and an organic material layer disposed therebetween, and the organic electroluminescent compound according to the present invention may be used for an organic material layer And can be manufactured using conventional device manufacturing methods and materials.
본 발명에 따른 유기전계발광소자의 유기물층은 단층 구조로 이루어질 수도 있으나, 2층 이상의 유기물층이 적층된 다층 구조로 이루어질 수 있다. 예컨대, 정공 주입층, 정공 수송층, 발광층, 전자 수송층, 전자 주입층 등을 포함하는 구조를 가질 수 있다. 그러나, 이에 한정되지 않고 더 적은 수의 유기물층을 포함할 수도 있다.The organic material layer of the organic electroluminescent device according to the present invention may have a single layer structure, but may have a multilayer structure in which two or more organic material layers are stacked. For example, a structure including a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and an electron injecting layer. However, it is not limited to this and may include a smaller number of organic layers.
따라서, 본 발명의 유기전계발광소자에서, 상기 유기물층은 정공 주입층, 정공 수송층, 전자 수송층, 전자 주입층, 정공 주입 및 정공 수송을 동시에 하는 층, 전자 주입 및 전자수송을 동시에 하는 층 및 발광층 중 1층 이상을 포함할 수 있고, 상기 층들 중 1층 이상이 상기 [화학식 1]로 표시되는 화합물을 포함할 수 있다.Therefore, in the organic electroluminescent device of the present invention, the organic material layer may be a hole injecting layer, a hole transporting layer, an electron transporting layer, an electron injecting layer, a layer simultaneously injecting and transporting holes, a layer simultaneously performing electron injection and electron transporting, One or more layers may be included, and at least one of the layers may include a compound represented by the above formula (1).
특히, 본 발명에 따른 유기발광 화합물은 정공수송 기능층 또는 발광층에 포함될 수 있으며, 발광층 내 호스트 물질로서 포함될 수 있다.In particular, the organic luminescent compound according to the present invention may be contained in the hole transporting functional layer or the luminescent layer, and may be included as a host material in the luminescent layer.
상기 [화학식 1]로 표시되는 화합물이 발광층 내 호스트 물질로서 포함되는 경우에, 상기 발광층은 1종 이상의 인광 도펀트를 포함할 수 있으며, 상기 발광층이 호스트 및 도펀트를 포함할 경우, 도펀트의 함량은 통상적으로 호스트 약 100 중량부를 기준으로 하여 약 0.01 내지 약 20 중량부의 범위에서 선택될 수 있다.In the case where the compound represented by
본 발명의 일 실시예에 의하면, 상기 발광층에 본 발명에 따른 [화학식 1]로 표시되는 호스트 화합물과 하기의 [구조식 2] 내지 [구조식 8] 중에서 선택되는 도펀트 화합물을 1종 이상 더 포함할 수 있다.According to an embodiment of the present invention, the light emitting layer may further contain at least one dopant compound selected from the following [structural formulas 2] to [structural formula 8] in the host compound represented by the general formula [1] have.
[구조식 2][Structural formula 2]
[구조식 3][Structural Formula 3]
[구조식 4][Structural Formula 4]
[구조식 5][Structural Formula 5]
[구조식 6][Structural Formula 6]
[구조식 7][Structural Formula 7]
[구조식 8][Structural formula 8]
이와 같은 다층 구조의 유기물층에서 상기 [화학식 1]로 표시되는 화합물은 발광층, 정공 주입/정공 수송과 발광을 동시에 하는 층, 정공 수송과 발광을 동시에 하는 층, 또는 전자 수송과 발광을 동시에 하는 층 등에 포함될 수 있다.In the organic compound layer having such a multilayer structure, the compound represented by the formula (1) may be used in combination with a light emitting layer, a layer that simultaneously transports holes and holes, a layer that simultaneously transports holes and emits light, .
예컨대, 본 발명에 따른 유기 전자 소자의 구조는 도 1 내지 5에 예시되어 있다.For example, the structure of an organic electronic device according to the present invention is illustrated in Figs.
도 1에는 기판(1) 위에 양극(2), 정공 주입층(3), 정공 수송층(4), 발광층(5), 전자 수송층(6) 및 음극(7)이 순차적으로 적층된 유기 전자 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 화학식 1로 표시되는 화합물은 상기 정공 주입층(3), 정공 수송층(4), 발광층(5) 또는 전자 수송층(6)에 포함될 수 있다.1 shows an organic electronic device in which an
도 2에는 기판(1) 위에 양극(2), 정공 주입층(3), 정공 수송층(4), 발광층(5) 및 음극(7)이 순차적으로 적층된 유기 전자 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 화학식 1로 표시되는 화합물은 상기 정공 주입층(3), 정공 수송층(4) 또는 전자 수송층(6)에 포함될 수 있다.2 shows the structure of an organic electronic device in which an
도 3에는 기판(1) 위에 양극(2), 정공 수송층(4), 발광층(5), 전자 수송층(6) 및 음극(7)이 순차적으로 적층된 유기 전자 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 화학식 1로 표시되는 화합물은 상기 정공 수송층(4), 발광층(5) 또는 전자 수송층(6)에 포함될 수 있다.3 illustrates the structure of an organic electronic device in which an
도 4에는 기판(1) 위에 양극(2), 발광층(5), 전자 수송층(6) 및 음극(7)이 순차적으로 적층된 유기 전자 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 화학식 1로 표시되는 화합물은 상기 발광층(5) 또는 전자 수송층(6)에 포함될 수 있다.4 illustrates the structure of an organic electronic device in which an
도 5에는 기판(1) 위에 양극(2), 발광층(5) 및 음극(7)이 순차적으로 적층된 유기 전자 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 화학식 1로 표시되는 화합물은 상기 발광층(5)에 포함될 수 있다.5 illustrates the structure of an organic electronic device in which an
예컨대, 본 발명에 따른 유기 전자 소자의 구조는 도 1 내지 5에 예시되어 있다.For example, the structure of an organic electronic device according to the present invention is illustrated in Figs.
도 1에는 기판(1) 위에 양극(2), 정공 주입층(3), 정공 수송층(4), 발광층(5), 전자 수송층(6) 및 음극(7)이 순차적으로 적층된 유기전계발광소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1]로 표시되는 화합물은 상기 정공 주입층(3), 정공 수송층(4), 발광층(5) 또는 전자 수송층(6)에 포함될 수 있다.1 shows an
도 2에는 기판(1) 위에 양극(2), 정공 주입층(3), 정공 수송층(4), 발광층(5) 및 음극(7)이 순차적으로 적층된 유기전계발광소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1]로 표시되는 화합물은 상기 정공 주입층(3), 정공 수송층(4) 또는 전자 수송층(6)에 포함될 수 있다.2 shows a structure of an organic electroluminescent device in which an
도 3에는 기판(1) 위에 양극(2), 정공 수송층(4), 발광층(5), 전자 수송층(6) 및 음극(7)이 순차적으로 적층된 유기전계발광소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1]로 표시되는 화합물은 상기 정공 수송층(4), 발광층(5) 또는 전자 수송층(6)에 포함될 수 있다.3 illustrates the structure of an organic electroluminescent device in which an
도 4에는 기판(1) 위에 양극(2), 발광층(5), 전자 수송층(6) 및 음극(7)이 순차적으로 적층된 유기전계발광소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1]로 표시되는 화합물은 상기 발광층(5) 또는 전자 수송층(6)에 포함될 수 있다.4 shows the structure of an organic electroluminescent device in which an
도 5에는 기판(1) 위에 양극(2), 발광층(5) 및 음극(7)이 순차적으로 적층된 유기전계발광소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1]로 표시되는 화합물은 상기 발광층(5)에 포함될 수 있다.5 illustrates the structure of an organic electroluminescent device in which an
예컨대, 본 발명에 따른 유기전계발광소자는 스퍼터링(sputtering)이나 전자빔 증발(e-beam evaporation)과 같은 PVD(physical vapor deposition) 방법을 이용하여, 기판 상에 금속 또는 전도성을 가지는 금속 산화물 또는 이들의 합금을 증착시켜 양극을 형성하고, 그 위에 정공 주입층, 정공 수송층, 발광층, 전자 수송층을 포함하는 유기물층을 형성한 후, 그 위에 음극으로 사용할 수 있는 물질을 증착시킴으로써 제조될 수 있다.For example, the organic electroluminescent device according to the present invention can be manufactured by using a physical vapor deposition (PVD) method such as sputtering or e-beam evaporation to form a metal oxide or a conductive metal oxide on the substrate, An anode is formed by depositing an alloy on the anode, and an organic material layer including a hole injecting layer, a hole transporting layer, a light emitting layer, and an electron transporting layer is formed on the anode, and then a substance usable as a cathode is deposited thereon.
이와 같은 방법 외에도, 기판 상에 음극 물질부터 유기물층, 양극 물질을 차례로 증착시켜 유기전계발광소자를 만들 수도 있다. 상기 유기물층은 정공 주입층, 정공 수송층, 발광층 및 전자 수송층 등을 포함하는 다층 구조일 수도 있으나, 이에 한정되지 않고 단층 구조일 수 있다. 또한, 상기 유기물층은 다양한 고분자 소재를 사용하여 증착법이 아닌 솔벤트 프로세스(solvent process), 예컨대 스핀 코팅, 딥 코팅, 닥터 블레이딩, 스크린 프린팅, 잉크젯 프린팅 또는 열 전사법 등의 방법에 의하여 더 적은 수의 층으로 제조할 수 있다.In addition to such a method, an organic electroluminescent device may be formed by sequentially depositing a cathode material, an organic material layer, and a cathode material on a substrate. The organic material layer may have a multi-layer structure including a hole injection layer, a hole transport layer, a light emitting layer, and an electron transport layer, but is not limited thereto and may have a single layer structure. In addition, the organic material layer may be formed using a variety of polymer materials by a solvent process such as a spin coating process, a dip coating process, a doctor blading process, a screen printing process, an inkjet printing process or a thermal transfer process, Layer.
상기 양극 물질로는 통상 유기물층으로 정공주입이 원활할 수 있도록 일함수가 큰 물질이 바람직하다. 본 발명에서 사용될 수 있는 양극 물질의 구체적인 예로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금, 아연 산화물, 인듐 산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물, ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 및 폴리아닐린과 같은 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다.As the anode material, a material having a large work function is preferably used so that hole injection can be smoothly conducted into the organic material layer. Specific examples of the cathode material that can be used in the present invention include metals such as vanadium, chromium, copper, zinc and gold or alloys thereof, zinc oxide, indium oxide, indium tin oxide (ITO), indium zinc oxide (IZO) metal oxides, ZnO: Al or SnO 2: a combination of a metal and an oxide such as Sb, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT) , Conductive polymers such as polypyrrole and polyaniline, but are not limited thereto.
상기 음극 물질로는 통상 유기물층으로 전자 주입이 용이하도록 일함수가 작은 물질인 것이 바람직하다. 음극 물질의 구체적인 예로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석 및 납과 같은 금속 또는 이들의 합금, LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있으나, 이들에만 한정되는 것은 아니다.The negative electrode material is preferably a material having a small work function to facilitate electron injection into the organic material layer. Specific examples of the negative electrode material include a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin and lead or an alloy thereof, a multilayer such as LiF / Al or LiO 2 / Structural materials, and the like, but are not limited thereto.
정공 주입 물질로는 낮은 전압에서 양극으로부터 정공을 잘 주입받을 수 있는 물질로서, 정공 주입 물질의 HOMO(highest occupied molecular orbital)가 양극 물질의 일함수와 주변 유기물층의 HOMO 사이인 것이 바람직하다. 정공 주입 물질의 구체적인 예로는 금속 포피린(porphyrine), 올리고티오펜, 아릴아민 계열의 유기물, 헥사니트릴 헥사아자트리페닐렌, 퀴나크리돈(quinacridone) 계열의 유기물, 페릴렌(perylene) 계열의 유기물, 안트라퀴논 및 폴리아닐린과 폴리티오펜 계열의 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다.As the hole injecting material, it is preferable that the highest occupied molecular orbital (HOMO) of the hole injecting material be between the work function of the anode material and the HOMO of the surrounding organic layer. Specific examples of the hole injecting material include metal porphyrine, oligothiophene, arylamine-based organic materials, hexanitrile hexaazatriphenylene, quinacridone-based organic materials, perylene-based organic materials, Anthraquinone, polyaniline and a polythiophene-based conductive polymer, but are not limited thereto.
정공 수송 물질로는 양극이나 정공 주입층으로부터 정공을 수송 받아 발광층으로 옮겨줄 수 있는 물질로 정공에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 아릴아민 계열의 유기물, 전도성 고분자, 및 공액 부분과 비공액 부분이 함께 있는 블록 공중합체 등이 있으나, 이들에만 한정되는 것은 아니다.As the hole transporting material, a material capable of transporting holes from the anode or the hole injection layer to the light emitting layer and having high mobility to holes is suitable. Specific examples include arylamine-based organic materials, conductive polymers, and block copolymers having a conjugated portion and a non-conjugated portion together, but are not limited thereto.
발광 물질로는 정공 수송층과 전자 수송층으로부터 정공과 전자를 각각 수송받아 결합시킴으로써 가시광선 영역의 빛을 낼 수 있는 물질로서, 형광이나 인광에 대한 양자효율이 좋은 물질이 바람직하다. 구체적인 예로는 8-히드록시-퀴놀린 알루미늄 착물(Alq3), 카르바졸 계열 화합물, 이량체화 스티릴(dimerized styryl) 화합물, BAlq, 10-히드록시벤조 퀴놀린-금속 화합물, 벤족사졸, 벤즈티아졸 및 벤즈이미다졸 계열의 화합물, 폴리(p-페닐렌비닐렌)(PPV) 계열의 고분자, 스피로(spiro) 화합물, 폴리플루오렌, 루브렌 등이 있으나, 이들에만 한정되는 것은 아니다.The light emitting material is preferably a material capable of emitting light in the visible light region by transporting and combining holes and electrons from the hole transporting layer and the electron transporting layer, respectively, and having a high quantum efficiency for fluorescence or phosphorescence. Specific examples include 8-hydroxy-quinoline aluminum complex (Alq 3 ), carbazol-based compounds, dimerized styryl compounds, BAlq, 10-hydroxybenzoquinoline-metal compounds, benzoxazole, benzthiazole and A benzimidazole-based compound, a poly (p-phenylene vinylene) (PPV) -based polymer, a spiro compound, polyfluorene, rubrene, and the like.
전자 수송 물질로는 음극으로부터 전자를 잘 주입 받아 발광층으로 옮겨줄 수 있는 물질로서, 전자에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 8-히드록시퀴놀린의 Al 착물, Alq3를 포함한 착물, 유기 라디칼 화합물, 히드록시플라본-금속 착물 등이 있으나, 이들에만 한정되는 것은 아니다.
As the electron transporting material, a material capable of transferring electrons from the cathode well into the light emitting layer, which is highly mobile, is suitable. Specific examples thereof include, but are not limited to, an Al complex of 8-hydroxyquinoline, a complex containing Alq 3 , an organic radical compound, and a hydroxyflavone-metal complex.
본 발명에 따른 유기전계발광소자는 사용되는 재료에 따라 전면 발광형, 후면 발광형 또는 양면 발광형일 수 있다.The organic electroluminescent device according to the present invention may be a front emission type, a back emission type, or a both-sided emission type, depending on the material used.
또한, 본 발명에 따른 유기발광 화합물은 유기 태양 전지, 유기 감광체, 유기 트랜지스터 등을 비롯한 유기 전자 소자에서도 유기전계발광소자에 적용되는 것과 유사한 원리로 작용할 수 있다.
In addition, the organic electroluminescent compound according to the present invention can act on a principle similar to that applied to an organic electroluminescent device in an organic electronic device including an organic solar cell, an organophotoreceptor, an organic transistor and the like.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시한다. 그러나, 하기의 실시예는 본 발명을 예시하기 위한 것이며, 이에 의하여 본 발명의 범위가 한정되는 것은 아니다.
Hereinafter, preferred embodiments of the present invention will be described in order to facilitate understanding of the present invention. However, the following examples are intended to illustrate the invention and are not intended to limit the scope of the invention.
실시예Example 1 : 화합물 366의 합성 1: Synthesis of Compound 366
(1) (One) 제조예Manufacturing example 1 : 중간체 1-1의 합성 1: Synthesis of intermediate 1-1
2-nitroaniline(3.0 g, 0.022 mol)에 phenylmethanamine(7.0 g, 0.066 mol), Ferric chloride(0.07 g, 0.0004 mol) 넣고, 120 ℃에서 48시간 교반하여 반응시켰다. 반응 종료 후 실온으로 냉각하여 M.C 50 mL 넣고 30분간 교반 후 여과하였다. 얻어진 고체를 컬럼정제(n-Hexane:EA)하여 중간체 1-1을 3.1 g (수율 80%) 수득하였다.(m/z=194)
Phenylmethanamine (7.0 g, 0.066 mol) and ferric chloride (0.07 g, 0.0004 mol) were added to 2-nitroaniline (3.0 g, 0.022 mol) and the mixture was reacted at 120 ° C for 48 hours with stirring. After completion of the reaction, the reaction mixture was cooled to room temperature, and 50 mL of MC was added thereto, followed by stirring for 30 minutes, followed by filtration. The obtained solid was subjected to column purification (n-hexane: EA) to obtain 3.1 g (yield 80%) of Intermediate 1-1. (M / z = 194)
(2) (2) 제조예Manufacturing example 2 : 중간체 1-2의 합성 2: Synthesis of intermediate 1-2
중간체 1-1(2.0 g, 0.010 mol)에 methyl 2,6-dibromobenzoate(3.0 g, 0.015 mol), Potassium carbonate(2.8 g, 0.020 mol), Copper(0.1 g, 0.0020 mol), iodine copper(1.1 g, 0.006 mol)에 n-butyl ether 70 mL에 녹인 후 질소 하에서 48시간 교반하여 반응시켰다. 반응 종료 후 실온으로 냉각하여 H20 : MC 층분리 후 컬럼정제(n-Hexane : EA)하여 중간체 1-2을 2.8 g(수율 68%)수득하였다.(m/z=407)
Potassium carbonate (2.8 g, 0.020 mol), Copper (0.1 g, 0.0020 mol), iodine copper (1.1 g, 0.020 mol) were added to intermediate 1-1 (2.0 g, 0.010 mol) , 0.006 mol) were dissolved in 70 mL of n-butyl ether and reacted under nitrogen for 48 hours with stirring. After completion of the reaction, the reaction mixture was cooled to room temperature, and subjected to column separation (n-hexane: EA) after separation of H 2 O: MC layer to obtain 2.8 g (m / z = 407)
(3) (3) 제조예Manufacturing example 3 : 중간체 1-3의 합성 3: Synthesis of intermediate 1-3
중간체 1-2(4.0 g, 0.010 mol)를 30 mL ehter에 녹이고, -78 ℃로 냉각시킨 후 2.5 M BuLi(0.01 mL, 0.0005 mol)을 dropping시킨 후, 1시간 동안 교반하였다. 이를 서서히 실온으로 올려 4 시간 동안 더 교반하였다. 반응 완료 후 물 100 mL로 추출하여 유기층을 감압 건조하였다. 이를 EtOH : Acetone으로 재결정하여 중간체 1-3 (2.7 g ,67%)수득하였다 .(m/z= 407)
Intermediate 1-2 (4.0 g, 0.010 mol) was dissolved in a 30 mL ehter, cooled to -78 ° C, and 2.5 M BuLi (0.01 mL, 0.0005 mol) was dropwise added thereto, followed by stirring for 1 hour. The mixture was slowly warmed to room temperature and stirred for 4 hours. After completion of the reaction, the reaction mixture was extracted with 100 mL of water, and the organic layer was dried under reduced pressure. This was recrystallized from EtOH: Acetone to give intermediate 1-3 (2.7 g, 67%). (M / z = 407)
(4) (4) 제조예Manufacturing example 4 : 중간체 1-4의 합성 4: Synthesis of intermediate 1-4
중간체 1-3(4.0 g, 0.010 mol)를 50 mL의 농축된 H3PO4에 녹인 후 5 시간 동안 교반시켰다. 이를 물 100 mL와 Ethyl Acetate 100 mL로 추출하고, 유기층을 감압 건조하였다. 이를 EtOH 100 mL로 재결정하여 중간체 1-4 (2.8 g ,72%)수득하였다. (m/z=389)
Intermediate 1-3 (4.0 g, 0.010 mol) was dissolved in 50 mL of concentrated H 3 PO 4 and stirred for 5 h. It was extracted with 100 mL of water and 100 mL of Ethyl Acetate, and the organic layer was dried under reduced pressure. This was recrystallized from 100 mL of EtOH to obtain intermediate 1-4 (2.8 g, 72%). (m / z = 389)
(5) (5) 제조예Manufacturing example 5 : 중간체 1-4'의 합성 5: Synthesis of intermediate 1-4 '
중간체 1-4(3.0 g, 0.008 mol)에 bis(pinacolato)dibron(2.5 g, 0.010 mol), PdCl2(dppf)(0.3 g, 0.0004 mol), potassium-acetate(2.2 g, 0.016 mol)에 1,4-dioxane 80 mL를 넣고 95 ℃에서 24시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane : MC)하여 중간체 1-4' 2.5 g (수율 71%) 수득하였다. (m/z=436)
To a solution of bis (pinacolato) dibron (2.5 g, 0.010 mol), PdCl 2 (dppf) (0.3 g, 0.0004 mol) and potassium acetate (2.2 g, 0.016 mol) in Intermediate 1-4 (3.0 g, 0.008 mol) , 4-dioxane (80 mL), and the mixture was reacted at 95 ° C for 24 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 2.5 g (yield 71%) of intermediate 1-4 '. (m / z = 436)
(6) (6) 제조예Manufacturing example 6 : 중간체 1-5의 합성 6: Synthesis of intermediate 1-5
중간체 1-4'(3.0 g, 0.007 mol)에 1,4-dibromobenzene(1.3 g, 0.006 mol) Pd(dba)2(0.5 g, 0.00006 mol), sodium-tert-butoxide(2.2 g, 0.022 mol)에 Tol 80 mL를 넣고 95 ℃에서 4 시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane : MC)하여 중간체 1-5를 2.1 g(수율 77%)수득하였다.(m/z=465)
Pd (dba) 2 (0.5 g, 0.00006 mol) and sodium-tert-butoxide (2.2 g, 0.022 mol) in 1,4-dibromobenzene (1.3 g, 0.006 mol) Was added 80 mL of Tol, and the mixture was reacted at 95 DEG C for 4 hours with stirring. After completion of the reaction, the reaction mixture was cooled, and the product was separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 2.1 g (m / z = 465)
(7) (7) 제조예Manufacturing example 7 : 중간체 1-5'의 합성 7: Synthesis of intermediate 1-5 '
중간체 1-5(3.0 g, 0.006 mol)에 bis(pinacolato)dibron(2.0 g, 0.008 mol) 를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 1-5'> 2.2 g (수율 71%)을 얻었다. (m/z=512)
Intermediate 1-5 'was synthesized in the same manner as in Example 1 (5) except that bis (pinacolato) dibron (2.0 g, 0.008 mol) was added to Intermediate 1-5 (3.0 g, 0.006 mol) 2.2 g (71% yield) was obtained. (m / z = 512)
(8) (8) 제조예Manufacturing example 8 : 화합물 366의 합성 8: Synthesis of Compound 366
중간체 1-5'(5.0 g, 0.010 mol)에 2-bromo-4,6-diphenyl-1,3,5-triazine(2.5 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 366> 4.4 g (수율 71%)을 얻었다.(2.5 g, 0.008 mol) was added to Intermediate 1-5 '(5.0 g, 0.010 mol) in the same manner as in Example 1 (6) except that 2-bromo-4,6-diphenyl- (Compound 366) (4.4 g, Yield: 71%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.71/d, 7.61/d, 7.41/d, 7.33/m, 7.22/d, 7.14/m) 2H(7.85/d, 7.25/d, 1.72/s) 3H(7.41/m) 6H(8.28/d, 7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.71 / d, 7.61 / d, 7.41 / d, 7.33 / m, 7.22 / d, 7.14 / m) 2H (7.85 / d, 7.25 / d, 1.72 / s) 3H (7.41 / m) 6H (8.28 / d, 7.51 / m)
LC/MS: m/z= 618[(M+1)+]
LC / MS: m / z = 618 [(M + 1) < + &
실시예Example 2 : 화합물 371의 합성 2: Synthesis of Compound 371
(1) (One) 제조예Manufacturing example 1 : 화합물 371의 합성 1: Synthesis of Compound 371
중간체 1-5'(5.0 g, 0.010 mol)에 2-bromotriphenylene(2.5 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 371> 3.6 g (수율 73%)을 얻었다.(2.5 g, 0.008 mol) was added to Intermediate 1-5 '(5.0 g, 0.010 mol) in the same manner as in Example 1- (6) 73%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(9.15/s, 8.18/d, 8.04/d, 7.71/d, 7.61/d, 7.41/m, 7.41/d, 7.33/m, 7.22/d, 7.14/m) 2H(8.93/d, 8.28/d, 8.12/d, 7.88/m, 7.82/m, 7.51/m, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (9.15 / s, 8.18 / d, 8.04 / d, 7.71 / d, 7.61 / d, 7.41 / m, 7.41 / d, 7.33 / m, 7.22 / d , 7.14 / m) 2H (8.93 d, 8.28 d, 8.12 d, 7.88 m, 7.82 m, 7.51 m, 1.72 s)
LC/MS: m/z=613 [(M+1)+]
LC / MS: m / z = 613 [(M + 1) < + &
실시예Example 3 : 화합물 380의 합성 3: Synthesis of Compound 380
(1) (One) 제조예Manufacturing example 1 : 중간체 3-1의 합성 1: Synthesis of intermediate 3-1
중간체 1-5(3.0 g, 0.008 mol)에 9H-carbazol-3-ylboronic acid(2.1 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 3-1> 2.8 g (수율 73%)을 얻었다. (m/z=475)
3-ylboronic acid (2.1 g, 0.010 mol) was added to Intermediate 1-5 (3.0 g, 0.008 mol), and <Intermediate 3- 1> 2.8 g (yield: 73%). (m / z < / RTI > = 475)
(2) (2) 제조예Manufacturing example 2 : 화합물 380의 합성 2: Synthesis of Compound 380
중간체 3-1(3.0 g, 0.011 mol)에 2-bromo-4,6-diphenyl-1,3,5-triazine(3.5 g, 0.011 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 380> 5.8 g (수율 75%)을 얻었다.To the intermediate 3-1 (3.0 g, 0.011 mol) was added 2-bromo-4,6-diphenyl-1,3,5-triazine (3.5 g, 0.011 mol) Synthesis was conducted in the same manner to obtain 5.8 g (yield 75%) of Compound 380.
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 7.94/d, 7.87/d, 7.77/d, 7.71/d, 7.69/d, 7.61/d, 7.41/d, 7.25/m, 7.22/d, 7.14/m) 2H(7.33/m, 1.72/s) 3H(7.41/m) 6H(8.28/d, 7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 7.94 / d, 7.87 / d, 7.77 / d, 7.71 / d, 7.69 / d, 7.61 / d, 7.41 / d, 7.25 / m (7.28 / d, 7.14 / m) 2H (7.33 / m, 1.72 / s)
LC/MS: m/z= 707[(M+1)+]
LC / MS: m / z = 707 [(M + 1) < + &
실시예 4 : 화합물 377의 합성Example 4: Synthesis of Compound 377
(1) (One) 제조예Manufacturing example 1 : 중간체 4-1의 합성 1: Synthesis of Intermediate 4-1
5-bromo-2-nitroaniline(3.0 g, 0.014 mol)에 phenylmethanamine(4.4 g, 0.041 mol)를 넣고 실시예 1-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 4-1> 3.0 g (수율 79%)을 얻었다.(m/z=273)
Intermediate 4-1 was synthesized in the same manner as in Example 1 (1) except that phenylmethanamine (4.4 g, 0.041 mol) was added to 5-bromo-2-nitroaniline (3.0 g, 0.014 mol) (Yield: 79%). (M / z = 273)
(2) (2) 제조예Manufacturing example 2 : 중간체 4-2의 합성 2: Synthesis of intermediate 4-2
중간체 4-1(3.0 g, 0.011 mol)에 methyl 2-iodobenzoate(2.9 g, 0.011 mol)을 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 4-2> 3.4 g (수율 77%)을 얻었다.(m/z=407)
Intermediate 4-2 was synthesized in the same manner as in Example 1 (2), except that methyl 2-iodobenzoate (2.9 g, 0.011 mol) was added to Intermediate 4-1 (3.0 g, 0.011 mol) (Yield: 77%). (M / z = 407)
(3) (3) 제조예Manufacturing example 3 : 중간체 4-3의 합성 3: Synthesis of intermediate 4-3
중간체 4-2(3.3 g, 0.008 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 4-3> 2.3 g (수율 72%)을 얻었다.(m/z=407)
2.3 g (yield 72%) of Intermediate 4-3 (m / z) was obtained by the same method as in Example 1- (3) except that Intermediate 4-2 (3.3 g, 0.008 mol) = 407)
(4) (4) 제조예Manufacturing example 4 : 중간체 4-4의 합성 4: Synthesis of intermediate 4-4
중간체 4-3(3.3 g, 0.008 mol)을 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <중간체 4-4> 2.2 g (수율 70%)을 얻었다.(m/z=389)
2.2 g (yield 70%) of Intermediate 4-4 was obtained by the same procedure as in Example 1 (4) except that Intermediate 4-3 (3.3 g, 0.008 mol) was added. M / z = 389)
(5) (5) 제조예Manufacturing example 5 : 중간체 4-5의 합성 5: Synthesis of intermediate 4-5
2-bromo-9H-carbazole(3.0 g, 0.012 mol)에 triisopropyl borate(2.6 g, 0.014 mol)를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 4-5> 1.9 g (수율 75%)을 얻었다.(m/z=211)
Synthesis was conducted in the same manner as in Example 1 (5), except that triisopropyl borate (2.6 g, 0.014 mol) was added to 2-bromo-9H-carbazole (3.0 g, 0.012 mol) g (yield: 75%). (m / z = 211)
(6) (6) 제조예Manufacturing example 6 : 중간체 4-6의 합성 6: Synthesis of intermediate 4-6
중간체 4-4(3.0 g, 0.008 mol)에 중간체 4-5(2.1 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 4-6> 2.7g (수율 70%)을 얻었다.(m/z=475)
Intermediate 4-6 (2.1 g, 0.010 mol) was added to Intermediate 4-4 (3.0 g, 0.008 mol) and 2.7 g of Intermediate 4-6 was synthesized in the same manner as in Example 1- (Yield: 70%). (M / z = 475)
(7) (7) 제조예Manufacturing example 7 : 화합물 377의 합성 7: Synthesis of Compound 377
중간체 4-6(5.0 g, 0.010 mol)에 2-bromo-4,6-diphenyl-1,3,5-triazine(3.1 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 377> 4.9 g (수율 70%)을 얻었다.To the intermediate 4-6 (5.0 g, 0.010 mol) was added 2-bromo-4,6-diphenyl-1,3,5-triazine (3.1 g, 0.010 mol) Synthesis was conducted in the same manner to obtain 4.9 g (yield 70%) of <Compound 377>.
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 8.18/d, 7.99/d, 7.94/d, 7.79/d, 7.62/s, 7.47/d, 7.40/m, 7.37/m, 7.33/m, 7.30/d, 7.26/d, 7.25/m) 2H(1.72/s) 3H(7.41/m) 6H(8.28/d, 7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 8.18 / d, 7.99 / d, 7.94 / d, 7.79 / d, 7.62 / s, 7.47 / d, 7.40 / m, 7.37 / m M, 7,30 / d, 7.26 / d, 7.25 / m) 2H (1.72 / s) 3H (7.41 / m) 6H (8.28 / d, 7.51 /
LC/MS: m/z=707[(M+1)+]
LC / MS: m / z = 707 [(M + 1) < + &
실시예Example 5 : 화합물 420의 합성 5: Synthesis of Compound 420
(1) (One) 제조예Manufacturing example 1 : 화합물 420의 합성 1: Synthesis of Compound 420
중간체 1-5'(4.1 g, 0.008 mol)에 4-bromodibenzo[b,d]thiophene(1.8 g, 0.007 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 420> 2.9 g (수율 73%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (6), except that 4-bromodibenzo [b, d] thiophene (1.8 g, 0.007 mol) was added to Intermediate 1-5 '(4.1 g, 0.008 mol) 420> 2.9 g (yield: 73%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.45/d, 8.41/d, 8.20/d, 7.98/d, 7.71/d, 7.61/d, 7.58/m, 7.52/m, 7.50/m, 7.41/d, 7.41/m, 7.33/m, 7.22/d, 7.14/m) 2H(8.28/d, 7.51/m, 1.72/s) 4H(7.25/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.45 / d, 8.41 / d, 8.20 / d, 7.98 / d, 7.71 / d, 7.61 / d, 7.58 / m, 7.52 / m, 7.50 / m , 7.41 / d, 7.41 / m, 7.33 / m, 7.22 / d, 7.14 / m) 2H (8.28 / d, 7.51 / m, 1.72 / s)
LC/MS: m/z=569 [(M+1)+]
LC / MS: m / z = 569 [(M + 1) < + &
실시예Example 6 : 화합물 435의 합성 6: Synthesis of Compound 435
(1) (One) 제조예Manufacturing example 1 : 중간체 6-1의 합성 1: Synthesis of intermediate 6-1
중간체 1-4'(3.05 g, 0.008 mol)에 1,3,5-tribromobenzene(2.2 g, 0.007 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 6-1> 2.7 g (수율 70%)을 얻었다. (m/z=544)
Synthesis was conducted in the same manner as in Example 1 (6), except that 1,3,5-tribromobenzene (2.2 g, 0.007 mol) was added to Intermediate 1-4 '(3.05 g, 0.008 mol) 1> 2.7 g (yield 70%). (m / z = 544)
(2) (2) 제조예Manufacturing example 2 : 화합물 435의 합성 2: Synthesis of Compound 435
중간체 6-1(5.0 g, 0.009 mol)에 9H-carbazole(4.4 g, 0.018 mol) 를 넣고 실시예1-제조예(2)에서 사용된 동일한 방법으로 합성하여 <화합물 435> 4.7 g (수율 73%)을 얻었다.Synthesis was conducted in the same manner as in Example 1-Preparation Example (2), except that 9H-carbazole (4.4 g, 0.018 mol) was added to Intermediate 6-1 (5.0 g, 0.009 mol) to obtain 4.7 g (yield: 73% %).
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.71/d, 7.61/d, 7.41/m, 7.41/d, 7.33/m, 7.22/d, 7.20/s, 7.14/m) 2H(8.55/d, 8.28/d, 8.12/d, 8.09/s, 7.94/d, 7.63/d, 7.51/m, 7.50/m, 7.33/m, 7.29/m, 7.25/m, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.71 / d, 7.61 / d, 7.41 / m, 7.41 / d, 7.33 / m, 7.22 / d, 7.20 / s, 7.14 / m) 2H (8.55 7.51 / m, 7.50 / m, 7.33 / m, 7.29 / m, 7.25 / m, 1.72 / s)
LC/MS: m/z=717 [(M+1)+]
LC / MS: m / z = 717 [(M + 1) < + &
실시예Example 7 : 화합물 393의 합성 7: Synthesis of Compound 393
(1) (One) 제조예Manufacturing example 1 : 중간체 7-1의 합성 1: Synthesis of Intermediate 7-1
2-bromo-2'-nitrobiphenyl(5.0 g, 0.017 mol)에 triphenylphosphine(4.5 g, 0.017 mol)에 1,2-dichlorobenzene 100 mL를 넣고 180 ℃에서 24시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane : MC)하여 중간체 7-1을 4.2 g (수율 83%)수득하였다.(m/z=246)
100 mL of 1,2-dichlorobenzene was added to triphenylphosphine (4.5 g, 0.017 mol) in 2-bromo-2'-nitrobiphenyl (5.0 g, 0.017 mol) and the mixture was reacted at 180 ° C for 24 hours with stirring. After completion of the reaction, the reaction mixture was cooled, and the resultant product was separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 4.2 g (m / z = 246)
(2) (2) 제조예Manufacturing example 2 : 중간체 7-2의 합성 2: Synthesis of intermediate 7-2
중간체 7-1(3.0 g, 0.012 mol)에 무수 THF 30 mL에 녹인 후, -78 ℃에서 n-BuLi(2.5M) 5.9 mL를 천천히 적가하였다. 1시간 동안 유지시킨 후, triisopropyl borate(3.4 g, 0.018 mol)을 첨가한 후, 상온에서 24시간 교반하였다. 반응 종료 후 1 N HCl을 넣고 1시간 교반한 뒤, EA : H2O에 층분리 후 n-Hexane으로 재결정 하여 <중간체 7-2> 1.8 g (수율 70%)을 얻었다.(m/z=211)
After dissolving 30 mL of anhydrous THF in Intermediate 7-1 (3.0 g, 0.012 mol), 5.9 mL of n-BuLi (2.5 M) was slowly added dropwise at -78 ° C. After maintaining for 1 hour, triisopropyl borate (3.4 g, 0.018 mol) was added and stirred at room temperature for 24 hours. After completion of the reaction, 1 N HCl was added and the mixture was stirred for 1 hour. After separation into EA: H 2 O, the reaction product was recrystallized with n-hexane to obtain 1.8 g (yield 70% 211)
(3) (3) 제조예Manufacturing example 3 : 중간체 7-3의 합성 3: Synthesis of intermediate 7-3
중간체 1-4(3.0 g, 0.008 mol)에 중간체 7-2(2.1 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 7-3> 2.7 g (수율 70%)을 얻었다. (m/z=475)
Intermediate 7-3 (2.7 g, 0.010 mol) was added to intermediate 1-4 (3.0 g, 0.008 mol) and synthesized in the same manner as in Example 1- (6) (Yield: 70%). (m / z < / RTI > = 475)
(4) (4) 제조예Manufacturing example 4 : 화합물 393의 합성 4: Synthesis of compound 393
중간체 7-3(3.0 g, 0.011 mol)에 4-bromodibenzo[b,d]thiophene(2.9 g, 0.011 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 393> 5.6 g (수율 77%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (2) except that 4-bromodibenzo [b, d] thiophene (2.9 g, 0.011 mol) was added to Intermediate 7-3 (3.0 g, 0.011 mol) > 5.6 g (yield 77%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 7.98/d, 7.94/d, 7.79/d, 7.71/d, 7.61/d, 7.59/d, 7.50/m, 7.43/m, 7.41/d, 7.30/d, 7.25/m, 7.22/d, 7.14/m) 2H(8.45/d, 8.28/d, 7.52/m, 7.51/m, 7.33/m, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 7.98 / d, 7.94 / d, 7.79 / d, 7.71 / d, 7.61 / d, 7.59 / d, 7.50 / m, 7.43 / m M, 7.32 / d, 7.14 / m) 2H (8.45 / d, 8.28 / d, 7.52 / m, 7.51 / m, 7.33 / m, 1.72 / s)
LC/MS: m/z= 658[(M+1)+]
LC / MS: m / z = 658 [(M + 1) < + &
실시예Example 8 : 화합물 395의 합성 8: Synthesis of Compound 395
(1) (One) 제조예Manufacturing example 1 : 중간체 8-1의 합성 1: Synthesis of Intermediate 8-1
3,6-dibromo-9H-carbazole(3.0 g, 0.009 mol)에 iodobenzene(1.8 g, 0.009 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 8-1> 2.6 g (수율 71%)을 얻었다.(m/z=401)
Intermediate 8-1 was synthesized in the same manner as in Example 1 (2) except that iodobenzene (1.8 g, 0.009 mol) was added to 3,6-dibromo-9H-carbazole (3.0 g, 0.009 mol) 2.6 g (yield 71%) was obtained. (M / z = 401)
(2) (2) 제조예Manufacturing example 2 : 중간체 8-2의 합성 2: Synthesis of Intermediate 8-2
중간체 8-1(3.0 g, 0.007 mol)에 bis(pinacolato)dibron(2.0 g, 0.008 mol)를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 8-2> 2.7 g (수율 77%)을 얻었다.(m/z=495)
<Intermediate 8-2> 2.7 (2 g, 0.008 mol) was added to the intermediate 8-1 (3.0 g, 0.007 mol) and bis (pinacolato) dibron g (yield: 77%). (m / z = 495)
(3) (3) 제조예Manufacturing example 3 : 화합물 395의 합성 3: Synthesis of Compound 395
중간체 1-4(6.0 g, 0.016 mol)에 중간체 8-2(5.0 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 395> 4.8 g (수율 70%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (6), except that Intermediate 8 (5.0 g, 0.010 mol) was added to intermediate 1-4 (6.0 g, 0.016 mol) 70%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.18/d, 8.00/d, 7.87/d, 7.69/d, 7.45/m) 2H(7.77/s, 7.71/d, 7.61/d, 7.58/m, 7.50/d, 7.41/m, 7.41/d, 7.33/m, 7.22/d, 7.14/m) 4H(8.28/d, 7.51/m, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.18 / d, 8.00 / d, 7.87 / d, 7.69 / d, 7.45 / m) 2H (7.77 / s, 7.71 / d, 7.61 / d, 7.58 7.41 / d, 7.33 / m, 7.22 / d, 7.14 / m) 4H (8.28 / d, 7.51 / m, 1.72 / s)
LC/MS: m/z=861[(M+1)+]
LC / MS: m / z = 861 [(M + 1) < + &
실시예Example 9 : 화합물 405의 합성 9: Synthesis of Compound 405
(1) (One) 제조예Manufacturing example 1 : 화합물 405의 합성 1: Synthesis of compound 405
중간체 6-1(3.0 g, 0.009 mol)에 triphenylen-2-ylboronic acid(5.4 g, 0.020 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 405> 5.5 g (수율 73%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (6), except that triphenylen-2-ylboronic acid (5.4 g, 0.020 mol) was added to Intermediate 6-1 (3.0 g, 0.009 mol) (Yield: 73%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.71/d, 7.61/d, 7.41/d, 7.41/m, 7.33/m, 7.22/d, 7.14/m) 2H(9.15/s, 8.28/d, 8.18/d, 8.04/d, 7.51/m, 1.72/s) 3H(7.66/s) 4H(8.93/d, 8.12/d, 7.88/m, 7.82/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.71 / d, 7.61 / d, 7.41 / d, 7.41 / m, 7.33 / m, 7.22 / d, 7.14 / m) 2H (9.15 / s, 8.28 d, 8.08 / d, 7.51 / m, 1.72 / s) 3H (7.66 /
LC/MS: m/z=840[(M+1)+]
LC / MS: m / z = 840 [(M + 1) < + &
실시예Example 10 : 화합물 407의 합성 10: Synthesis of Compound 407
(1) (One) 제조예Manufacturing example 1 : 화합물 407의 합성 1: Synthesis of compound 407
중간체 6-1(3.0 g, 0.009 mol), dibenzo[b,d]thiophen-4-ylboronic acid(4.6 g, 0.020 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 407> 4.5 g (수율 67%)을 얻었다.Was synthesized in the same manner as in Example 1 (6), except that Intermediate 6-1 (3.0 g, 0.009 mol) and dibenzo [b, d] thiophen-4-ylboronic acid (4.6 g, 0.020 mol) <Compound 407> 4.5 g (yield 67%) was obtained.
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.71/d, 7.61/d, 7.41/d, 7.41/m, 7.33/m, 7.22/d, 7.14/m) 2H(8.45/d, 8.41/d, 8.28/d, 8.20/d, 7.98/d, 7.58/m, 7.52/m, 7.51/m, 7.50/m, 1.72/s) 3H(7.66/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.71 / d, 7.61 / d, 7.41 / d, 7.41 / m, 7.33 / m, 7.22 / d, 7.14 / m) 2H (8.45 / d, 8.41 7.58 / m, 7.50 / m, 1.72 / s) 3H (7.66 / s)
LC/MS: m/z=751[(M+1)+]
LC / MS: m / z = 751 [(M + 1) < + &
실시예Example 11 : 화합물 441의 합성 11: Synthesis of compound 441
(1) (One) 제조예Manufacturing example 1 : 중간체 11-1의 합성 1: Synthesis of intermediate 11-1
9H-carbazol-3-ylboronic acid(3.0 g, 0.014 mol), 2-bromo-9,9-dimethyl-9H-fluorene(3.2 g, 0.012 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 11-1> 3.2 g (수율 67%)을 얻었다. (m/z=359)
The same procedure as in Example 1 (6) was repeated except that 9H-carbazol-3-ylboronic acid (3.0 g, 0.014 mol) and 2-bromo-9,9- Synthesis was conducted in the same manner to obtain 3.2 g (yield 67%) of Intermediate 11-1. (m / z = 359)
(2) (2) 제조예Manufacturing example 2 : 화합물 441의 합성 2: Synthesis of compound 441
중간체 1-4(3.0 g, 0.008 mol)에 중간체 11-1(3.2 g, 0.008 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 441> 3.9 g (수율 73%)을 얻었다.(3.2 g, 0.008 mol) was added to Intermediate 1-4 (3.0 g, 0.008 mol) in the same manner as in Example 1- (2) 73%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 7.94/d, 7.93/d, 7.69/d, 7.63/d, 7.61/d, 7.55/d, 7.41/m, 7.41/d, 7.38/m, 7.33/m, 7.28/m, 7.27/m, 7.25/m, 7.14/m) 2H(8.28/d, 7.87/d, 7.77/s, 7.51/m, 7.26/d) 4H(1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 7.94 / d, 7.93 / d, 7.69 / d, 7.63 / d, 7.61 / d, 7.55 / d, 7.41 / m, 7.41 / d 7.28 / m, 7.17 / m) 2H (8.28 / d, 7.87 / d, 7.77 / s, 7.51 / m, 7.26 / / s)
LC/MS: m/z=668[(M+1)+]
LC / MS: m / z = 668 [(M + 1) < + &
실시예Example 12 : 화합물 450의 합성 12: Synthesis of Compound 450
(1) (One) 제조예Manufacturing example 1 : 중간체 12-1의 합성 1: Synthesis of Intermediate 12-1
1,4-dibromobenzene(3.5 g, 0.015 mol), dibenzo[b,d]thiophen-4-ylboronic acid(4.1 g, 0.018 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 12-1> 3.6 g (수율 71%)을 얻었다. (m/z=339)
Synthesis was carried out in the same manner as in Example 1 (6) except that 1,4-dibromobenzene (3.5 g, 0.015 mol) and dibenzo [b, d] thiophen-4-ylboronic acid (4.1 g, 0.018 mol) To obtain 3.6 g (yield 71%) of Intermediate 12-1. (m / z < / RTI > = 339)
(2) (2) 제조예Manufacturing example 2 : 중간체 12-2의 합성 2: Synthesis of intermediate 12-2
중간체 7-2(2.1 g, 0.010 mol), 중간체 12-1(2.7 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 12-2> 3.4 g (수율 67%)을 얻었다. (m/z=425)
Intermediate 12-2 was obtained from Intermediate 7-2 (2.1 g, 0.010 mol) and Intermediate 12-1 (2.7 g, 0.008 mol) in the same manner as in Example 1- (6) (Yield: 67%). (m / z = 425)
(3) (3) 제조예Manufacturing example 3 : 화합물 450의 합성 3: Synthesis of Compound 450
중간체 1-4(3.0 g, 0.008 mol)에 중간체 12-2(3.4 g, 0.008 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 450> 4.3 g (수율 73%)을 얻었다.Synthesis was conducted in the same manner as in Example 1-Preparation Example (2), except that Intermediate 12 (3.4 g, 0.008 mol) was added to Intermediate 1-4 (3.0 g, 0.008 mol) 73%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 8.45/d, 8.41/d, 8.20/d, 7.98/d, 7.94/d, 7.79/d, 7.61/d, 7.59/d, 7.58/m, 7.52/m, 7.50/m, 7.43/m, 7.41/d, 7.41/m, 7.33/m, 7.27/m, 7.25/m, 7.14/m) 2H(8.28/d, 7.51/m, 7.26/d, 1.72/s) 4H(7.25/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 8.45 / d, 8.41 / d, 8.20 / d, 7.98 / d, 7.94 / d, 7.79 / d, 7.61 / d, 7.59 / d 7.58 m, 7.50 m, 7.50 m, 7.43 m, 7.41 / d, 7.41 m, 7.33 m, 7.27 m, 7.25 m, 7.14 m) , 7.26 / d, 1.72 / s) 4H (7.25 / d)
LC/MS: m/z=734[(M+1)+]
LC / MS: m / z = 734 [(M + 1) < + &
실시예Example 13 : 화합물 471의 합성 13: Synthesis of compound 471
(1) (One) 제조예Manufacturing example 1 : 화합물 471의 합성 1: Synthesis of compound 471
중간체 3-1(3.0 g, 0.011 mol)에 2-bromotriphenylene(3.5 g, 0.011 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 13> 5.8 g (수율 75%)을 얻었다.(2.5 g, 0.011 mol) was added to Intermediate 3-1 (3.0 g, 0.011 mol) and the compound obtained in Synthesis Example 2 (5.8 g, yield 75% %).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.93/d, 8.55/d, 8.12/d, 7.94/d, 7.90/m, 7.88/m, 7.87/d, 7.82/m, 7.77/s, 7.71/d, 7.69/d, 7.61/d, 7.41/d, 7.41/m, 7.25/m, 7.22/d, 7.14/m) 2H(8.90/s, 8.28/d, 8.10/d, 7.80/d, 7.51/m, 7.33/m, 7.20/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.93 / d, 8.55 / d, 8.12 / d, 7.94 / d, 7.90 / m, 7.88 / m, 7.87 / d, 7.82 / m, 7.77 / s , 7.71 / d, 7.69 / d, 7.61 / d, 7.41 / d, 7.41 / m, 7.25 / m, 7.22 / d, 7.14 / , 7.51 / m, 7.33 / m, 7.20 / s)
LC/MS: m/z=702[(M+1)+]
LC / MS: m / z = 702 [(M + 1) < + &
실시예Example 14 : 화합물 476의 합성 14: Synthesis of compound 476
(1) (One) 제조예Manufacturing example 1 : 중간체 14-1의 합성 1: Synthesis of intermediate 14-1
2-bromo-5-chloro-1H-benzo[d]imidazole(3.0 g, 0.013 mol)에 phenyl boronic acid(1.8 g, 0.015 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 14-1> 2.1 g (수율 71%)을 얻었다.(m/z=228)
Phenylboronic acid (1.8 g, 0.015 mol) was added to 2-bromo-5-chloro-1H-benzo [d] imidazole (3.0 g, 0.013 mol) in the same manner as in Example 1- To obtain 2.1 g (yield: 71%) of Intermediate 14-1 (m / z = 228)
(2) (2) 제조예Manufacturing example 2 : 중간체 14-2의 합성 2: Synthesis of intermediate 14-2
중간체 1-4'(4.4 g, 0.010 mol)에 중간체 14-1(1.8 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 14-2> 2.9 g (수율 71%)을 얻었다.(m/z=502)
Synthesis was conducted in the same manner as in Example 1 (6) to give Intermediate 14-1 (1.8 g, 0.008 mol) and Intermediate 14-2> 2.9 (4.4 g, 0.010 mol) g (yield: 71%). (m / z = 502)
(3) (3) 제조예Manufacturing example 3 : 중간체 14-3의 합성 3: Synthesis of intermediate 14-3
중간체 14-2(5.0 g, 0.010 mol)에 1,4-dibromobenzene(2.4 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 14-3> 4.8 g (수율 73%)을 얻었다.(m/z=657)
Intermediate 14-3> 4.8 g (0.010 mol) was obtained by synthesizing 1,4-dibromobenzene (2.4 g, 0.010 mol) in Intermediate 14-2 (5.0 g, 0.010 mol) g (yield: 73%). (m / z = 657)
(4) (4) 제조예Manufacturing example 4 : 중간체 14-4의 합성 4: Synthesis of intermediate 14-4
중간체 14-3(5.0 g, 0.008 mol)에 bis(pinacolato)dibron(2.5 g, 0.010 mol)를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 14-4> 4.1 g (수율 73%)을 얻었다.(m/z=704)
Synthesis was conducted in the same manner as in Example 1 (5), except that bis (pinacolato) dibron (2.5 g, 0.010 mol) was added to Intermediate 14-3 (5.0 g, 0.008 mol) g (yield: 73%). (m / z = 704)
(5) (5) 제조예Manufacturing example 5 : 화합물 476의 합성 5: Synthesis of compound 476
중간체 14-4(5.6 g, 0.008 mol)에 2-bromotriphenylene(2.1 g, 0.007 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 476> 4.1 g (수율 73%)을 얻었다.Synthesis was conducted in the same manner as in Example 1-Preparation Example (6), except that 2-bromotriphenylene (2.1 g, 0.007 mol) was added to Intermediate 14-4 (5.6 g, 0.008 mol) %).
H-NMR (200MHz, CDCl3):δ ppm, 1H(9.15/s, 8.29/d, 8.18/d, 8.07/d, 8.04/d, 7.92/d, 7.71/d, 7.61/d, 7.41/d, 7.33/m, 7.22/d, 7.14/d) 2H(8.93/d, 8.12/d, 7.88/m, 7.82/m, 7.79/d, 7.68/d, 7.41/m, 1.72/s) 4H(8.28/d, 7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (9.15 / s, 8.29 / d, 8.18 / d, 8.07 / d, 8.04 / d, 7.92 / d, 7.71 / d, 7.61 / d, 7.41 / d 8.38 / d, 7.88 / d, 7.79 / d, 7.68 / d, 7.41 / m, 1.72 / s) / d, 7.51 / m)
LC/MS: m/z=805[(M+1)+]
LC / MS: m / z = 805 [(M + 1) < + &
실시예Example 15 : 화합물 531의 합성 15: Synthesis of Compound 531
(1) (One) 제조예Manufacturing example 1 : 중간체 15-1의 합성 1: Synthesis of intermediate 15-1
3-iodo-1H-indole(3.0 g, 0.012 mol)에 phenyl boronic acid(1.7 g, 0.014 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 15-1> 1.6 g (수율 68%)을 얻었다.(m/z=193)
(Intermediate 15-1) was synthesized in the same manner as in Example 1 (6), except that phenyl boronic acid (1.7 g, 0.014 mol) was added to 3-iodo-1H-indole (3.0 g, 0.012 mol) 1.6 g (yield 68%) of (m / z = 193)
(2) (2) 제조예Manufacturing example 2 : 중간체 15-2의 합성 2: Synthesis of intermediate 15-2
중간체 15-1(1.4 g, 0.007 mol)에 methyl 2,6-dibromobenzoate(2.9 g, 0.010 mol)을 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 15-2> 1.8 g (수율 62%)을 얻었다.(m/z=406)
Intermediate 15-2 was synthesized in the same manner as in Example 1 (2) except that
(3) (3) 제조예Manufacturing example 3 : 중간체 15-3의 합성 3: Synthesis of intermediate 15-3
중간체 15-2(3.2 g, 0.008 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 15-3> 2.3 g (수율 70%)을 얻었다.(m/z=406)
2.3 g (yield: 70%) of Intermediate 15-3 (3.2 g, 0.008 mol) was obtained in the same manner as in Example 1- (3) = 406)
(4) (4) 제조예Manufacturing example 4 : 중간체 15-4의 합성 4: Synthesis of intermediate 15-4
중간체 15-3(4.5 g, 0.011 mol)를 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <중간체 15-4> 3.1g (수율 73%)을 얻었다.(m/z=388)
3.1 g (yield: 73%) of Intermediate 15-4 was obtained by the same procedure as in Example 1 (4), except that Intermediate 15-3 (4.5 g, 0.011 mol) = 388)
(5) (5) 제조예Manufacturing example 5 : 중간체 15-4'의 합성 5: Synthesis of intermediate 15-4 '
중간체 15-4(3.0 g, 0.008 mol)에 bis(pinacolato)dibron(2.5 g, 0.010 mol)를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 15-4'> 2.5 g (수율 71%)을 얻었다.(m/z=435)
Intermediate 15-4 'was synthesized in the same manner as in Example 1 (5) except that bis (pinacolato) dibron (2.5 g, 0.010 mol) was added to Intermediate 15-4 (3.0 g, 0.008 mol) 2.5 g (yield 71%) of the title compound was obtained (m / z = 435)
(6) (6) 제조예Manufacturing example 6 : 중간체 15-5의 합성 6: Synthesis of intermediate 15-5
중간체 15-4'(4.0 g, 0.009 mol)에 1,4-dibromobenzene(1.8 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 15-5> 2.6 g (수율 71%)을 얻었다.(m/z=464)
Intermediate 15-5 was synthesized in the same manner as in Example 1 (6) except that 1,4-dibromobenzene (1.8 g, 0.008 mol) was added to Intermediate 15-4 '(4.0 g, 0.009 mol) 2.6 g (yield: 71%) was obtained. (M / z = 464)
(7) (7) 제조예Manufacturing example 7 : 중간체 15-5'의 합성 7: Synthesis of intermediate 15-5 '
중간체 15-5(3.7 g, 0.008 mol)에 bis(pinacolato)dibron(2.5 g, 0.010 mol) 를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 15-5'> 2.9 g (수율 71%)을 얻었다.(m/z=511)
Intermediate 15-5 'was synthesized in the same manner as in Example 1 (5) except that bis (pinacolato) dibron (2.5 g, 0.010 mol) was added to Intermediate 15-5 (3.7 g, 0.008 mol) 2.9 g (71% yield) of the title compound was obtained. (M / z = 511)
(8) (8) 제조예Manufacturing example 8 : 화합물 531의 합성 8: Synthesis of Compound 531
중간체 15-5'(5.0 g, 0.010 mol)에 3-bromo-9-phenyl-9H-carbazole(2.6 g, 0.008 mol)를 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <화합물 531> 3.6 g (수율 71%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (4) except that 3-bromo-9-phenyl-9H-carbazole (2.6 g, 0.008 mol) was added to Intermediate 15-5 '(5.0 g, 0.010 mol) <Compound 531> 3.6 g (yield: 71%) was obtained.
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 7.99/d, 7.94/d, 7.87/d, 7.77/s, 7.71/d, 7.69/d, 7.45/m, 7.41/m, 7.36/s, 7.34/m, 7.25/m, 7.22/d, 7.04/d) 2H(7.58/m, 7.52/d, 7.51/m, 7.50/d, 7.33/m, 1.72/s) 4H(7.25/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 7.99 / d, 7.94 / d, 7.87 / d, 7.77 / s, 7.71 / d, 7.69 / d, 7.45 / m, 7.41 / m 7.51 / m, 7.50 / d, 7.33 / m, 1.72 / s) 4H (7.25 / m, 7.36 / s, 7.34 / m, 7.25 / / d)
LC/MS: m/z=627[(M+1)+]
LC / MS: m / z = 627 [(M + 1) < + &
실시예Example 16 : 화합물 540의 합성 16: Synthesis of compound 540
(1) (One) 제조예Manufacturing example 1 : 중간체 16-1의 합성 1: Synthesis of intermediate 16-1
중간체 15-1(1.4 g, 0.007 mol)에 methyl 2-bromobenzoate(2.1 g, 0.010 mol)을 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 16-1> 1.4 g (수율 62%)을 얻었다.(m/z=327)
Intermediate 16-1 (1.4 g, 0.007 mol) was synthesized in the same manner as in Example 1 (2), except that methyl 2-bromobenzoate (2.1 g, 0.010 mol) (Yield: 62%). (M / z = 327)
(2) (2) 제조예Manufacturing example 2 : 중간체 16-2의 합성 2: Synthesis of intermediate 16-2
중간체 16-1(2.6 g, 0.008 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 16-2> 1.8 g (수율 70%)을 얻었다.(m/z=327)
1.8 g (yield 70%) of <Intermediate 16-2> was obtained by the same method as employed in the preparation example (3) of Example 1, except that Intermediate 16-1 (2.6 g, 0.008 mol) = 327)
(3) (3) 제조예Manufacturing example 3 : 중간체 16-3의 합성 3: Synthesis of intermediate 16-3
중간체 16-2(3.6 g, 0.011 mol)를 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <중간체 16-3> 2.5 g (수율 73%)을 얻었다.(m/z=309)
2.5 g (yield 73%) of <Intermediate 16-3> was obtained by the same method as in Example 1 (4), except that Intermediate 16-2 (3.6 g, 0.011 mol) = 309)
(4) (4) 제조예Manufacturing example 4 : 중간체 16-4의 합성 4: Synthesis of intermediate 16-4
중간체 16-3(3.0 g, 0.010 mol)에 N-bromosuccinimide(1.8 g, 0.010 mol)에 DMF 100 mL를 넣고 20 ℃에서 8시간 교반하여 반응시켰다. 반응 종료 후 H20 : 아세트산에틸로 층분리 후 컬럼정제(n-Hexane : MC)하여 중간체 16-4을 1.9 g(48%)수득하였다.(m/z=388)
100 mL of DMF was added to N-bromosuccinimide (1.8 g, 0.010 mol) in Intermediate 16-3 (3.0 g, 0.010 mol) and the mixture was reacted at 20 ° C for 8 hours with stirring. After completion of the reaction H 2 0: After phase separation with ethyl acetate and column purification (n-Hexane: MC) to give the intermediate 16-4 1.9 g (48%) ( m / z = 388).
(5) (5) 제조예Manufacturing example 5 : 중간체 16-5의 합성 5: Synthesis of intermediate 16-5
중간체 16-4(3.0 g, 0.008 mol)에 bis(pinacolato)dibron (2.5 g, 0.010 mol)을 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 16-5>을 2.5 g(73%)수득하였다.(m/z=435)
Intermediate 16-5 was synthesized by the same method as in Example 1 (5) except that bis (pinacolato) dibron (2.5 g, 0.010 mol) was added to Intermediate 16-4 (3.0 g, 0.008 mol) 2.5 g (73%) of (m / z = 435)
(6) (6) 제조예Manufacturing example 6 : 중간체 16-6의 합성 6: Synthesis of intermediate 16-6
중간체 16-5(3.0 g, 0.007 mol)에 1,4-dibromobenzene(1.4 g, 0.006 mol)을 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 16-6>을2.0 g(73%)수득하였다.(m/z=464)
Intermediate 16-6 was synthesized in the same manner as in Example 1- (6), except that 1,4-dibromobenzene (1.4 g, 0.006 mol) was added to Intermediate 16-5 (3.0 g, 0.007 mol) 2.0 g (73%) of (m / z = 464)
(7) (7) 제조예Manufacturing example 7 : 중간체 16-7의 합성 7: Synthesis of intermediate 16-7
1,3-dihydroindolo[2,3-b]carbazole(5.0 g, 0.020 mol) N-bromosuccinimide (3.5 g, 0.020 mol)을 넣은 후 실시예 16-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <중간체 16-7> 2.8 g (수율 43%)을 얻었다.(m/z=335)
(2.5 g, 0.020 mol) and N-bromosuccinimide (3.5 g, 0.020 mol) were added to the reaction mixture and the mixture was reacted in the same manner as in Example 16 (4) (M / z = 335) of <Intermediate 16-7> (yield: 43%).
(8) (8) 제조예Manufacturing example 8 : 중간체 16-8의 합성 8: Synthesis of intermediate 16-8
중간체 25-1(5.0 g, 0.020 mol)에 phenyl-boronic acid(2.4 g, 0.024 mol)에 THF 100 mL를 넣고 -78 ℃에서 5시간 교반하여 반응시켰다. 반응종료 후 H20 :MC에 층분리 후 컬럼정제(n-HEXANE : MC)하여 중간체 16-8를 4.9 g (72%)수득하였다 (m/z =339)
To the intermediate 25-1 (5.0 g, 0.020 mol) was added 100 mL of THF to phenyl-boronic acid (2.4 g, 0.024 mol) and the mixture was reacted at -78 ° C for 5 hours with stirring. After completion of the reaction H 2 0: column purification after separating layer on MC: the (n-HEXANE MC) to afford the intermediate 16-8 4.9 g (72%) ( m / z = 339)
(9) (9) 제조예Manufacturing example 9 : 중간체 16-9의 합성 9: Synthesis of intermediate 16-9
중간체 16-8(6.3 g, 0.020 mol), methyl magnesium iodide(4.0 g, 0.024 mol)에 THF 100 mL를 넣고 -78 ℃에서 5시간 교반하여 반응시켰다. 반응종료 후H20 : MC에 층분리 후 컬럼정제(n-HEXANE : MC)하여 중간체 16-9를 5.3 g (90%)수득하였다 (m/z =296)
100 mL of THF was added to intermediate 16-8 (6.3 g, 0.020 mol) and methyl magnesium iodide (4.0 g, 0.024 mol), and the mixture was reacted at -78 ° C for 5 hours with stirring. After completion of the reaction H 2 0: column purification after separating layer on MC: the (n-HEXANE MC) to afford the intermediate 16-9 5.3 g (90%) ( m / z = 296)
(10) (10) 제조예Manufacturing example 10 : 중간체 16-10의 합성 10: Synthesis of intermediate 16-10
중간체 16-9(3.0 g, 0.010 mol)에 bromobenzene(1.6 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 16-10> 2.8 g (수율 75%)을 얻었다.(m/z=372)
(2.5 g, 0.010 mol) was added to intermediate 16-9 (3.0 g, 0.010 mol), and 2.8 g of Intermediate 16-10 (yield: 75%) was obtained in the same manner as in Example 1- %). (M / z = 372)
(11) (11) 제조예Manufacturing example 11 : 화합물 540의 합성 11: Synthesis of compound 540
중간체 16-6(5.0 g, 0.011 mol)에 중간체 16-10(4.1 g, 0.011 mol)을 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 16>을 6.1 g(73%)수득하였다.Compound 16 was synthesized in the same manner as in Example 1 (2) except that Intermediate 16-10 (4.1 g, 0.011 mol) was added to Intermediate 16-6 (5.0 g, 0.011 mol) 73%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.19/d, 8.12/d, 7.93/d, 7.76/d, 7.63/d, 7.50/m, 7.45/m, 7.41/m, 7.40/m, 7.37/d, 7.36/s, 7.30/d, 7.29/m, 7.26/d, 7.25/m, 7.22/s, 6.87/d) 2H(7.79/d, 7.68/d, 7.58/m, 7.52/d, 7.51/m, 7.50/d) 4H(1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.19 / d, 8.12 / d, 7.93 / d, 7.76 / d, 7.63 / d, 7.50 / m, 7.45 / m, 7.41 / m, 7.40 / m 7.7 / d, 7.68 / d, 7.29 / d, 7.36 / d, 7.26 / d, 7.25 / , 7.51 / m, 7.50 / d) 4H (1.72 / s)
LC/MS: m/z=756[(M+1)+]
LC / MS: m / z = 756 [(M + 1) < + &
실시예Example 17 : 화합물 572의 합성 17: Synthesis of compound 572
(1) (One) 제조예Manufacturing example 1 : 중간체 17-1의 합성 1: Synthesis of intermediate 17-1
중간체 15-4(3.0 g, 0.008 mol)에 3,6-dibromo-9H-carbazole(2.6 g, 0.008 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체17-1> 3.6 g (수율 71%)을 얻었다.(m/z=632)
Intermediate 17 (3.0 g, 0.008 mol) was added to 3,6-dibromo-9H-carbazole (2.6 g, 0.008 mol) -1> 3.6 g (yield: 71%). (M / z = 632)
(2) (2) 제조예Manufacturing example 2 : 화합물 572의 합성 2: Synthesis of compound 572
중간체 17-1(5.0 g, 0.008 mol)에 2-phenyl-1H-benzo[d]imidazole(3.1 g, 0.016 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 572> 5.6g (수율 81%)을 얻었다.(m/z=632)Synthesis was conducted in the same manner as in Example 1 (2) except that 2-phenyl-1H-benzo [d] imidazole (3.1 g, 0.016 mol) was added to Intermediate 17-1 (5.0 g, 0.008 mol) To obtain 5.6 g (yield: 81%) of the compound 572. (m / z = 632)
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.99/d, 7.94/d, 7.63/d, 7.62/d, 7.36/s, 7.34/m, 7.31/d, 7.27/m, 7.04/d) 2H(8.56/d, 7.59/d, 7.52/d, 7.50/s, 7.26/d, 1.72/s) 3H(7.41/m) 4H(8.28/d, 7.22/m) 6H(7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.99 / d, 7.94 / d, 7.63 / d, 7.62 / d, 7.36 / s, 7.34 / m, 7.31 / d, 7.27 / m, 7.04 / d M) 2H (8.56 / d, 7.59 / d, 7.52 / d, 7.50 / s, 7.26 / d, 1.72 / s)
LC/MS: m/z=860[(M+1)+]
LC / MS: m / z = 860 [(M + 1) < + &
실시예Example 18 : 화합물 573의 합성 18: Synthesis of compound 573
(1) (One) 제조예Manufacturing example 1 : 중간체 18-1의 합성 1: Synthesis of intermediate 18-1
중간체 15-5(3.7 g, 0.008 mol)에 1,3,5-tribromobenzene(2.2 g, 0.007 mol) 를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 15-5'> 3.1 g (수율 71%)을 얻었다.(m/z=619)
Intermediate 15-5 (3.7 g, 0.008 mol) was reacted with 1,3,5-tribromobenzene (2.2 g, 0.007 mol), and the reaction mixture was treated in the same manner as in Example 1- (M / z = 619) of 3.1 g (yield 71%).
(2) (2) 제조예Manufacturing example 2 : 화합물 573의 합성 2: Synthesis of compound 573
중간체 18-1(5.0 g, 0.008 mol)에 2-phenyl-1H-benzo[d]imidazole(3.1 g, 0.016 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 573> 4.8 g (수율 71%)을 얻었다.Synthesis was carried out in the same manner as in Example 1 (2) except that 2-phenyl-1H-benzo [d] imidazole (3.1 g, 0.016 mol) was added to Intermediate 18-1 (5.0 g, 0.008 mol) Compound 573> 4.8 g (71% yield) was obtained.
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.99/d, 7.71/d, 7.36/s, 7.34/m, 7.33/m, 7.22/d, 7.20/s, 7.04/d) 2H(7.52/d, 1.72/s) 4H(8.56/d, 8.28/d, 8.09/d, 7.59/d, 7.25/d, 7.41/m, 7.22/m) 6H(7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.99 / d, 7.71 / d, 7.36 / s, 7.34 / m, 7.33 / m, 7.22 / d, 7.20 / s, 7.04 / d) 2H (7.52 m), 6H (7.51 / m), < / RTI >
LC/MS: m/z=847[(M+1)+]
LC / MS: m / z = 847 [(M + 1) < + &
실시예Example 19 : 화합물 596의 합성 19: Synthesis of compound 596
(1) (One) 제조예Manufacturing example 1 : 중간체 19-1의 합성 1: Synthesis of intermediate 19-1
perchloropyrimidine(3.0 g, 0.013 mol)에 phenyl boronic acid(3.6 g, 0.030 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 19-1> 2.8 g (수율 71%)을 얻었다.(m/z=301)
2.8 g (71%) of Intermediate 19-1 was synthesized in the same manner as in Example 1 (6) except that phenyl boronic acid (3.6 g, 0.030 mol) was added to perchloropyrimidine (3.0 g, 0.013 mol) ). (M / z = 301)
(2) (2) 제조예Manufacturing example 2 : 중간체 19-2의 합성 2: Synthesis of intermediate 19-2
중간체 19-1(3.0 g, 0.010 mol)에 bis(pinacolato)dibron(3.0 g, 0.012 mol) 를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 19-2> 3.6 g (수율 74%)을 얻었다.(m/z=484)
Intermediate 19-2> 3.6 (4-aminopyridine) was synthesized in the same manner as in Example 1 (5) except that bis (pinacolato) dibron (3.0 g, 0.012 mol) g (yield: 74%). (m / z = 484)
(3) (3) 제조예Manufacturing example 3 : 중간체 19-3의 합성 3: Synthesis of intermediate 19-3
중간체 19-2(5.0 g, 0.010 mol)에 2-chloro-4,6-diphenyl-1,3,5-triazine (2.1 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 19-3> 3.5 g (수율 74%)을 얻었다.(m/z=589)
To the intermediate 19-2 (5.0 g, 0.010 mol) was added 2-chloro-4,6-diphenyl-1,3,5-triazine (2.1 g, 0.008 mol) Synthesis was conducted in the same manner to obtain 3.5 g (yield: 74%) of Intermediate 19-3 (m / z = 589)
(4) (4) 제조예Manufacturing example 4 : 화합물 596의 합성 4: Synthesis of compound 596
중간체 15-4(3.0 g, 0.009 mol)에 중간체 19-3(6.5 g, 0.011 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 596> 5.1 g (수율 74%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (6) to give Intermediate 15-3 (3.0 g, 0.009 mol) and Intermediate 19-3 (6.5 g, 0.011 mol) 74%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.99/d, 7.71/d, 7.36/s, 7.34/m, 7.33/m, 7.22/d, 7.04/d) 2H(7.52/d, 1.72/s) 4H(8.28/d, 7.79/d) 5H(7.41/m) 10H(7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.99 / d, 7.71 / d, 7.36 / s, 7.34 / m, 7.33 / m, 7.22 / d, 7.04 / d) 2H (7.52 / d, 1.72 / s) 4H (8.28 / d, 7.79 / d) 5H (7.41 / m) 10H (7.51 /
LC/MS: m/z=771[(M+1)+]
LC / MS: m / z = 771 [(M + 1) < + &
실시예Example 20 : 화합물 609의 합성 20: Synthesis of Compound 609
(1) (One) 제조예Manufacturing example 1 : 중간체 20-1의 합성 1: Synthesis of intermediate 20-1
중간체 15-4'(4.0 g, 0.009 mol)에 1,3,5-tribromobenzene(2.5 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 20-1> 3.1 g (수율 71%)을 얻었다.(m/z=543)
Intermediate 20-4 was synthesized in the same manner as in Example 1- (6) except that 1,3,5-tribromobenzene (2.5 g, 0.008 mol) was added to Intermediate 15-4 '(4.0 g, 0.009 mol) 1> 3.1 g (yield: 71%). (M / z = 543)
(2) (2) 제조예Manufacturing example 2 : 중간체 20-2의 합성 2: Synthesis of intermediate 20-2
중간체 20-1(4.9 g, 0.009 mol)에 bis(pinacolato)dibron(2.7 g, 0.011 mol)를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 20-2> 4.1 g (수율 71%)을 얻었다.(m/z=637)
Intermediate 20-2 was synthesized according to the same procedure as in Preparation Example 5 (5), except that bis (pinacolato) dibron (2.7 g, 0.011 mol) was added to Intermediate 20-1 (4.9 g, 0.009 mol) g (yield: 71%). (m / z = 637)
(3) (3) 제조예Manufacturing example 3 : 화합물 609의 합성 3: Synthesis of Compound 609
중간체 20-2(5.0 g, 0.008 mol)에 2-bromo-1,8-naphthyridine(3.0 g, 0.014 mol)를 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <화합물 609> 3.2 g (수율 71%)을 얻었다.Synthesis was carried out in the same manner as in Example 1 (4), except that 2-bromo-1,8-naphthyridine (3.0 g, 0.014 mol) was added to Intermediate 20-2 (5.0 g, 0.008 mol) > 3.2 g (yield 71%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.68/s, 7.99/d, 7.71/d, 7.41/m, 7.36/s, 7.34/m, 7.33/m, 7.22/d, 7.04/d) 2H(8.70/d, 8.39/d, 8.23/d, 8.11/d, 7.61/d, 7.52/d, 7.51/m, 7.41/m, 1.72/s)7.36 / s, 7.32 / d, 7.02 / d, 7.04 / d (1 H-NMR (200 MHz, CDCl 3 ) D, 7.61 / d, 7.52 / d, 7.51 / m, 7.41 / m, 1.72 / s)
LC/MS: m/z=642[(M+1)+]
LC / MS: m / z = 642 [(M + 1) < + &
실시예Example 21 : 화합물 647의 합성 21: Synthesis of Compound 647
(1) (One) 제조예Manufacturing example 1 : 중간체 21-1의 합성 1: Synthesis of intermediate 21-1
2-iodo-1H-benzo[d]imidazole(3.0 g, 0.012 mol)에 phenyl boronic acid(1.7 g, 0.014 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 21-1> 1.5 g (수율 65%)을 얻었다.(m/z=194)
Was synthesized in the same manner as in Example 1 (6), except that phenyl boronic acid (1.7 g, 0.014 mol) was added to 2-iodo-1H- benzo [d] imidazole (3.0 g, 0.012 mol) 21-1> 1.5 g (yield 65%). (M / z = 194)
(2) (2) 제조예Manufacturing example 2 : 중간체 21-2의 합성 2: Synthesis of intermediate 21-2
중간체 21-1(2.0 g, 0.010 mol), methyl 3-bromo-6-fluoropicolinate(2.3 g, 0.010 mol)을 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 21-2> 2.2 g (수율 64%)을 얻었다.(m/z=347)
Intermediate 21-1 (2.0 g, 0.010 mol) and methyl 3-bromo-6-fluoropicolinate (2.3 g, 0.010 mol) were placed in a manner similar to that used in Example 1- 2> 2.2 g (yield 64%). (M / z = 347)
(3) (3) 제조예Manufacturing example 3 : 중간체 21-3의 합성 3: Synthesis of intermediate 21-3
중간체 21-2(3.0 g, 0.009 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 21-3> 1.7 g (수율 72%)을 얻었다.(m/z=347)
Intermediate 21-2 (3.0 g, 0.009 mol) was used to synthesize 1.7 g (yield 72%) of Intermediate 21-3 in the same manner as in Example 1- (3) = 347)
(4) (4) 제조예Manufacturing example 4 : 중간체 21-4의 합성 4: Synthesis of Intermediate 21-4
중간체 21-3(3.0 g, 0.009 mol)을 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <중간체 21-4> 2.1 g (수율 70%)을 얻었다.(m/z=329)
2.1 g (yield: 70%) of Intermediate 21-4 was obtained by the same procedure as in Example 1 (4), except that Intermediate 21-3 (3.0 g, 0.009 mol) = 329)
(5) (5) 제조예Manufacturing example 5 : 중간체 21-5의 합성 5: Synthesis of intermediate 21-5
2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine(3.0 g, 0.008 mol)에 bis(pinacolato)dibron(2.5 g, 0.010 mol)를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 21-5> 2.6 g (수율 74%)을 얻었다.(m/z=435)
(Pinacolato) dibron (2.5 g, 0.010 mol) was added to 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.0 g, 0.008 mol) 5) (2.6 g, yield 74%) as an intermediate 21-5 (m / z = 435).
(6) (6) 제조예Manufacturing example 6 : 화합물 647의 합성 6: Synthesis of Compound 647
중간체 21-4(3.0 g, 0.009 mol)에 중간체 21-5(3.9 g, 0.011 mol)를 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <화합물 647> 4.1g (수율 74%)을 얻었다.Intermediate 21-5 (3.9 g, 0.011 mol) was added to Intermediate 21-4 (3.0 g, 0.009 mol) and the compound was synthesized by the same method as in Example 1 (4) 74%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.82/d, 7.77/d, 7.61/d, 7.41/d, 7.14/m) 2H(8.81/d, 7.88/d, 1.72/s) 3H(7.41/m) 6H(8.28/d, 7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.82 / d, 7.77 / d, 7.61 / d, 7.41 / d, 7.14 / m) 2H (8.81 / d, 7.88 / d, 1.72 / s) 3H (7.41 / m) 6H (8.28 / d, 7.51 / m)
LC/MS: m/z=619[(M+1)+]
LC / MS: m / z = 619 [(M + 1) < + &
실시예Example 22 : 화합물 656의 합성 22: Synthesis of Compound 656
(1) (One) 제조예Manufacturing example 1 : 중간체 22-1의 합성 1: Synthesis of Intermediate 22-1
중간체 21-1(2.0 g, 0.010 mol)에 methyl 2-bromo-5-iodoisonicotinate(5.1 g, 0.015 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 22-1> 2.8 g (수율 68%)을 얻었다.(m/z=408)
Intermediate 22-1 (2.0 g, 0.010 mol) was synthesized in the same manner as in Example 1 (2) except that methyl 2-bromo-5-iodoisonicotinate (5.1 g, 0.015 mol) 1> 2.8 g (yield: 68%). (M / z = 408)
(2) (2) 제조예Manufacturing example 2 : 중간체 22-2의 합성 2: Synthesis of Intermediate 22-2
중간체 22-1(3.0 g, 0.007 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 22-2> 1.9 g (수율 67%)을 얻었다.(m/z=408)
Intermediate 22-1 (3.0 g, 0.007 mol) was synthesized in the same manner as in Example 1 (3) to give 1.9 g (yield 67%) of Intermediate 22-2. M / z = 408)
(3) (3) 제조예Manufacturing example 3 : 중간체 22-3의 합성 3: Synthesis of intermediate 22-3
중간체 22-2(3.0 g, 0.007 mol)을 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <중간체 22-3> 2.1g (수율 74%)을 얻었다.(m/z=408)
2.1 g (yield 74%) of Intermediate 22-3 was obtained by the same method as in Example 1 (4), except that Intermediate 22-2 (3.0 g, 0.007 mol) was added. M / z = 408)
(4) (4) 제조예Manufacturing example 4 : 중간체 22-4의 합성 4: Synthesis of intermediate 22-4
triphenylen-2-ylboronic acid(3.0 g, 0.011 mol)에 1,4-dibromobenzene (2.1 g, 0.009 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 22-4> 2.6 g (수율 74%)을 얻었다.(m/z=383)
dibromobenzene (2.1 g, 0.009 mol) was added to triphenylen-2-ylboronic acid (3.0 g, 0.011 mol) in the same manner as in Example 1 (6) > 2.6 g (yield: 74%). (M / z = 383)
(5) (5) 제조예Manufacturing example 5 : 중간체 22-5의 합성 5: Synthesis of intermediate 22-5
중간체 22-4(3.0 g, 0.008 mol)에 bis(pinacolato)dibron(2.5 g, 0.010 mol)를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 22-5> 2.5 g (수율 74%)을 얻었다.(m/z=430)
(Intermediate 22-5) 2.5 (2.5 g, 0.010 mol) was added to Intermediate 22-4 (3.0 g, 0.008 mol) and bis (pinacolato) dibron g (yield: 74%). (m / z = 430)
(6) (6) 제조예Manufacturing example 6 : 화합물 656의 합성 6: Synthesis of compound 656
중간체 22-4(3.0 g, 0.008 mol)에 중간체 22-5(4.3 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 22> 3.5 g (수율 72%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (6) to give Intermediate 22-5 (4.3 g, 0.010 mol) and Intermediate 22-4 (3.0 g, 0.008 mol) 72%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(9.15/s, 8.60/s, 8.18/d, 8.04/d, 7.91/d, 7.61/d, 7.41/d, 7.41/m, 7.14/m) 2H(8.93/d, 8.81/d, 8.28/d, 8.12/d, 7.88/m, 7.88/d, 7.82/m, 7.51/m, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (9.15 / s, 8.60 / s, 8.18 / d, 8.04 / d, 7.91 / d, 7.61 / d, 7.41 / d, 7.41 / m, 7.14 / m 7.81 / d, 7.88 / d, 7.82 / m, 7.51 / m, 1.72 / s)
LC/MS: m/z=614[(M+1)+]
LC / MS: m / z = 614 [(M + 1) < + &
실시예Example 23 : 화합물 662의 합성 23: Synthesis of Compound 662
(1) (One) 제조예Manufacturing example 1 : 중간체 23-1의 합성 1: Synthesis of intermediate 23-1
중간체 21-1(2.0 g, 0.010 mol)에 methyl 6-bromo-3-iodopyrazine-2-carboxylate(5.1 g, 0.015 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 23-1> 2.8 g (수율 68%)을 얻었다.(m/z=409)
2-carboxylate (5.1 g, 0.015 mol) was added to Intermediate 21-1 (2.0 g, 0.010 mol) in the same manner as in Example 1 (2) (M / z = 409) of <Intermediate 23-1> (yield: 68%).
(2) (2) 제조예Manufacturing example 2 : 중간체 23-2의 합성 2: Synthesis of intermediate 23-2
중간체 23-1(3.0 g, 0.009 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 23-2> 2.7 g (수율 72%)을 얻었다.(m/z=409)
2.7 g (yield 72%) of Intermediate 23-2 was obtained by the same method as in Example 1 (3), except that Intermediate 23-1 (3.0 g, 0.009 mol) was added. M / z = 409)
(3) (3) 제조예Manufacturing example 3 : 중간체 23-3의 합성 3: Synthesis of intermediate 23-3
중간체 23-2(3.0 g, 0.007 mol)을 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <중간체 23-3> 2.0 g (수율 74%)을 얻었다.(m/z=391)
2.0 g (yield 74%) of Intermediate 23-3 was obtained in the same manner as in Example 1- (4), except that Intermediate 23-2 (3.0 g, 0.007 mol) = 391)
(4) (4) 제조예Manufacturing example 4 : 중간체 23-4의 합성 4: Synthesis of intermediate 23-4
9-phenyl-9H-carbazol-3-ylboronic acid(3.0 g, 0.010 mol)에 1,4-dibromobenzene(1.9 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 23-4> 2.3 g (수율 72%)을 얻었다.(m/z=398)
Synthesis was carried out in the same manner as in Example 1 (6), except that 1,4-dibromobenzene (1.9 g, 0.008 mol) was added to 9-phenyl-9H-carbazol-3-ylboronic acid (3.0 g, 0.010 mol) 2.3 g (yield: 72%) of Intermediate 23-4 was obtained (m / z = 398)
(5) (5) 제조예Manufacturing example 5 : 중간체 23-5의 합성 5: Synthesis of intermediate 23-5
중간체 23-4(3.0 g, 0.008 mol)에 bis(pinacolato)dibron(2.5 g, 0.010 mol) 를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 23-5> 2.6 g (수율 72%)을 얻었다.(m/z=445)
(Intermediate 23-5) 2.6 (0.2 g, 0.010 mol) was added to Intermediate 23-4 (3.0 g, 0.008 mol) and bis (pinacolato) dibron g (yield: 72%). (m / z = 445)
(6) (6) 제조예Manufacturing example 6 : 화합물 662의 합성 6: Synthesis of Compound 662
중간체 23-4(3.0 g, 0.008 mol)에 중간체 23-5(4.5 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 662> 3.6 g (수율 72%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (6) to give Intermediate 23-5 (3.0 g, 0.008 mol) and Intermediate 23-5 (4.5 g, 0.010 mol) 72%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 8.54/s, 7.94/d, 7.87/d, 7.77/s, 7.69/d, 7.61/d, 7.45/m, 7.41/m, 7.41/d, 7.33/m, 7.25/m, 7.14/m) 2H(8.30/d, 8.28/d, 7.85/d, 7.58/m, 7.51/m, 7.50/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 8.54 / s, 7.94 / d, 7.87 / d, 7.77 / s, 7.69 / d, 7.61 / d, 7.45 / m, 7.41 / m 7.51 / m, 7.14 / m) 2H (8.30 d, 8.28 d, 7.85 d, 7.58 m, 7.51 m, 7.50 d, 1.72 s)
LC/MS: m/z=630[(M+1)+]
LC / MS: m / z = 630 [(M + 1) < + &
실시예Example 24 : 화합물 651의 합성 24: Synthesis of Compound 651
(1) (One) 제조예Manufacturing example 1 : 중간체 24-1의 합성 1: Synthesis of intermediate 24-1
8-iodo-7H-purine (3.0g ,0.012mol)에 phenyl boronic acid(1.7g,0.014mol) 를 넣고 실시예1-제조예(6)에서 사용된 동일한 방법으로 합성하여 <중간체24-1>1.4g (수율 60%)을 얻었다.(m/z=196)
Synthesis was conducted in the same manner as in Example 1 (6), except that phenyl boronic acid (1.7 g, 0.014 mol) was added to 8-iodo-7H-purine (3.0 g, 0.012 mol) 1.4 g (yield: 60%) was obtained. (M / z = 196)
(2) (2) 제조예Manufacturing example 2 : 중간체 24-2의 합성 2: Synthesis of intermediate 24-2
중간체 24-1(2.0 g, 0.010 mol)에 methyl 2,6-dibromobenzoate(4.4 g, 0.015 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 24-2> 2.8 g (수율 68%)을 얻었다.(m/z=409)
Intermediate 24-2 was synthesized in the same manner as in Example 1 (2) except that
(3) (3) 제조예Manufacturing example 3 : 중간체 24-3의 합성 3: Synthesis of intermediate 24-3
중간체 24-2(3.0 g, 0.007 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 24-3> 2.1 g (수율 72%)을 얻었다.(m/z=409)
2.1 g (yield 72%) of Intermediate 24-3 was obtained in the same manner as in Example 1- (3), except that Intermediate 24-2 (3.0 g, 0.007 mol) = 409)
(4) (4) 제조예Manufacturing example 4 : 중간체 24-4의 합성 4: Synthesis of intermediate 24-4
중간체 24-3(3.0 g, 0.007 mol)을 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <중간체 24-4> 2.0 g (수율 72%)을 얻었다.(m/z=391)
2.0 g (yield 72%) of <Intermediate 24-4> was obtained by the same method as in Example 1- (4), except that Intermediate 24-3 (3.0 g, 0.007 mol) = 391)
(5) (5) 제조예Manufacturing example 5 : 화합물 651의 합성 5: Synthesis of Compound 651
중간체 24-4(3.0 g, 0.008 mol)에 중간체 21-5(4.4 g, 0.010 mol)를 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <화합물 651> 3.6 g (수율 72%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (4), except that Intermediate 21-5 (4.4 g, 0.010 mol) was added to Intermediate 24-4 (3.0 g, 0.008 mol) 72%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.86/s, 7.86/s, 7.61/d, 7.60/d) 2H(7.85/d, 7.25/d, 1.72/s) 3H(7.41/m) 6H(8.28/d, 7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.86 / s, 7.86 / s, 7.61 / d, 7.60 / d) 2H (7.85 / d, 7.25 / d, 1.72 / s) 3H (7.41 / m ) 6H (8.28 / d, 7.51 / m)
LC/MS: m/z=620[(M+1)+]
LC / MS: m / z = 620 [(M + 1) < + &
실시예Example 25 : 화합물 664의 합성 25: Synthesis of compound 664
(1) (One) 제조예Manufacturing example 1 : 중간체 25-1의 합성 1: Synthesis of intermediate 25-1
2-amino-5-chlorophenol(3.0 g, 0.014 mol)에 1,2,3-tribromobenzene5(4.4 g, 0.014 mol)를 넣고 PPA(polyphosphoric acid) 100 mL를 넣고 180 ℃에서 4시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane : MC)하여 중간체 25-1을 2.1 g(51%)수득하였다.(m/z=296)
1,2,3-tribromobenzene 5 (4.4 g, 0.014 mol) was added to 2-amino-5-chlorophenol (3.0 g, 0.014 mol) and 100 mL of PPA (polyphosphoric acid) was added thereto and reacted at 180 ° C. for 4 hours with stirring. After completion of the reaction, the reaction mixture was cooled, and the product was separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 2.1 g (51%) of Intermediate 25-1 (m / z = 296)
(2) (2) 제조예Manufacturing example 2 : 중간체 25-2의 합성 2: Synthesis of intermediate 25-2
중간체 25-1(3.0 g, 0.010 mol)에 carbonimidic dibromide(2.2 g, 0.012 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 25-2> 1.8 g (수율 57%)을 얻었다.(m/z=321)
Intermediate 25-1 (3.0 g, 0.010 mol) was reacted with carbonimidic dibromide (2.2 g, 0.012 mol), and the reaction mixture was reacted in the same manner as in Example 1 (2) 25-2> 1.8 g (yield: 57%). (M / z = 321)
(3) (3) 제조예Manufacturing example 3 : 중간체 25-3의 합성 3: Synthesis of intermediate 25-3
중간체 25-2(3.0 g, 0.010 mol)에 phenyl boronic acid(1.5 g, 0.012 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 25-3> 2.2 g (수율 70%)을 얻었다.(m/z=318)
Intermediate 25-3 was synthesized in the same manner as in Example 1 (6), except that phenyl boronic acid (1.5 g, 0.012 mol) was added to Intermediate 25-2 (3.0 g, 0.010 mol) Yield: 70%). (M / z = 318)
(4) (4) 제조예Manufacturing example 4 : 화합물 664의 합성 4: Synthesis of Compound 664
중간체 25-3(3.0 g, 0.010 mol)에 중간체 22-5(5.1 g, 0.012 mol)를 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <화합물 664> 4.1 g (수율 70%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (4) to give Intermediate 22-5 (5.1 g, 0.012 mol) and Intermediate 25-3 (3.0 g, 0.010 mol) 70%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(9.15/s, 8.18/d, 8.04/d, 7.64/d, 7.41/m, 7.31/d, 7.18/m, 7.08/d) 2H(8.93/d, 8.28/d, 8.12/d, 7.88/m, 7.82/m, 7.51/m, 7.51/d) 4H(7.25/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (9.15 / s, 8.18 / d, 8.04 / d, 7.64 / d, 7.41 / m, 7.31 / d, 7.18 / m, 7.08 / d) 2H (8.93 d, 8.28 d, 8.12 d, 7.88 m, 7.82 m, 7.51 m, 7.51 d) 4H (7.25 d)
LC/MS: m/z=587[(M+1)+]
LC / MS: m / z = 587 [(M + 1) < + &
실시예Example 26 : 화합물 671의 합성 26: Synthesis of Compound 671
(1) (One) 제조예Manufacturing example 1 : 중간체 26-1의 합성 1: Synthesis of intermediate 26-1
5-chlorobenzene-1,2-diamine(2.2 g, 0.010 mol)에 1,2,3-tribromobenzene(3.7 g, 0.012 mol)를 넣고 실시예 25-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 26-1> 1.4 g (수율 48%)을 얻었다.(m/z=295)
1,2,3-tribromobenzene (3.7 g, 0.012 mol) was added to 5-chlorobenzene-1,2-diamine (2.2 g, 0.010 mol) in the same manner as in Example 25- 1.4 g (yield: 48%) of Intermediate 26-1 (m / z = 295) was obtained.
(2) (2) 제조예Manufacturing example 2 : 중간체 26-2의 합성 2: Synthesis of intermediate 26-2
중간체 26-1(3.0 g, 0.010 mol)에 1,1-dibromoethene(2.1 g, 0.012 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 26-2> 1.8 g (수율 57%)을 얻었다.(m/z=320)
<Intermediate 26-2> 1.8 (dibromoethene) was synthesized in the same manner as in Example 1 (2) except that 1,1-dibromoethene (2.1 g, 0.012 mol) was added to Intermediate 26-1 g (yield: 57%). (m / z = 320)
(3) (3) 제조예Manufacturing example 3 : 중간체 26-3의 합성 3: Synthesis of intermediate 26-3
중간체 26-2(3.0 g, 0.010 mol)에 phenyl boronic acid(1.5 g, 0.012 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 26-3> 2.0 g (수율 71%)을 얻었다.(m/z=283)
2.0 g of Intermediate 26-3 was synthesized in the same manner as in Example 1 (6) except that phenyl boronic acid (1.5 g, 0.012 mol) was added to Intermediate 26-2 (3.0 g, 0.010 mol) Yield: 71%). (M / z = 283)
(4) (4) 제조예Manufacturing example 4 : 중간체 26-4의 합성 4: Synthesis of intermediate 26-4
중간체 26-3(3.0 g, 0.010 mol)에 bromobenzene(1.6 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 26-4> 2.8 g (수율 71%)을 얻었다.(m/z=393)
(2.5 g, 0.010 mol) was added to intermediate 26-3 (3.0 g, 0.010 mol), and 2.8 g (yield: 71%) of Intermediate 26-4 was synthesized in the same manner as in Example 1- %). (M / z = 393)
(5) (5) 제조예Manufacturing example 5 : 화합물 671의 합성 5: Synthesis of Compound 671
중간체 26-4(3.0 g, 0.008 mol)에 중간체 21-5(4.3 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 671> 3.9 g (수율 73%)을 얻었다.Intermediate 21-5 (4.3 g, 0.010 mol) was added to Intermediate 26-4 (3.0 g, 0.008 mol) and the compound obtained in Synthesis Example 6 was reacted with 3.9 g (yield: 73%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.43/d, 7.15/d, 6.97/m, 6.95/d, 6.89/s, 6.81/m, 6.46/d) 2H(7.85/d, 7.25/d, 7.20/m, 6.63/d) 3H(7.41/m) 6H(8.28/d, 7.51/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.43 / d, 7.15 / d, 6.97 / m, 6.95 / d, 6.89 / s, 6.81 / m, 6.46 / d) 2H (7.85 / d, 7.25 / d, 7.20 / m, 6.63 / d) 3H (7.41 / m) 6H (8.28 / d, 7.51 / d)
LC/MS: m/z=667[(M+1)+]
LC / MS: m / z = 667 [(M + 1) < + &
실시예Example 27 : 화합물 678의 합성 27: Synthesis of compound 678
(1) (One) 제조예Manufacturing example 1 : 중간체 27-1의 합성 1: Synthesis of intermediate 27-1
benzene-1,2-diamine(1.9 g, 0.010 mol)에 1,2,3-tribromobenzene6(3.7 g, 0.012 mol)를 넣고 실시예 25-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 27-1> 1.4 g (수율 52%)을 얻었다.(m/z=261)
1,2,3-tribromobenzene-6 (3.7 g, 0.012 mol) was added to benzene-1,2-diamine (1.9 g, 0.010 mol) (M / z = 261) was obtained in an amount of 1.4 g (yield: 52%).
(2) (2) 제조예Manufacturing example 2 : 중간체 27-2의 합성 2: Synthesis of intermediate 27-2
중간체 27-1(2.6 g, 0.010 mol)에 1,1-dibromoethene(2.1 g, 0.012 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 26-2> 1.7 g (수율 59%)을 얻었다.(m/z=286)
<Intermediate 26-2> 1.7 (1) Synthesis was conducted in the same manner as in Example 1 (2) except that 1,1-dibromoethene (2.1 g, 0.012 mol) was added to Intermediate 27-1 g (yield: 59%). (m / z = 286)
(3) (3) 제조예Manufacturing example 3 : 중간체 27-3의 합성 3: Synthesis of intermediate 27-3
중간체 27-2(3.0 g, 0.0010 mol)에 phenyl boronic acid(1.5 g, 0.012 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 27-3> 2.1 g (수율 73%)을 얻었다.(m/z=283)
2.1 g (intermediate 27-3) was synthesized in the same manner as in Example 1 (6), except that phenyl boronic acid (1.5 g, 0.012 mol) was added to Intermediate 27-2 (3.0 g, 0.0010 mol) Yield: 73%). (M / z = 283)
(4) (4) 제조예Manufacturing example 4 : 화합물 678의 합성 4: Synthesis of Compound 678
중간체 27-3(3.0 g, 0.0010 mol)에 중간체 23-4(4.0 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 678> 4.6 g (수율 77%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (2) to give Intermediate 23-4 (4.0 g, 0.010 mol) and Intermediate 27-3 (3.0 g, 0.0010 mol) 77%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 7.94/d, 7.87/d, 7.77/s, 7.69/d, 7.45/m, 7.41/m, 7.37/d, 7.33/m, 7.25/m, 7.20/m, 6.97/m, 6.95/d, 6.94/m, 6.63/d, 6.46/d) 2H(8.28/d, 7.58/m, 7.54/d, 7.51/m, 7.50/d, 6.69/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 7.94 / d, 7.87 / d, 7.77 / s, 7.69 / d, 7.45 / m, 7.41 / m, 7.37 / d, 7.33 / m 7.58 / m, 6.95 / d, 6.94 / m, 6.63 / d, 6.46 / d) 2H (8.28 / d, 7.58 / , 6.69 / d)
LC/MS: m/z=601[(M+1)+]
LC / MS: m / z = 601 [(M + 1) < + &
실시예Example 28 : 화합물 668의 합성 28: Synthesis of compound 668
(1) (One) 제조예Manufacturing example 1 : 중간체 28-1의 합성 1: Synthesis of intermediate 28-1
2-amino-5-chlorobenzenethiol(2.4 g, 0.010 mol)에 1,2,3-tribromobenzene6(3.7 g, 0.012 mol)를 넣고 실시예 25-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 28-1> 1.3 g (수율 41%)을 얻었다.(m/z=312)
1,2,3-tribromobenzene6 (3.7 g, 0.012 mol) was added to 2-amino-5-chlorobenzenethiol (2.4 g, 0.010 mol) (M / z = 312) (yield: 41%).
(2) (2) 제조예Manufacturing example 2 : 중간체 28-2의 합성 2: Synthesis of intermediate 28-2
중간체 28-1(3.1 g, 0.010 mol)에 1,1-dibromoethene(2.1 g, 0.012 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 28-2> 1.9g (수율 55%)을 얻었다.(m/z=337)
Intermediate 28-2 1.9 g (0.012 mol) was obtained by synthesizing 1,1-dibromoethene (2.1 g, 0.012 mol) in Intermediate 28-1 (3.1 g, 0.010 mol) g (yield: 55%). (m / z = 337)
(3) (3) 제조예Manufacturing example 3 : 중간체 28-3의 합성 3: Synthesis of intermediate 28-3
중간체 28-2(3.0 g, 0.0009 mol)에 phenyl boronic acid(1.5 g, 0.011 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 28-3> 2.1 g (수율 71%)을 얻었다.(m/z=334)
2.1 g (intermediate 28-3) was synthesized in the same manner as in Example 1 (6) except that phenyl boronic acid (1.5 g, 0.011 mol) was added to Intermediate 28-2 (3.0 g, 0.0009 mol) Yield: 71%). (M / z = 334)
(4) (4) 제조예Manufacturing example 4 : 화합물 668의 합성 4: Synthesis of compound 668
중간체 28-3(3.0 g, 0.0009 mol)에 중간체 22-5(4.7 g, 0.011 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 668> 4.0 g (수율 73%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (6) to give Intermediate 22-5 (4.7 g, 0.011 mol) and Intermediate 28-3 (3.0 g, 0.0009 mol) 73%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(9.15/s, 8.18/d, 8.04/d, 7.53/d, 7.48/d, 7.41/m, 7.40/s, 7.33/d, 7.20/d, 7.02/m) 2H(8.93/d, 8.28/d, 8.12/d, 7.88/m, 7.82/m, 7.51/m) 4H(7.25/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (9.15 / s, 8.18 / d, 8.04 / d, 7.53 / d, 7.48 / d, 7.41 / m, 7.40 / s, 7.33 / d, 7.20 / d , 7.02 / m) 2H (8.93 d, 8.28 d, 8.12 d, 7.88 m, 7.82 m, 7.51 m)
LC/MS: m/z=603[(M+1)+]
LC / MS: m / z = 603 [(M + 1) < + &
실시예Example 29 : 화합물 680의 합성 29: Synthesis of Compound 680
(1) (One) 제조예Manufacturing example 1 : 중간체 29-1의 합성 1: Synthesis of intermediate 29-1
6-bromo-3-chloro-2-(trimethylsilyl)aniline(2.8 g, 0.010 mol)에 1,2-dibromobenzene6(3.7 g, 0.012 mol)를 넣고 실시예 25-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 29-1> 1.5 g (수율 45%)을 얻었다.(m/z=338)
1,2-dibromobenzene6 (3.7 g, 0.012 mol) was added to 6-bromo-3-chloro-2- (trimethylsilyl) aniline (2.8 g, 0.010 mol) To obtain 1.5 g (yield: 45%) of Intermediate 29-1 (m / z = 338)
(2) (2) 제조예Manufacturing example 2 : 중간체 29-2의 합성 2: Synthesis of intermediate 29-2
중간체 29-1(3.0 g, 0.009 mol)에 1,1-dibromoethene(2.0 g, 0.011 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 29-2> 1.8g (수율 55%)을 얻었다.(m/z=362)
Intermediate 29-2> 1.8 (2.0 g, 0.011 mol) was synthesized in the same manner as in Example 1 (2) except that 1,1-dibromoethene (2.0 g, 0.011 mol) g (yield: 55%). (m / z = 362)
(3) (3) 제조예Manufacturing example 3 : 중간체 29-3의 합성 3: Synthesis of intermediate 29-3
중간체 29-2(3.0 g, 0.0008 mol)에 phenyl boronic acid(1.2 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 27-3> 1.8 g (수율 63%)을 얻었다.(m/z=361)
Intermediate 27-3 was synthesized in the same manner as in Example 1- (6), except that phenyl boronic acid (1.2 g, 0.010 mol) was added to Intermediate 29-2 (3.0 g, 0.0008 mol) Yield: 63%). (M / z = 361)
(4) (4) 제조예Manufacturing example 4 : 화합물 680의 합성 4: Synthesis of Compound 680
중간체 29-3(3.0 g, 0.008 mol)에 중간체 21-5(4.3 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 29> 3.6 g (수율 71%)을 얻었다.Synthesis was conducted in the same manner as in Example 1- (6), except that Intermediate 21-5 (4.3 g, 0.010 mol) was added to Intermediate 29-3 (3.0 g, 0.008 mol) 71%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.17/d, 7.75/d, 7.72/d, 7.68/m, 7.46/d, 7.37/m) 2H(7.85/d, 7.25/d, 0.66/s) 3H(7.41/m) 6H(8.28/d, 7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.17 / d, 7.75 / d, 7.72 / d, 7.68 / m, 7.46 / d, 7.37 / m) 2H (7.85 / d, 7.25 / d, 0.66 / s) 3H (7.41 / m) 6H (8.28 / d, 7.51 / m)
LC/MS: m/z=634[(M+1)+]
LC / MS: m / z = 634 [(M + 1) < + &
실시예Example 30 : 화합물 684의 합성 30: Synthesis of compound 684
(1) (One) 제조예Manufacturing example 1 : 중간체 30-1의 합성 1: Synthesis of intermediate 30-1
중간체 1-1(2.0 g, 0.010 mol)에 methyl 2-bromo-5-iodopyrimidine-4-carboxylate(5.1 g, 0.015 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 30-1> 2.5 g (수율 61%)을 얻었다.(m/z=409)
Synthesis was conducted in the same manner as in Example 1 (2) except that methyl 2-bromo-5-iodopyrimidine-4-carboxylate (5.1 g, 0.015 mol) was added to Intermediate 1-1 (2.0 g, 0.010 mol) 2.5 g (yield: 61%) of Intermediate 30-1 (m / z = 409)
(2) (2) 제조예Manufacturing example 2 : 중간체 30-2의 합성 2: Synthesis of intermediate 30-2
중간체 30-1(3.0 g, 0.007 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 30-2> 1.7 g (수율 60%)을 얻었다.(m/z=409)
Intermediate 30-1 (1.7 g, yield 60%) was obtained by the same method as in Example 1- (3), except that 3.0 g (0.007 mol) of m / z = 409)
(3) (3) 제조예Manufacturing example 3 : 중간체 30-3의 합성 3: Synthesis of intermediate 30-3
중간체 30-2(3.0 g, 0.008 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 30-3> 2.2 g (수율 70%)을 얻었다.(m/z=391)
2.2 g (yield 70%) of <Intermediate 30-3> was obtained by the same method as in Example 1- (3), except that Intermediate 30-2 (3.0 g, 0.008 mol) = 391)
(4) (4) 제조예Manufacturing example 4 : 화합물 684의 합성 4: Synthesis of Compound 684
중간체 30-3(3.0 g, 0.008 mol)에 중간체 23-5(3.6 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 684> 3.2 g (수율 63%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (6), except that Intermediate 23-5 (3.6 g, 0.010 mol) was added to Intermediate 30-3 (3.0 g, 0.008 mol) 63%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.60/s, 8.55/d, 7.94/d, 7.87/d, 7.77/s, 7.75/d, 7.69/d, 7.45/m, 7.41/m, 7.33/m, 7.25/m, 7.17/m, 7.00/s, 6.60/s) 2H(7.85/d, 7.79/d, 7.58/m, 7.51/m, 7.50/d, 7.25/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.60 / s, 8.55 / d, 7.94 / d, 7.87 / d, 7.77 / s, 7.75 / d, 7.69 / d, 7.45 / m, 7.41 / m 7.51 / m, 7.17 / m, 7.00 / s, 6.60 / s) 2H (7.85 / d, 7.79 / d, 7.58 / )
LC/MS: m/z=628[(M+1)+]
LC / MS: m / z = 628 [(M + 1) < + &
실시예Example 31 : 화합물 686의 합성 31: Synthesis of Compound 686
(1) (One) 제조예Manufacturing example 1 : 중간체 31-1의 합성 1: Synthesis of intermediate 31-1
2-amino-phenol(3.0 g, 0.016 mol)에 1,2,3-tribromo-4-chlorobenzene(5.6 g, 0.016 mol)를 넣고 실시예 25-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 31-1> 2.1 g (수율 45%)을 얻었다.(m/z=296)
Was synthesized in the same manner as in Example 25 (1) except that 1,2,3-tribromo-4-chlorobenzene (5.6 g, 0.016 mol) was added to 2-amino-phenol (3.0 g, 0.016 mol) 2.1 g (yield: 45%) of Intermediate 31-1 (m / z = 296) was obtained.
(2) (2) 제조예Manufacturing example 2 : 중간체 31-2의 합성 2: Synthesis of intermediate 31-2
중간체 31-1(3.0 g, 0.010 mol)에 1,1-dibromoethene(1.8 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 31-2> 1.6 g (수율 51%)을 얻었다.(m/z=321)
<Intermediate 31-2> 1.6 (1 g, 0.010 mol) was synthesized in the same manner as in Example 1 (2) except that 1,1-dibromoethene (1.8 g, 0.010 mol) was added to Intermediate 31-1 g (yield: 51%). (m / z = 321)
(3) (3) 제조예Manufacturing example 3 : 중간체 31-3의 합성 3: Synthesis of intermediate 31-3
중간체 31-2(3.0 g, 0.0009 mol)에 phenyl boronic acid(1.3 g, 0.011 mol) 를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 31-3> 2.0 g (수율 71%)을 얻었다.(m/z=317)
Intermediate 31-3 was synthesized in the same manner as in Example 1 (6), except that phenyl boronic acid (1.3 g, 0.011 mol) was added to Intermediate 31-2 (3.0 g, 0.0009 mol) Yield: 71%). (M / z = 317)
(4) (4) 제조예Manufacturing example 4 : 화합물 686의 합성 4: Synthesis of Compound 686
중간체 31-3(3.0 g, 0.0009 mol)에 중간체 22-5(4.7 g, 0.011 mol)를 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <화합물 31> 3.7 g (수율 71%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (4), except that Intermediate 22-5 (4.7 g, 0.011 mol) was added to Intermediate 31-3 (3.0 g, 0.0009 mol) 71%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(9.15/s, 8.21/d, 8.18/d, 8.06/d, 8.04/d, 7.58/d, 7.30/m, 7.14/d, 6.60/s) 2H(8.93/d, 8.12/d, 7.88/m, 7.82/m, 7.79/d, 7.51/m, 7.41/m) 4H(7.25/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (9.15 / s, 8.21 / d, 8.18 / d, 8.06 / d, 8.04 / d, 7.58 / d, 7.30 / m, 7.14 / d, 6.60 / s ), 2H (8.93 / d, 8.12 / d, 7.88 / m, 7.82 / m, 7.79 / d, 7.51 / m, 7.41 /
LC/MS: m/z=586[(M+1)+]
LC / MS: m / z = 586 [(M + 1) < + &
실시예Example 32 : 화합물 689의 합성 32: Synthesis of Compound 689
(1) (One) 제조예Manufacturing example 1 : 중간체 32-1의 합성 1: Synthesis of intermediate 32-1
6-phosphinoaniline(3.0 g, 0.015 mol)에 1,2,3-tribromo-4-chlorobenzene (5.5 g, 0.015 mol)를 넣고 실시예 25-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 32-1> 1.5 g (수율 41%)을 얻었다.(m/z=312)
Was synthesized in the same manner as in Example 25 (1) except that 1,2,3-tribromo-4-chlorobenzene (5.5 g, 0.015 mol) was added to 6-phosphinoaniline (3.0 g, 0.015 mol) 32-1> 1.5 g (yield 41%). (M / z = 312)
(2) (2) 제조예Manufacturing example 2 : 중간체 32-2의 합성 2: Synthesis of intermediate 32-2
중간체 32-1(3.0 g, 0.010 mol)에 1,1-dibromoethene(1.8 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 32-2> 1.6 g (수율 47%)을 얻었다.(m/z=337)
<Intermediate 32-2> 1.6 (0.010 mol) was synthesized in the same manner as in Example 1 (2) except that 1,1-dibromoethene (1.8 g, 0.010 mol) was added to Intermediate 32-1 g (yield: 47%). (m / z = 337)
(3) (3) 제조예Manufacturing example 3 : 중간체 32-3의 합성 3: Synthesis of intermediate 32-3
중간체 32-2(3.0 g, 0.009 mol)에 bromobenzene(1.4 g, 0.009 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 32-3> 2.9 g (수율 77%)을 얻었다.(m/z=413)
Intermediate 32-3 was obtained in a yield of 2.9 g (yield: 77%). Intermediate 32-2 (3.0 g, 0.009 mol) was added bromobenzene (1.4 g, 0.009 mol) %). (M / z = 413)
(4) (4) 제조예Manufacturing example 4 : 중간체 32-4의 합성 4: Synthesis of intermediate 32-4
중간체 32-3(3.0 g, 0.007mol)에 phenyl boronic acid(1.0 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 32-4> 2.0 g (수율 71%)을 얻었다.(m/z=410)
Intermediate 32-4 was synthesized in the same manner as in Example 1 (6), except that phenyl boronic acid (1.0 g, 0.008 mol) was added to Intermediate 32-3 (3.0 g, 0.007 mol) Yield: 71%). (M / z = 410)
(5) (5) 제조예Manufacturing example 5 : 화합물 689의 합성 5: Synthesis of compound 689
중간체 32-4(3.0 g, 0.007 mol)에 중간체 21-5(2.8 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 689> 3.4 g (수율 71%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (6), except that Intermediate 21-5 (2.8 g, 0.008 mol) was added to Intermediate 32-4 (3.0 g, 0.007 mol) 71%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.82/d, 8.43/d, 7.91/m, 7.41/m, 6.60/s) 2H(7.85/d, 7.79/d, 7.51/m, 7.41/m, 7.25/d) 4H(8.28/d, 7.78/d, 7.51/m, 7.36/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.82 / d, 8.43 / d, 7.91 / m, 7.41 / m, 6.60 / s) 2H (7.85 / d, 7.79 / d, 7.51 / m, 7.41 / m, 7.25 / d) 4H (8.28 / d, 7.78 / d, 7.51 / m, 7.36 / m)
LC/MS: m/z=683[(M+1)+]
LC / MS: m / z = 683 [(M + 1) < + &
실시예Example 33 : 화합물 690의 합성 33: Synthesis of Compound 690
(1) (One) 제조예Manufacturing example 1 : 중간체 33-1의 합성 1: Synthesis of intermediate 33-1
2-bromo-3-chloro-6-(trimethylsilyl)aniline(3.0 g, 0.011 mol)에 1,2, -dibromobenzene(3.4 g, 0.011 mol)를 넣고 실시예 25-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 33-1> 1.2 g (수율 31%)을 얻었다.(m/z=338)
1,2-dibromobenzene (3.4 g, 0.011 mol) was added to 2-bromo-3-chloro-6- (trimethylsilyl) aniline (3.0 g, 0.011 mol) To obtain 1.2 g (yield: 31%) of intermediate < 33-1 > (m / z = 338)
(2) (2) 제조예Manufacturing example 2 : 중간체 33-2의 합성 2: Synthesis of intermediate 33-2
중간체 33-1(3.0 g, 0.009 mol)에 1,1-dibromoethene(1.6 g, 0.009 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 33-2> 1.6 g (수율 50%)을 얻었다.(m/z=362)
Intermediate 33-2> 1.6 (0.009 mol) was synthesized in the same manner as in Example 1 (2) except that 1,1-dibromoethene (1.6 g, 0.009 mol) was added to Intermediate 33-1 g (yield: 50%). (m / z = 362)
(3) (3) 제조예Manufacturing example 3 : 중간체 33-3의 합성 3: Synthesis of intermediate 33-3
중간체 33-2(3.0 g, 0.008 mol)에 phenyl boronic acid(1.2 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 33-3> 2.0 g (수율 70%)을 얻었다.(m/z=359)
Intermediate 33-3 was synthesized in the same manner as in Example 1- (6), except that phenyl boronic acid (1.2 g, 0.010 mol) was added to Intermediate 33-2 (3.0 g, 0.008 mol) Yield: 70%). (M / z = 359)
(4) (4) 제조예Manufacturing example 4 : 화합물 690의 합성 4: Synthesis of Compound 690
중간체 33-3(3.0 g, 0.008 mol)에 중간체 22-5(3.5 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 690> 3.6 g (수율 71%)을 얻었다.Synthesis was carried out in the same manner as in Example 1 (6), except that Intermediate 22-5 (3.5 g, 0.010 mol) was added to Intermediate 33-3 (3.0 g, 0.008 mol) 71%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(9.15/s, 8.27/d, 8.18/d, 8.04/d, 7.72/d, 7.68/m, 7.52/m, 7.50/d, 7.46/d, 7.37/m) 2H(8.93/d, 8.12/d, 7.88/m, 7.82/m, 7.79/d, 7.51/m, 0.66/s) 4H(7.25/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (9.15 / s, 8.27 / d, 8.18 / d, 8.04 / d, 7.72 / d, 7.68 / m, 7.52 / m, 7.50 / d, 7.46 / d (7.35 / d), 7.37 / m) 2H (8.93 d, 8.12 d, 7.88 m, 7.82 m, 7.79 d, 7.51 m, 0.66 s)
LC/MS: m/z=628[(M+1)+]
LC / MS: m / z = 628 [(M + 1) < + &
실시예Example 34 : 화합물 691의 합성 34: Synthesis of Compound 691
(1) (One) 제조예Manufacturing example 1 : 중간체 34-1의 합성 1: Synthesis of Intermediate 34-1
2-iodo-1H-benzo[d]imidazole(3.0 g, 0.012 mol)에 triisopropyl borate(3.4 g, 0.018 mol)를 넣고 실시예 7-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 34-1> 1.4 g (수율 71%)을 얻었다.(m/z=161)
Was synthesized in the same manner as in Example 7-Preparation Example (2), except that triisopropyl borate (3.4 g, 0.018 mol) was added to 2-iodo-1H-benzo [d] imidazole (3.0 g, 0.012 mol) -1> 1.4 g (yield: 71%). (M / z = 161)
(2) (2) 제조예Manufacturing example 2 : 중간체 34-2의 합성 2: Synthesis of intermediate 34-2
중간체 34-1(2.0 g, 0.012 mol)에 2,5-dibromothiophene(2.4 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 34-2> 2.0 g (수율 73%)을 얻었다.(m/z=279)
Intermediate 34-2> 2.0 (2.0 g, 0.012 mol) was synthesized in the same manner as in Example 1- (6) except that 2,5-dibromothiophene (2.4 g, 0.010 mol) g (yield: 73%). (m / z = 279)
(3) (3) 제조예Manufacturing example 3 : 중간체 34-3의 합성 3: Synthesis of intermediate 34-3
중간체 34-2(3.0 g, 0.010 mol)에 triphenylen-2-ylboronic acid(3.4 g, 0.012 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 34-3> 3.2 g (수율 75%)을 얻었다.(m/z=426)
Intermediate 34-3 was synthesized in the same manner as in Example 1 (6) except that triphenylen-2-ylboronic acid (3.4 g, 0.012 mol) was added to intermediate 34-2 (3.0 g, 0.010 mol) 3.2 g (yield 75%) was obtained. (M / z = 426)
(4) (4) 제조예Manufacturing example 4 : 중간체 34-4의 합성 4: Synthesis of intermediate 34-4
중간체 34-3(3.0 g, 0.007 mol)에 methyl 2-bromobenzoate(1.5 g, 0.007 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 34-4> 2.7 g (수율 68%)을 얻었다.(m/z=560)
Intermediate 34-4 was synthesized in the same manner as in Example 1 (2), except that methyl 2-bromobenzoate (1.5 g, 0.007 mol) was added to Intermediate 34-3 (3.0 g, 0.007 mol) (Yield: 68%). (M / z = 560)
(5) (5) 제조예Manufacturing example 5 : 중간체 34-5의 합성 5: Synthesis of intermediate 34-5
중간체 34-4(3.0 g, 0.009 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 34-5> 3.6 g (수율 72%)을 얻었다.(m/z=560)
And 3.6 g (yield 72%) of Intermediate 34-5 (3.0 g, 0.009 mol) were synthesized in the same manner as in Example 1- (3) = 560)
(6) (6) 제조예Manufacturing example 6 : 화합물 691의 합성 6: Synthesis of Compound 691
중간체 34-5(3.0 g, 0.009 mol)을 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <화합물 691> 3.5 g (수율 72%)을 얻었다.3.5 g (yield 72%) of Compound 691 was obtained by the same method as in Example 1- (4), except that Intermediate 34-5 (3.0 g, 0.009 mol) was added.
H-NMR (200MHz, CDCl3):δ ppm, 1H(9.15/s, 8.18/d, 8.04/d, 7.61/d, 7.41/m, 7.40/m, 7.37/m, 7.30/d, 7.26/d, 7.14/m) 2H(8.93/d, 8.12/d, 7.88/m, 7.82/m, 7.73/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (9.15 / s, 8.18 / d, 8.04 / d, 7.61 / d, 7.41 / m, 7.40 / m, 7.37 / m, 7.30 / d, 7.26 / d , 7.14 / m) 2H (8.93 d, 8.12 d, 7.88 m, 7.82 m, 7.73 d, 1.72 s)
LC/MS: m/z=543[(M+1)+]
LC / MS: m / z = 543 [(M + 1) < + &
실시예Example 35 : 화합물 692의 합성 35: Synthesis of Compound 692
(1) (One) 제조예Manufacturing example 1 : 중간체 35-1의 합성 1: Synthesis of intermediate 35-1
중간체 34-1(2.0 g, 0.012 mol)에 2,5-dibromofuran(2.3 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 35-1> 1.8 g (수율 70%)을 얻었다.(m/z=263)
Synthesis was conducted in the same manner as in Example 1 (6), except that 2,5-dibromofuran (2.3 g, 0.010 mol) was added to Intermediate 34-1 (2.0 g, 0.012 mol) g (yield: 70%). (m / z = 263)
(2) (2) 제조예Manufacturing example 2 : 중간체 35-2의 합성 2: Synthesis of intermediate 35-2
중간체 35-1(3.0 g, 0.010 mol)에 triphenylen-2-ylboronic acid(3.4 g, 0.012 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 35-2> 3.0 g (수율 73%)을 얻었다.(m/z=410)
Intermediate 35-2 was synthesized in the same manner as in Example 1 (6) except that triphenylen-2-ylboronic acid (3.4 g, 0.012 mol) was added to Intermediate 35-1 (3.0 g, 0.010 mol) 3.0 g (yield: 73%). (M / z = 410)
(3) (3) 제조예Manufacturing example 3 : 중간체 35-3의 합성 3: Synthesis of intermediate 35-3
중간체 35-2(3.0 g, 0.007 mol)에 methyl 2-bromobenzoate(1.5 g, 0.007 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 35-3> 2.3 g (수율 65%)을 얻었다.(m/z=544)
2.3 g (0.007 mol) of intermediate <35-3> were synthesized in the same manner as in Example 1 (2) except that methyl 2-bromobenzoate (1.5 g, 0.007 mol) (Yield: 65%). (M / z = 544)
(4) (4) 제조예Manufacturing example 4 : 중간체 35-4의 합성 4: Synthesis of intermediate 35-4
중간체 35-3(3.0 g, 0.009 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 35-4> 3.1g (수율 70%)을 얻었다.(m/z=544)
Intermediate 35-3 (3.0 g, 0.009 mol) was added thereto, and 3.1 g (yield 70%) of <Intermediate 35-4> was obtained in the same manner as in Example 1- = 544)
(5) (5) 제조예Manufacturing example 5 : 화합물 692의 합성 5: Synthesis of compound 692
중간체 35-4(3.0 g, 0.009 mol)을 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <화합물 692> 3.1 g (수율 71%)을 얻었다.3.1 g (yield 71%) of Compound 692 was obtained by the same method as in Example 1- (4), except that Intermediate 35-4 (3.0 g, 0.009 mol) was added.
H-NMR (200MHz, CDCl3):δ ppm, 1H(9.15/s, 8.18/d, 8.04/d, 7.61/d, 7.41/m, 7.40/m, 7.37/m, 7.30/d, 7.26/d, 7.14/m) 2H(8.93/d, 8.12/d, 7.88/m, 7.82/m, 7.07/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (9.15 / s, 8.18 / d, 8.04 / d, 7.61 / d, 7.41 / m, 7.40 / m, 7.37 / m, 7.30 / d, 7.26 / d , 7.14 / m) 2H (8.93 d, 8.12 d, 7.88 m, 7.82 m, 7.07 d, 1.72 s)
LC/MS: m/z=527[(M+1)+]
LC / MS: m / z = 527 [(M + 1) < + &
실시예Example 36 : 화합물 693의 합성 36: Synthesis of Compound 693
(1) (One) 제조예Manufacturing example 1 : 중간체 36-1의 합성 1: Synthesis of Intermediate 36-1
3,6-dibromobenzene-1,2-diamine(3.0 g, 0.011 mol)에 dibromochloromethane (2.3 g, 0.011 mol)를 넣고 실시예 25-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 36-1> 1.4 g (수율 41%)을 얻었다.(m/z=312)
Dibromochloromethane (2.3 g, 0.011 mol) was added to 3,6-dibromobenzene-1,2-diamine (3.0 g, 0.011 mol) and the reaction was conducted in the same manner as in Example 25- 1> 1.4 g (yield 41%). (M / z = 312)
(2) (2) 제조예Manufacturing example 2 : 중간체 36-2의 합성 2: Synthesis of intermediate 36-2
중간체 36-1(3.0 g, 0.010 mol)에 1-bromo-2-tert-butylbenzene(2.1 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 36-2> 1.9 g (수율 50%)을 얻었다.(m/z=386)
The intermediate 36-1 (3.0 g, 0.010 mol) was synthesized in the same manner as in Example 1 (2) except that 1-bromo-2-tert-butylbenzene (2.1 g, 0.010 mol) -2> 1.9 g (yield: 50%). (M / z = 386)
(3) (3) 제조예Manufacturing example 3 : 중간체 36-3의 합성 3: Synthesis of intermediate 36-3
중간체 36-2(3.0 g, 0.0008 mol)에 phenyl boronic acid(1.2 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 36-3> 2.1 g (수율 60%)을 얻었다.(m/z=428)
2.1 g (intermediate 36-3) was synthesized in the same manner as in Example 1 (6), except that phenyl boronic acid (1.2 g, 0.010 mol) was added to Intermediate 36-2 (3.0 g, 0.0008 mol) Yield: 60%). (M / z = 428)
(4) (4) 제조예Manufacturing example 4 : 중간체 36-4의 합성 4: Synthesis of intermediate 36-4
중간체 36-3(3.0 g, 0.007 mol)에 N-bromosuccinimide(1.2 g, 0.007 mol)에 DMF 100 mL를 넣고 20 ℃에서 8시간 교반하여 반응시켰다. 반응 종료 후 H20 : 아세트산에틸로 층분리 후 컬럼정제(n-Hexane : MC)하여 중간체 36-4을 1.4 g(40%)수득하였다.(m/z=507)
100 mL of DMF was added to N-bromosuccinimide (1.2 g, 0.007 mol) in Intermediate 36-3 (3.0 g, 0.007 mol), and the mixture was reacted at 20 ° C for 8 hours with stirring. After completion of the reaction H 2 0: After phase separation with ethyl acetate and column purification: the (n-Hexane MC) to the intermediate 36-4 to give 1.4 g (40%) (m / z = 507).
(5) (5) 제조예Manufacturing example 5 : 중간체 36-4'의 합성 5: Synthesis of intermediate 36-4 '
중간체 36-4(5.0 g, 0.010 mol)에 bis(pinacolato)dibron(3.0 g, 0.012 mol)를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 36-4'> 3.9 g (수율 71%)을 얻었다.(m/z=554)
Intermediate 36-4 'was synthesized in the same manner as in Example 1 (5) except that bis (pinacolato) dibron (3.0 g, 0.012 mol) was added to Intermediate 36-4 (5.0 g, 0.010 mol) 3.9 g (yield 71%) of the title compound was obtained (m / z = 554)
(6) (6) 제조예Manufacturing example 6 : 중간체 36-5의 합성 6: Synthesis of intermediate 36-5
2-bromo-4,6-diphenyl-1,3,5-triazine(2.5 g, 0.008 mol)에 bis(pinacolato)dibron(3.0 g, 0.012 mol)를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 36-5> 2.1 g (수율 73%)을 얻었다.(m/z=359)
Bis (pinacolato) dibron (3.0 g, 0.012 mol) was added to 2-bromo-4,6-diphenyl-1,3,5-triazine (2.5 g, 0.008 mol) (M / z = 359) (yield: 73%). ≪ / RTI >
(7) (7) 제조예Manufacturing example 7 : 중간체 36-6의 합성 7: Synthesis of Intermediate 36-6
중간체 36-5(3.0 g, 0.008 mol)에 1,4-dibromobenzene(1.6 g, 0.007 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 693> 2.0 g (수율 73%)을 얻었다.(m/z=388)
2.0 g (Compound 693) was synthesized in the same manner as in Example 1 (6), except that 1,4-dibromobenzene (1.6 g, 0.007 mol) was added to Intermediate 36-5 (3.0 g, 0.008 mol) Yield: 73%). (M / z = 388)
(8) (8) 제조예Manufacturing example 8 : 화합물 693의 합성 8: Synthesis of Compound 693
중간체 36-4'(5.0 g, 0.009 mol)에 중간체 36-6(3.1 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 693> 4.3 g (수율 73%)을 얻었다.4.3 g (Compound 693) was synthesized in the same manner as in Example 1- (6) except that Intermediate 36-6 (3.1 g, 0.008 mol) was added to Intermediate 36-4 '(5.0 g, 0.009 mol) Yield: 73%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.26/m, 6.88/s, 5.04/s) 2H(7.85/d, 7.43/d, 7.41/m, 7.33/m, 7.25/d, 7.08/d, 7.05/m, 6.69/m, 6.52/d) 4H(8.28/d, 7.51/m, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.26 / m, 6.88 / s, 5.04 / s) 2H (7.85 / d, 7.43 / d, 7.41 / m, 7.33 / m, 7.25 / d, 7.08 / d, 7.05 / m, 6.69 / m, 6.52 / d) 4H (8.28 / d, 7.51 /
LC/MS: m/z= 736[(M+1)+]
LC / MS: m / z = 736 [(M + 1) < + &
실시예Example 37 : 화합물 694의 합성 37: Synthesis of Compound 694
(1) (One) 제조예Manufacturing example 1 : 화합물 694의 합성 1: Synthesis of compound 694
중간체 36-2(3.0 g, 0.008 mol), 중간체 21-5(4.3 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 694> 3.7g (수율 70%)을 얻었다.The compound obtained in the same manner as in Example 1 (6) was used in place of Intermediate 36-2 (3.0 g, 0.008 mol) and Intermediate 21-5 (4.3 g, 0.010 mol) 70%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(5.04/d) 2H(8.52/d, 7.41/m, 7.29/d, 7.08/d, 7.05/m, 6.69/m, 6.52/d, 6.32/d) 4H(8.28/d, 7.51/m, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (5.04 / d) 2H (8.52 / d, 7.41 / m, 7.29 / d, 7.08 / d, 7.05 / m, 6.69 / m, 6.52 / d, 6.32 / d) 4H (8.28 / d, 7.51 / m, 1.72 / s)
LC/MS: m/z=660 [(M+1)+]
LC / MS: m / z = 660 [(M + 1) < + &
실시예Example 38 : 화합물 695의 합성 38: Synthesis of Compound 695
(1) (One) 제조예Manufacturing example 1 : 화합물 695의 합성 1: Synthesis of Compound 695
중간체 36-4(5.0 g, 0.010 mol), 중간체 22-5(5.1 g, 0.012 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 695> 5.3 g (수율 73%)을 얻었다.(Compound 695) (synthesis amount: 5.3 g, yield: 5.0 g, 0.010 mol) and Intermediate 22-5 (5.1 g, 0.012 mol) 73%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(9.15/s, 8.18/d, 8.04/d, 7.26/m, 6.88/s, 5.04/s) 2H(8.93/d, 8.12/d, 7.88/m, 7.82/m, 7.43/d, 7.33/m, 7.08/d, 7.05/m, 6.69/m, 6.52/d) 4H(7.25/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (9.15 / s, 8.18 / d, 8.04 / d, 7.26 / m, 6.88 / s, 5.04 / s) 2H (8.93 / d, 8.12 / d, 7.88 d, 7.02 / d, 7.05 / m, 6.69 / m, 6.52 / d) 4H (7.25 / d, 1.72 / s)
LC/MS: m/z=731[(M+1)+]
LC / MS: m / z = 731 [(M + 1) < + &
실시예Example 39 : 화합물 696의 합성 39: Synthesis of Compound 696
(1) (One) 제조예Manufacturing example 1 : 중간체 39-1의 합성 1: Synthesis of intermediate 39-1
dibenzo[b,d]thiophen-4-ylboronic acid(2.3 g, 0.010 mol), 1,4-dibromobenzene(1.9 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 39-1> 1.9 g (수율 70%)을 얻었다.(m/z=339)
(6.9 g, 0.008 mol) and 1,4-dibromobenzene (1.9 g, 0.008 mol) were added in the same manner as in Example 1-Preparation Example (6), except that dibenzo [b, d] thiophen- 1.9 g (yield: 70%) of Intermediate 39-1 was obtained. (M / z = 339)
(2) (2) 제조예Manufacturing example 2 : 화합물 696의 합성 2: Synthesis of Compound 696
중간체36-4'(5.0 g, 0.009 mol), 중간체 39-1(2.7 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 696> 4.0 g (수율 73%)을 얻었다.4.0 g (Compound 696) was synthesized in the same manner as in Example 1- (6) except that Intermediate 36-4 '(5.0 g, 0.009 mol) and Intermediate 39-1 (2.7 g, 0.008 mol) Yield: 73%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.45/d, 8.41/d, 8.20/d, 7.98/d, 7.58/m, 7.52/m, 7.50/m, 7.26/m, 6.88/s, 5.04/s) 2H(7.43/d, 7.33/m, 7.08/d, 7.05/m, 6.69/m, 6.52/d) 4H(7.25/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.45 / d, 8.41 / d, 8.20 / d, 7.98 / d, 7.58 / m, 7.52 / m, 7.50 / m, 7.26 / m, 6.88 / s , 7.04 / s, 7.04 / s) 2H (7.43 / d, 7.33 / m, 7.08 / d, 7.05 /
LC/MS: m/z=687[(M+1)+]
LC / MS: m / z = 687 [(M + 1) < + &
실시예Example 40 : 화합물 697의 합성 40: Synthesis of Compound 697
(1) (One) 제조예Manufacturing example 1 : 중간체 40-1의 합성 1: Synthesis of intermediate 40-1
중간체 36-4'(5.0 g, 0.009 mol), 1,4-dibromobenzene(1.9 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 40-1> 3.4 g (수율 73%)을 얻었다.(m/z=583)
Intermediate 40-1 was synthesized in the same manner as in Example 1- (6) except that Intermediate 36-4 '(5.0 g, 0.009 mol) and 1,4-dibromobenzene (1.9 g, 0.008 mol) 3.4 g (yield: 73%) was obtained. (M / z = 583)
(2) (2) 제조예Manufacturing example 2 : 화합물 697의 합성 2: Synthesis of compound 697
중간체 40-1(5.0 g, 0.009 mol), 9H-carbazole(2.2 g, 0.009 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 697> 4.8 g (수율 79%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (2), except that Intermediate 40-1 (5.0 g, 0.009 mol) and 9H-carbazole (2.2 g, 0.009 mol) %).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 8.12/d, 7.94/d, 7.63/d, 7.50/m, 7.33/m, 7.29/m, 7.26/m, 7.25/m, 6.88/s, 5.04/s) 2H(7.79/d, 7.68/d, 7.43/d, 7.33/m, 7.08/d, 7.05/m, 6.69/m, 6.52/d) 4H(1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 8.12 / d, 7.94 / d, 7.63 / d, 7.50 / m, 7.33 / m, 7.29 / m, 7.26 / m, 7.25 / m , 6.88 / s, 5.04 / s) 2H (7.79 d, 7.68 d, 7.43 d, 7.33 m, 7.08 d, 7.05 m, 6.69 m, 6.52 d)
LC/MS: m/z=670[(M+1)+]
LC / MS: m / z = 670 [(M + 1) < + &
실시예Example 41 : 화합물 698의 합성 41: Synthesis of compound 698
(1) (One) 제조예Manufacturing example 1 : 화합물 698의 합성 1: Synthesis of Compound 698
중간체 40-1(5.0 g, 0.009 mol), 9-phenyl-9H-carbazol-3-ylboronic acid(3.2 g, 0.011 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 698> 4.9 g (수율 73%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (6), except that Intermediate 40-1 (5.0 g, 0.009 mol) and 9-phenyl-9H-carbazol-3-ylboronic acid (3.2 g, 0.011 mol) <Compound 698> 4.9 g (yield: 73%) was obtained.
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 7.94/d, 7.87/d, 7.77/s, 7.69/d, 7.45/m, 7.33/m, 7.26/m, 7.25/m, 6.88/s, 5.04/s) 2H(7.58/m, 7.50/d, 7.43/d, 7.33/m, 7.08/d, 7.05/m, 6.69/m, 6.52/d) 4H(7.25/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 7.94 / d, 7.87 / d, 7.77 / s, 7.69 / d, 7.45 / m, 7.33 / m, 7.26 / m, 7.25 / m , 6.88 / s, 5.04 / s) 2H (7.58 / m, 7.50 / d, 7.43 / d, 7.33 / m, 7.08 / d, 7.05 / / s)
LC/MS: m/z=746[(M+1)+]
LC / MS: m / z = 746 [(M + 1) < + &
실시예Example 42 : 화합물 699의 합성 42: Synthesis of Compound 699
(1) (One) 제조예Manufacturing example 1 : 중간체 42-1의 합성 1: Synthesis of intermediate 42-1
중간체 42-1(5.0 g, 0.009 mol)에 3-bromo-9H-carbazole(1.8 g, 0.007 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 42-1> 2.9g (수율 71%)을 얻었다.(m/z=593)
Synthesis was conducted in the same manner as in Example 1 (6), except that 3-bromo-9H-carbazole (1.8 g, 0.007 mol) was added to Intermediate 42-1 (5.0 g, 0.009 mol) > 2.9 g (yield: 71%). (M / z = 593)
(2) (2) 제조예Manufacturing example 2 : 화합물 699의 합성 2: Synthesis of Compound 699
중간체 42-2(5.0 g, 0.008 mol)에 4-bromo-2,6-diphenylpyridine(2.6 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 699> 4.7g (수율 71%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (6), except that 4-bromo-2,6-diphenylpyridine (2.6 g, 0.008 mol) was added to Intermediate 42-2 (5.0 g, 0.008 mol) (Yield: 71%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 7.94/d, 7.87/d, 7.77/s, 7.69/d, 7.33/m, 7.26/m, 7.25/m, 6.88/s, 5.04/s) 2H(7.47/m, 7.43/d, 7.33/m, 7.10/s, 7.08/d, 7.05/m, 6.69/m, 6.52/d) 4H(8.30/d, 7.54/m, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 7.94 / d, 7.87 / d, 7.77 / s, 7.69 / d, 7.33 / m, 7.26 / m, 7.25 / m, 6.88 / s D, 7.54 / m, 7.72 / d), 5.04 / s) 2H (7.47 / m, 7.43 / d, 7.33 / m, 7.10 / s, 7.08 / d, 7.05 / / s)
LC/MS: m/z=824[(M+1)+]
LC / MS: m / z = 824 [(M + 1) < + &
실시예Example 43 : 화합물 700의 합성 43: Synthesis of Compound 700
(1) (One) 제조예Manufacturing example 1 : 화합물 700의 합성 1: Synthesis of Compound 700
중간체 42-1(5.0 g, 0.008 mol), 2-bromo-4,6-diphenyl-1,3,5-triazine (2.6 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 700> 4.7 g (수율 71%)을 얻었다.The same procedure as in Example 1 (6) was repeated except that Intermediate 42-1 (5.0 g, 0.008 mol) and 2-bromo-4,6-diphenyl-1,3,5-triazine (2.6 g, 0.008 mol) To obtain 4.7 g (yield 71%) of < Compound 700 >.
H-NMR (200MHz, CDCl3):δ ppm,1H(7.94/d, 7.87/d, 7.77/d, 7.69/d, 7.33/m, 7.26/m, 7.25/m, 6.88/s, 5.04/s) 2H(7.43/d, 7.41/m, 7.33/m, 7.08/d, 7.05/m, 6.69/m, 6.52/d) 4H(8.28/d, 7.51/m, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.94 / d, 7.87 / d, 7.77 / d, 7.69 / d, 7.33 / m, 7.26 / m, 7.25 / m, 6.88 / s, 5.04 / s ), 2H (7.43 / d, 7.41 / m, 7.33 / m, 7.08 / d, 7.05 / m, 6.69 /
LC/MS: m/z=826[(M+1)+]
LC / MS: m / z = 826 [(M + 1) < + &
실시예Example
44 : 화합물 2의 합성 44: Synthesis of
(1) (One) 제조예Manufacturing example 1 : 중간체 44-1의 합성 1: Synthesis of intermediate 44-1
1H-indol-3-ylboronic acid(2.0 g, 0.012 mol), N-(biphenyl-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine(5.2 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 44-1> 3.9g (수율 71%)을 얻었다.(m/z=552)
3-ylboronic acid (2.0 g, 0.012 mol), N- (biphenyl-4-yl) -N- (4-bromophenyl) -9,9-dimethyl-9H- (M / z = 552) was obtained in the same manner as in Example 1 (6), except that the compound (44)
(2) (2) 제조예Manufacturing example 2 : 중간체 44-2의 합성 2: Synthesis of intermediate 44-2
중간체 44-1(5.0 g, 0.008 mol), methyl 2-bromobenzoate(2.6 g, 0.012 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 44-2> 4.3g (수율 79%)을 얻었다.(m/z=686)
Intermediate 44-2 was synthesized in the same manner as in Example 1 (2) except that Intermediate 44-1 (5.0 g, 0.008 mol) and methyl 2-bromobenzoate (2.6 g, 0.012 mol) (Yield: 79%). (M / z = 686)
(3) (3) 제조예Manufacturing example 3 : 중간체 44-3의 합성 3: Synthesis of intermediate 44-3
중간체 44-2(5.0 g, 0.007 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 44-3> 3.6 g (수율 75%)을 얻었다.(m/z=686)
Synthesis was conducted in the same manner as in Example 1 (3), except that Intermediate 44-2 (5.0 g, 0.007 mol) was added to obtain 3.6 g (yield 75%) of Intermediate 44-3. M / z = 686)
(4) (4)
제조예Manufacturing example
4 : 화합물 2의 합성 4: Synthesis of
중간체 44-2(5.0 g, 0.007 mol)을 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 2> 3.5g (수율 75%)을 얻었다.3.5 g (yield 75%) of <
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.99/d, 7.87/d, 7.62/d, 7.55/d, 7.41/m, 7.40/m, 7.38/m, 7.37/m, 7.36/s, 7.34/m, 7.30/d, 7.28/m, 7.26/d, 7.04/d, 6.75/s, 6.58/d) 2H(7.52/d, 7.51/m) 4H(7.54/d, 6.69/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.99 / d, 7.87 / d, 7.62 / d, 7.55 / d, 7.41 / m, 7.40 / m, 7.38 / m, 7.37 / m, 7.36 / s , 7.54 / d, 6.69 / d, 6.72 / d, 7.58 / d) 2H (7.52 / d, 7.51 / / s)
LC/MS: m/z=669[(M+1)+]
LC / MS: m / z = 669 [(M + 1) < + &
실시예Example
45 : 화합물 4의 합성 45: Synthesis of
(1) (One) 제조예Manufacturing example 1 : 화합물 4의 합성 1: Synthesis of Compound (4)
N-(biphenyl-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine(5.2 g, 0.010 mol)대신에 N-(biphenyl-4-yl)-N-(4-bromophenyl)biphenyl-4-amine(4.8 g, 0.010 mol)을 사용하여 <화합물 2>와 동일한 방법을 사용하여 <화합물 4> 4.4g (수율 70%) 을 얻었다.4-yl) -N- (4-bromophenyl) -9,9-dimethyl-9H-fluoren-2-amine (5.2 g, 0.010 mol) instead of N- (biphenyl- 4.4 g (yield 70%) of
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.99/d, 7.40/m, 7.37/m, 7.36/s, 7.34/m, 7.30/d, 7.26/d, 7.04/d) 2H(7.41/m, 1.72/s) 4H(7.52/d, 7.51/m) 6H(7.54/d, 6.69/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.99 / d, 7.40 / m, 7.37 / m, 7.36 / s, 7.34 / m, 7.30 / d, 7.26 / d, 7.04 / d) 2H (7.41 / m, 1.72 / s) 4H (7.52 / d, 7.51 / m) 6H (7.54 / d, 6.69 / d)
LC/MS: m/z=629[(M+1)+]
LC / MS: m / z = 629 [(M + 1) < + &
실시예Example 46 : 화합물 11의 합성 46: Synthesis of Compound 11
(1) (One) 제조예Manufacturing example 1 : 화합물 11의 합성 1: Synthesis of Compound 11
N-(biphenyl-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine(5.2 g, 0.010 mol) 대신에 중간체 46-1(5.1 g, 0.010 mol)을 사용하여 <화합물 2>와 동일한 방법을 사용하여 <화합물 11> 5.4g (수율 72%) 을 얻었다.Intermediate 46-1 (5.1 g, 0.010 mol) was used in the place of N- (biphenyl-4-yl) -N- (4- bromophenyl) -9,9-dimethyl-9H- ) Was used to obtain Compound (11) (5.4 g, Yield: 72%) in the same manner as in <
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.99/d, 7.42/s, 7.40/m, 7.37/m, 7.34/m, 7.30/d, 7.26/d, 7.04/d, 6.49/s) 2H(7.87/d, 7.62/d, 7.55/d, 7.38/m, 7.28/m, 6.75/s, 6.58/d, 2.59/s) 6H(1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.99 / d, 7.42 / s, 7.40 / m, 7.37 / m, 7.34 / m, 7.30 / d, 7.26 / d, 7.04 / d, 6.49 / s ) 2H (7.87 d, 7.62 d, 7.55 d, 7.38 m, 7.28 m, 6.75 s, 6.58 d, 2.59 s)
LC/MS: m/z=737[(M+1)+]
LC / MS: m / z = 737 [(M + 1) < + &
실시예Example 47 : 화합물 12의 합성 47: Synthesis of Compound 12
(1) (One) 제조예Manufacturing example 1 : 화합물 12의 합성 1: Synthesis of Compound 12
N-(biphenyl-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine(5.2 g, 0.010 mol) 대신에 중간체 47-1(5.3 g, 0.010 mol)을 사용하여 <화합물 2>와 동일한 방법을 사용하여 <화합물 12> 5.2g (수율 72%) 을 얻었다.Intermediate 47-1 (5.3 g, 0.010 mol) was used in the place of N- (biphenyl-4-yl) -N- (4-bromophenyl) -9,9-dimethyl-9H- ), 5.2 g (yield 72%) of <Compound 12> was obtained in the same manner as in <
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.99/d, 7.87/d, 7.84/d, 7.74/d, 7.69/d, 7.64/d, 7.62/d, 7.55/d, 7.49/d, 7.46/s, 7.41/m, 7.40/m, 7.38/m, 7.37/m, 7.36/s, 7.34/m, 7.30/d, 7.28/m, 7.26/d, 7.04/d, 6.75/s, 6.58/d) 2H(7.54/d, 7.52/d, 7.51/m, 6.69/d) 4H(1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.99 / d, 7.87 / d, 7.84 / d, 7.74 / d, 7.69 / d, 7.64 / d, 7.62 / d, 7.55 / d, 7.49 / d 7.36 / s, 7.34 / m, 7.30 / d, 7.28 / m, 7.26 / d, 7.04 / d, 6.75 / s, 6.58 / d) 2H (7.54 / d, 7.52 / d, 7.51 / m, 6.69 /
LC/MS: m/z=719[(M+1)+]
LC / MS: m / z = 719 [(M + 1) < + &
실시예Example 48 : 화합물 19의 합성 48: Synthesis of Compound 19
(1) (One) 제조예Manufacturing example 1 : 화합물 19의 합성 1: Synthesis of Compound 19
N-(biphenyl-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine(5.2 g, 0.010 mol) 대신에 중간체 48-1(5.5 g, 0.010 mol)을 사용하여 <화합물 2>와 동일한 방법을 사용하여 <화합물 19> 5.3g (수율 75%) 을 얻었다.Intermediate 48-1 (5.5 g, 0.010 mol) was used instead of N- (biphenyl-4-yl) -N- (4-bromophenyl) -9,9-dimethyl- ) Was used to obtain 5.3 g (yield 75%) of <Compound 19> by the same method as in <
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.99/d, 7.40/m, 7.37/m, 7.36/s, 7.34/m, 7.26/d, 7.04/d, 5.73/s) 2H(6.25/s, 1.72/s) 4H(2.34/s) 8H(6.98/d, 6.51/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.99 / d, 7.40 / m, 7.37 / m, 7.36 / s, 7.34 / m, 7.26 / d, 7.04 / d, 5.73 / s) 2H (6.25 / s, 1.72 / s) 4H (2.34 / s) 8H (6.98 / d, 6.51 / d)
LC/MS: m/z=700[(M+1)+]
LC / MS: m / z = 700 [(M + 1) < + &
실시예Example 49 : 화합물 34의 합성 49: Synthesis of Compound 34
(1) (One) 제조예Manufacturing example 1 : 화합물 34의 합성 1: Synthesis of Compound 34
N-(biphenyl-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine(5.2 g, 0.010 mol) 대신에 중간체 49-2(6.5 g, 0.010 mol)을 사용하여 <화합물 2>와 동일한 방법을 사용하여 <화합물 34> 6.0 g (수율 75%) 을 얻었다.Intermediate 49-2 (6.5 g, 0.010 mol) was used in the place of N- (biphenyl-4-yl) -N- (4- bromophenyl) -9,9-dimethyl-9H- ) Was used to obtain 6.0 g (yield 75%) of Compound 34 by the same method as in <
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.99/d, 7.87/d, 7.70/s, 7.62/d, 7.57/m, 7.55/d, 7.44/m, 7.40/m, 7.38/m, 7.37/m, 7.36/s, 7.34/m, 7.30/d, 7.28/m, 7.26/d, 7.04/d, 6.89/s, 6.88/d, 6.75/s, 6.59/d, 6.58/d) 2H(7.54/d, 7.48/d, 7.38/d, 7.37/d, 6.69/d) 3H(1.35/s) 4H(1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.99 / d, 7.87 / d, 7.70 / s, 7.62 / d, 7.57 / m, 7.55 / d, 7.44 / m, 7.40 / m, 7.38 / m D, 7.28 / d, 7.04 / d, 6.89 / s, 6.88 / d, 6.75 / s, 6.59 / d, 6.58 / d) (7.54 / d, 7.48 / d, 7.38 / d, 7.37 / d, 6.69 /
LC/MS: m/z=802[(M+1)+]
LC / MS: m / z = 802 [(M + 1) < + &
실시예Example 50 : 화합물 39의 합성 50: Synthesis of Compound 39
(1) (One) 제조예Manufacturing example 1 : 중간체 50-1의 합성 1: Synthesis of intermediate 50-1
중간체 49-1(3.0 g, 0.007 mol)에 4-bromobiphenyl(1.6 g, 0.007 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 50-1> 2.7g (수율 65%)을 얻었다.(m/z=592)
Intermediate 49-1 (3.0 g, 0.007 mol) was mixed with 4-bromobiphenyl (1.6 g, 0.007 mol) and synthesized in the same manner as in Example 1- Yield: 65%). (M / z = 592)
(2) (2) 제조예Manufacturing example 2 : 중간체 50-2의 합성 2: Synthesis of intermediate 50-2
중간체 50-1(5.0 g, 0.008 mol)에 triisopropyl borate(1.9 g, 0.010 mol)을 넣고 실시예 7-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 50-2> 3.1g (수율 70%)을 얻었다.(m/z=557)
Synthesis was conducted in the same manner as in Example 7-Preparation Example (2), except that triisopropyl borate (1.9 g, 0.010 mol) was added to Intermediate 50-1 (5.0 g, 0.008 mol) 70%). (M / z = 557)
(3) (3) 제조예Manufacturing example 3 : 중간체 50-3의 합성 3: Synthesis of Intermediate 50-3
2-bromo-3-chloro-1H-indole(3.0 g, 0.013 mol)에 9,9-dimethyl-9H-fluoren-2-ylboronic acid(3.7 g, 0.016 mol)을 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 50-3> 3.3g (수율 75%)을 얻었다.(m/z=343)
2-ylboronic acid (3.7 g, 0.016 mol) was added to 2-bromo-3-chloro-1H-indole (3.0 g, 0.013 mol) ) To obtain 3.3 g (yield 75%) of Intermediate 50-3 (m / z = 343)
(4) (4) 제조예Manufacturing example 4 : 중간체 50-4의 합성 4: Synthesis of intermediate 50-4
중간체 50-3(3.0 g, 0.009 mol)에 중간체 50-2(5.8 g, 0.011 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 50-4> 5.4 g (수율 73%)을 얻었다.(m/z=821)
Intermediate 50-4 (5.8 g, 0.011 mol) was added to Intermediate 50-3 (3.0 g, 0.009 mol) and the reaction mixture was treated in the same manner as in Example 1- (6) (Yield: 73%). (M / z = 821)
(5) (5) 제조예Manufacturing example 5 : 화합물 39의 합성 5: Synthesis of Compound 39
N-(biphenyl-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine(5.2 g, 0.010 mol) 대신에 중간체 50-4(8.2 g, 0.010 mol)을 사용하여 <화합물 2>와 동일한 방법을 사용하여 <화합물 39> 5.7g (수율 61%) 을 얻었다.Intermediate 50-4 (8.2 g, 0.010 mol) was used in the place of N- (biphenyl-4-yl) -N- (4- bromophenyl) -9,9-dimethyl-9H- ) Was used to obtain 5.7 g (yield: 61%) of <Compound 39> by the same method as in <
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.99/d, 7.93/d, 7.77/s, 7.70/s, 7.63/d, 7.62/d, 7.57/m, 7.44/m, 7.40/m, 7.37/m, 7.34/m, 7.30/d, 7.26/d, 7.00/d, 6.89/s, 6.88/d, 6.75/s, 6.59/d, 6.58/d) 2H(7.87/d, 7.55/d, 7.54/d, 7.52/d, 7.51/m, 7.48/d, 7.38/m, 7.28/m, 6.69/d) 6H(1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.99 / d, 7.93 / d, 7.77 / s, 7.70 / s, 7.63 / d, 7.62 / d, 7.57 / m, 7.44 / m, 7.40 / m D, 6.75 / d, 6.75 / s, 6.59 / d, 6.58 / d) 2H (7.87 / d, 7.55 / d 7.58 / d, 7.51 / m, 7.48 / d, 7.38 / m, 7.28 /
LC/MS: m/z=938[(M+1)+]
LC / MS: m / z = 938 [(M + 1) < + &
실시예Example 51 : 화합물 46의 합성 51: Synthesis of Compound 46
(1) (One) 제조예Manufacturing example 1 : 중간체 51-1의 합성 1: Synthesis of Intermediate 51-1
2,7-dibromo-9,9-dimethyl-9H-fluorene(3.0 g, 0.008 mol)에 dibiphenyl-4-ylamine(2.6 g, 0.008 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 51-1> 3.4g (수율 71%)을 얻었다.(m/z=592)
(2.6 g, 0.008 mol) was added to 2,7-dibromo-9,9-dimethyl-9H-fluorene (3.0 g, 0.008 mol) (M / z = 592) (Intermediate 51-1) (3.4 g, Yield: 71%).
(2) (2) 제조예Manufacturing example 2 : 화합물 46의 합성 2: Synthesis of Compound 46
N-(biphenyl-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine(5.2 g, 0.010 mol) 대신에 중간체 51-1(5.9 g, 0.010 mol)을 사용하여 <화합물 2>와 동일한 방법을 사용하여 <화합물 46> 5.3g (수율 71%) 을 얻었다.Intermediate 51-1 (5.9 g, 0.010 mol) was used in the place of N- (biphenyl-4-yl) -N- (4- bromophenyl) -9,9-dimethyl-9H- fluoren- ), 5.3 g (yield: 71%) of Compound 46 was obtained in the same manner as in <
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.99/d, 7.93/d, 7.77/s, 7.63/d, 7.62/d, 7.40/m, 7.37/m, 7.36/s, 7.34/m, 7.30/d, 7.26/d, 7.04/d, 6.75/s, 6.58/d) 2H(7.41/m) 4H(7.54/d, 7.52/d, 7.51/m, 6.69/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.99 / d, 7.93 / d, 7.77 / s, 7.63 / d, 7.62 / d, 7.40 / m, 7.37 / m, 7.36 / s, 7.34 / m (7.54 / d, 7.52 / d, 7.51 / m, 6.69 / d, 1.72 / s), 7.30 / d, 7.26 / d, 7.04 / d, 6.75 / s, 6.58 /
LC/MS: m/z=745[(M+1)+]
LC / MS: m / z = 745 [(M + 1) < + &
실시예Example 52 : 화합물 50의 합성 52: Synthesis of Compound 50
(1) (One) 제조예Manufacturing example 1 : 중간체 52-1의 합성 1: Synthesis of Intermediate 52-1
2-bromo-1H-indol-3-ylboronic acid(2.2 g, 0.009 mol)에 naphthalen-2-ylboronic acid(1.9 g, 0.011 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 52-1> 1.9 g (수율 73%)을 얻었다.(m/z=287)
2-ylboronic acid (1.9 g, 0.011 mol) was added to 2-bromo-1H-indol-3-ylboronic acid (2.2 g, 0.009 mol) in the same manner as in Example 1- To obtain 1.9 g (yield 73%) of Intermediate 52-1 (m / z = 287)
(2) (2) 제조예Manufacturing example 2 : 중간체 52-2의 합성 2: Synthesis of intermediate 52-2
중간체 52-1(3.4 g, 0.012 mol), N-(biphenyl-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine(5.2 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 52-2> 4.8g (수율 71%)을 얻었다.(m/z=678)
N- (4-bromophenyl) -9,9-dimethyl-9H-fluoren-2-amine (5.2 g, 0.010 mol) (M / z = 678) (yield: 71%) was obtained by the same method as in the production example (6) of Example 1-
(3) (3) 제조예Manufacturing example 3 : 화합물 50의 합성 3: Synthesis of Compound 50
중간체 52-2(6.8 g, 0.010 mol)을 사용하여 <화합물 2>와 동일한 방법을 사용하여 <화합물 50> 5.7g (수율 71%) 을 얻었다.(Yield: 71%) was obtained in the same manner as in <
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.34/d, 7.99/d, 7.92/d, 7.55/m, 7.41/m, 7.40/m, 7.38/m, 7.37/m, 7.34/m, 7.30/d, 7.28/m, 7.26/d, 7.00/d, 6.75/s, 6.58/d) 2H(8.00/d, 7.87/d, 7.59/m, 7.52/d, 7.51/m) 4H(7.54/d, 6.69/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.34 / d, 7.99 / d, 7.92 / d, 7.55 / m, 7.41 / m, 7.40 / m, 7.38 / m, 7.37 / m, 7.34 / m 7.50 / d, 7.30 / d, 7.28 / d, 7.26 / d, 7.00 / d, 6.75 / s, 6.58 / d) 2H (8.00 / d, 7.87 / d, 7.59 / / d, 6.69 / d, 1.72 / s)
LC/MS: m/z=796[(M+1)+]
LC / MS: m / z = 796 [(M + 1) < + &
실시예Example 53 : 화합물 54의 합성 53: Synthesis of Compound 54
(1) (One) 제조예Manufacturing example 1 : 중간체 53-1의 합성 1: Synthesis of intermediate 53-1
3,3'-dibromobiphenyl(3.0 g, 0.010 mol)에 biphenyl-4-amine(1.7 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 53-1> 2.9g (수율 73%)을 얻었다.(m/z=400)
Was synthesized in the same manner as in Example 1 (2) except that biphenyl-4-amine (1.7 g, 0.010 mol) was added to 3,3'-dibromobiphenyl (3.0 g, 0.010 mol) > 2.9 g (yield: 73%). (M / z = 400)
(2) (2) 제조예Manufacturing example 2 : 중간체 53-2의 합성 2: Synthesis of intermediate 53-2
중간체 53-1(3.6 g, 0.009 mol)에 4-bromo-N,N-diphenylaniline(2.9 g, 0.009 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 53-2> 4.2g (수율 73%)을 얻었다.(m/z=643)
The intermediate 53-1 (3.6 g, 0.009 mol) was synthesized in the same manner as in Example 1 (2) except that 4-bromo-N, N-diphenylaniline (2.9 g, 0.009 mol) -2> 4.2 g (yield: 73%). (M / z = 643)
(3) (3) 제조예Manufacturing example 3 : 중간체 53-3의 합성 3: Synthesis of intermediate 53-3
중간체 53-2(5.0 g, 0.008 mol)에 1H-indol-3-ylboronic acid(1.6 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 53-3> 4.0 g (수율 73%)을 얻었다.(m/z=679)
Intermediate 53-2 (5.0 g, 0.008 mol) was synthesized in the same manner as in Example 1 (6) except that 1H-indol-3-ylboronic acid (1.6 g, 0.010 mol) 3> 4.0 g (yield: 73%). (M / z = 679)
(4) (4) 제조예Manufacturing example 4 : 화합물 54의 합성 4: Synthesis of Compound 54
중간체 53-3(6.8 g, 0.010 mol)을 사용하여 <화합물 2>와 동일한 방법을 사용하여 <화합물 54> 5.6g (수율 70%) 을 얻었다.(6.8 g, 0.010 mol) was used in place of Intermediate 53-3 to obtain 5.6 g (Yield: 70%) of Compound 54 by the same procedure as in <
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.99/d, 7.70/s, 7.57/m, 7.44/m, 7.41/m, 7.40/m, 7.37/m, 7.36/s, 7.34/m, 7.30/d, 7.26/d, 7.04/d, 6.89/d, 6.88/d, 6.59/d) 2H(7.54/d, 7.52/d, 7.51/m, 7.48/d, 6.81/m, 6.69/d, 1.72/s) 4H(7.20/m, 6.63/d, 6.38/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.99 / d, 7.70 / s, 7.57 / m, 7.44 / m, 7.41 / m, 7.40 / m, 7.37 / m, 7.36 / s, 7.34 / m 7.51 / d, 7.51 / m, 7.48 / d, 6.81 / m, 6.69 / d , 1.72 / s) 4H (7.20 / m, 6.63 / d, 6.38 / d)
LC/MS: m/z1=797[(M+1)+]
LC / MS: m /
실시예Example 54 : 화합물 84의 합성 54: Synthesis of Compound 84
(1) (One) 제조예Manufacturing example 1 : 중간체 54-1의 합성 1: Synthesis of intermediate 54-1
1,3,5-tribromobenzene(3.1 g, 0.010 mol)에 N-(biphenyl-4-yl)-9,9-dimethyl-9H-fluoren-2-amine(3.6 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 54-1> 4.3g (수율 73%)을 얻었다.(m/z=595)
(Biphenyl-4-yl) -9,9-dimethyl-9H-fluoren-2-amine (3.6 g, 0.010 mol) was added to 1,3,5-tribromobenzene (3.1 g, 0.010 mol) (M / z = 595) (Intermediate 54-1) (4.3 g, yield 73%) was synthesized in the same manner as in Preparation Example (2)
(2) (2) 제조예Manufacturing example 2 : 중간체 54-2의 합성 2: Synthesis of intermediate 54-2
중간체 54-1(5.0 g, 0.008 mol)에 1H-indol-3-ylboronic acid(1.6 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 54-2> 3.9 g (수율 73%)을 얻었다.(m/z=667)
Intermediate 54-1 (5.0 g, 0.008 mol) was synthesized in the same manner as in Example 1- (6) except that 1H-indol-3-ylboronic acid (1.6 g, 0.010 mol) 2> 3.9 g (yield: 73%). (M / z = 667)
(3) (3) 제조예Manufacturing example 3 : 중간체 54-3의 합성 3: Synthesis of intermediate 54-3
중간체 54-2(5.0 g, 0.007 mol)에 bromobenzene(1.1 g, 0.007 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 54-3> 4.0 g (수율 77%)을 얻었다.(m/z=743)
Intermediate 54-3 was synthesized in the same manner as in Example 1 (2), except that bromobenzene (1.1 g, 0.007 mol) was added to Intermediate 54-2 (5.0 g, 0.007 mol) %). (M / z = 743)
(4) (4) 제조예Manufacturing example 4 : 화합물 84의 합성 4: Synthesis of Compound 84
중간체 53-3(7.4 g, 0.010 mol)을 사용하여 <화합물 2>와 동일한 방법을 사용하여 <화합물 84> 6.3g (수율 73%) 을 얻었다.6.3 g (yield 73%) of Compound 84 was obtained using Intermediate 53-3 (7.4 g, 0.010 mol) using the same method as
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.17/d, 7.99/d, 7.87/d, 7.71/d, 7.62/d, 7.55/d, 7.40/m, 7.38/m, 7.37/m, 7.34/m, 7.30/d, 7.28/m, 7.26/d, 7.06/s, 7.04/d, 6.75/s, 6.58/d) 2H(7.58/m, 7.54/d, 7.52/d, 7.51/m, 7.50/d, 7.42/m, 7.41/m, 7.36/s, 6.85/s, 6.69/d) 4H(1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.17 / d, 7.99 / d, 7.87 / d, 7.71 / d, 7.62 / d, 7.55 / d, 7.40 / m, 7.38 / m, 7.37 / m 7.58 / d, 7.52 / d, 7.52 / d, 7.04 / d, 6.75 / , 7.50 / d, 7.42 / m, 7.41 / m, 7.36 / s, 6.85 / s, 6.69 /
LC/MS: m/z=861[(M+1)+]
LC / MS: m / z = 861 [(M + 1) < + &
실시예Example 55 : 화합물 93의 합성 55: Synthesis of compound 93
(1) (One) 제조예Manufacturing example 1 : 중간체 55-1의 합성 1: Synthesis of intermediate 55-1
3-bromo-5-chloro-1H-indole(3.0 g, 0.013 mol)에 methyl 2-iodobenzoate(4.7 g, 0.018 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 55-1> 3.1g (수율 65%)을 얻었다.(m/z=364)
Was synthesized in the same manner as in Example 1 (2), except that methyl 2-iodobenzoate (4.7 g, 0.018 mol) was added to 3-bromo-5-chloro-1H- indole (3.0 g, 0.013 mol) 3.1 g (yield 65%) of intermediate 55-1 (m / z = 364) was obtained.
(2) (2) 제조예Manufacturing example 2 : 중간체 55-2의 합성 2: Synthesis of intermediate 55-2
중간체 55-1(3.0 g, 0.008 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 55-2> 1.7g (수율 61%)을 얻었다.(m/z=340)
Intermediate 55-1 (3.0 g, 0.008 mol) was used to synthesize 1.7 g (yield: 61%) of Intermediate 55-2 in the same manner as in Example 1 (3) = 340)
(3) (3) 제조예Manufacturing example 3 : 중간체 55-3의 합성 3: Synthesis of intermediate 55-3
중간체 55-2(3.0 g, 0.009 mol)을 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <중간체 55-3> 2.2g (수율 72%)을 얻었다.(m/z=346)
2.2 g (yield 72%) of Intermediate 55-3 was obtained in the same manner as in Example 1 (4), except that Intermediate 55-2 (3.0 g, 0.009 mol) was added. M / z = 346)
(4) (4) 제조예Manufacturing example 4 : 중간체 55-4의 합성 4: Synthesis of Intermediate 55-4
중간체 55-3(3.0 g, 0.009 mol)에 phenyl boronic acid(1.3 g, 0.011 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 55-4> 1.9g (수율 60%)을 얻었다.(m/z=343)
Intermediate 55-4 was synthesized in the same manner as in Example 1 (6), except that phenyl boronic acid (1.3 g, 0.011 mol) was added to Intermediate 55-3 (3.0 g, 0.009 mol) Yield: 60%). (M / z = 343)
(5) (5) 제조예Manufacturing example 5 : 중간체 55-5의 합성 5: Synthesis of intermediate 55-5
중간체 55-4(3.0 g, 0.009 mol)에 bis(pinacolato)dibron(2.8 g, 0.011 mol)를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 55-5> 2.7g (수율 69%)을 얻었다.(m/z=435)
<Intermediate 55-5> 2.7 (4-aminopyrimidin-4-yl) pyridine was synthesized by the same method as in Example 1 (5), except that bis (pinacolato) dibron (2.8 g, 0.011 mol) was added to Intermediate 55-4 g (yield: 69%). (m / z = 435)
(6) (6) 제조예Manufacturing example 6 : 중간체 55-6의 합성 6: Synthesis of intermediate 55-6
중간체 55-5(3.0 g, 0.007 mol)에 1,4-dibromobenzene(1.4 g, 0.006 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 55-6> 1.9g (수율 69%)을 얻었다.(m/z=464)
Intermediate 55-6 was synthesized by the same method as in Example 1 (6), except that 1,4-dibromobenzene (1.4 g, 0.006 mol) was added to Intermediate 55-5 (3.0 g, 0.007 mol) g (yield: 69%). (m / z = 464)
(7) (7) 제조예Manufacturing example 7 : 화합물 93의 합성 7: Synthesis of compound 93
중간체 55-6(3.0 g, 0.006 mol)에 N-(biphenyl-4-yl)-9,9-dimethyl-9H-fluoren-2-amine(2.2 g, 0.006 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 93> 3.3g (수율 74%)을 얻었다.(Biphenyl-4-yl) -9,9-dimethyl-9H-fluoren-2-amine (2.2 g, 0.006 mol) was added to Intermediate 55-6 (3.0 g, 0.006 mol) (2), 3.3 g (yield: 74%) of Compound 93 was obtained.
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.63/s, 7.87/d, 7.62/d, 7.55/d, 7.40/m, 7.38/m, 7.37/m, 7.36/s, 7.30/d, 7.28/m, 7.26/d, 7.21/s, 6.75/s, 6.58/d) 2H(7.41/m) 4H(7.54/d, 7.51/m, 6.69/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.63 / s, 7.87 / d, 7.62 / d, 7.55 / d, 7.40 / m, 7.38 / m, 7.37 / m, 7.36 / s, 7.30 / d (7.24 / d, 7.51 / m, 6.69 / d, 1.72 / s)
LC/MS: m/z=745[(M+1)+]
LC / MS: m / z = 745 [(M + 1) < + &
실시예Example 56 : 화합물 110의 합성 56: Synthesis of compound 110
(1) (One) 제조예Manufacturing example 1 : 중간체 56-1의 합성 1: Synthesis of intermediate 56-1
5-bromobenzene-1,3-diamine(2.0 g, 0.011 mol)에 bromobenzene(6.8 g, 0.044 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 56-1> 3.9g (수율 72%)을 얻었다.(m/z=491)
Intermediate 56-1 was synthesized by the same method as in Example 1 (2), except that bromobenzene (6.8 g, 0.044 mol) was added to 5-bromobenzene-1,3-diamine (2.0 g, 0.011 mol) 3.9 g (yield: 72%) was obtained. (M / z = 491)
(2) (2) 제조예Manufacturing example 2 : 화합물 110의 합성 2: Synthesis of compound 110
중간체 55-5(3.0 g, 0.007 mol)에 중간체 56-1(2.9 g, 0.006 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 110> 3.1g (수율 72%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (6) to give Intermediate 56-1 (2.9 g, 0.006 mol) and Intermediate 55-5 (3.0 g, 0.007 mol) 72%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.63/d, 7.41/m, 7.40/m, 7.37/m, 7.36/s, 7.30/d, 7.26/d, 7.21/s, 5.73/s) 2H(7.52/d, 7.51/m, 6.25/s, 1.72/s) 4H(6.81/m) 8H(7.20/m, 6.63/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.63 / d, 7.41 / m, 7.40 / m, 7.37 / m, 7.36 / s, 7.30 / d, 7.26 / d, 7.21 / s, 5.73 / s ) 2H (7.52 / d, 7.51 / m, 6.25 / s, 1.72 / s)
LC/MS: m/z=720[(M+1)+]
LC / MS: m / z = 720 [(M + 1) < + &
실시예Example 57 : 화합물 125의 합성 57: Synthesis of compound 125
(1) (One) 제조예Manufacturing example 1 : 중간체 57-1의 합성 1: Synthesis of intermediate 57-1
1,4-dibromonaphthalene(3.0 g, 0.010 mol)에 phenyl boronic acid(1.4 g, 0.012 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 57-1> 2.0g (수율 72%)을 얻었다.(m/z=283)
2.0 g of Intermediate 57-1 was synthesized in the same manner as in Example 1 (6) except that phenyl boronic acid (1.4 g, 0.012 mol) was added to 1,4-dibromonaphthalene (3.0 g, 0.010 mol) (Yield: 72%). (M / z = 283)
(2) (2) 제조예Manufacturing example 2 : 중간체 57-2의 합성 2: Synthesis of intermediate 57-2
중간체 57-1(3.0 g, 0.010 mol)에 biphenyl-4-amine(1.7 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 57-1> 2.9 g (수율 77%)을 얻었다.(m/z=371)
Intermediate 57-1> 2.9 g (0.010 mol) of biphenyl-4-amine was added to Intermediate 57-1 (3.0 g, 0.010 mol) g (yield: 77%). (m / z = 371)
(3) (3) 제조예Manufacturing example 3 : 중간체 57-3의 합성 3: Synthesis of intermediate 57-3
중간체 55-5(3.0 g, 0.008 mol)에 3,3'-dibromobiphenyl(2.5 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 57-3> 3.6g (수율 75%)을 얻었다.(m/z=540)
Intermediate 57-3 was synthesized in the same manner as in Example 1 (6) except that 3,3'-dibromobiphenyl (2.5 g, 0.008 mol) was added to Intermediate 55-5 (3.0 g, 0.008 mol) 3.6 g (yield 75%) of the title compound (m / z = 540)
(4) (4) 제조예Manufacturing example 4 : 화합물 125의 합성 4: Synthesis of Compound 125
중간체 57-3(3.0 g, 0.007 mol)에 중간체 57-2(3.6 g, 0.006 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 125> 4.1g (수율 75%)을 얻었다.Intermediate 57-2 (3.6 g, 0.006 mol) was added to Intermediate 57-3 (3.0 g, 0.007 mol), and the compound was synthesized by the same method as in Example 1- (2) 75%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.49/d, 8.19/d, 8.06/d, 7.93/d, 7.78/d, 7.70/s, 7.59/d, 7.57/m, 7.44/m, 7.40/m, 7.37/m, 7.30/d, 7.26/d, 7.04/d, 6.89/s, 6.88/d) 2H(7.79/d, 7.48/d, 7.41/m, 6.69/d, 1.72/s) 4H(7.54/d, 7.52/d) 6H(7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.49 / d, 8.19 / d, 8.06 / d, 7.93 / d, 7.78 / d, 7.70 / s, 7.59 / d, 7.57 / m, 7.44 / m M, 7.69 / d, 7.72 / d, 7.04 / d, 6.89 / s, 6.88 / d) ) 4H (7.54 / d, 7.52 / d) 6H (7.51 / m)
LC/MS: m/z=832[(M+1)+]
LC / MS: m / z = 832 [(M + 1) < + &
실시예Example 58 : 화합물 132의 합성 58: Synthesis of Compound 132
(1) (One) 제조예Manufacturing example 1 : 화합물 132의 합성 1: Synthesis of Compound 132
중간체 57-3(5.0 g, 0.009 mol)에 N-(biphenyl-4-yl)naphthalen-1-amine(2.7 g, 0.009 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 132> 5.1g (수율 75%)을 얻었다.4-yl) naphthalen-1-amine (2.7 g, 0.009 mol) was added to Intermediate 57-3 (5.0 g, 0.009 mol) in the same manner as in Example 1- To obtain 5.1 g (yield 75%) of < Compound 132 >.
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.19/d, 8.02/d, 7.93/d, 7.70/s, 7.58/d, 7.57/m, 7.44/m, 7.40/m, 7.38/m, 7.37/m, 7.36/s, 7.30/d, 7.26/d, 6.98/d, 6.89/d, 6.88/d, 6.59/d) 2H(7.48/d, 7.41/m, 6.69/d, 1.72/s) 4H(7.54/d, 7.52/d, 7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.19 / d, 8.02 / d, 7.93 / d, 7.70 / s, 7.58 / d, 7.57 / m, 7.44 / m, 7.40 / m, 7.38 / m D, 7.41 / m, 6.69 / d, 1.72 / s, 7.37 / m, 7.36 / s, 7.30 / d, 7.26 / d, 6.98 / d, 6.89 / d, 6.88 / d, 6.59 / ) 4H (7.54 / d, 7.52 / d, 7.51 / m)
LC/MS: m/z=755[(M+1)+]
LC / MS: m / z = 755 [(M + 1) < + &
실시예Example 59 : 화합물 172의 합성 59: Synthesis of Compound 172
(1) (One) 제조예Manufacturing example 1 : 중간체 59-1의 합성 1: Synthesis of intermediate 59-1
2-bromo-1H-indol-3-ylboronic acid(2.4 g, 0.010 mol)에 N-(biphenyl-4-yl)-N-(4-bromophenyl)biphenyl-4-amine(3.8 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 59-1> 3.4 g (수율 71%)을 얻었다.(m/z=591)
(Biphenyl-4-yl) -N- (4-bromophenyl) biphenyl-4-amine (3.8 g, 0.008 mol) was added to a solution of 2-bromo-1H-indol- (M / z = 591) was obtained in the same manner as in Example 1 (6), and 3.4 g (yield: 71%) of Intermediate 59-1 was obtained.
(2) (2) 제조예Manufacturing example 2 : 중간체 59-2의 합성 2: Synthesis of intermediate 59-2
중간체 59-1(5.0 g, 0.011 mol)에 phenyl boronic acid(1.6 g, 0.013 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 59-2> 4.7g (수율 72%)을 얻었다.(m/z=588)
Intermediate 59-2 was synthesized in the same manner as in Example 1- (6), except that phenyl boronic acid (1.6 g, 0.013 mol) was added to Intermediate 59-1 (5.0 g, 0.011 mol) Yield: 72%). (M / z = 588)
(3) (3) 제조예Manufacturing example 3 : 화합물 172의 합성 3: Synthesis of Compound 172
중간체 59-2(5.9 g, 0.010 mol)을 사용하여 <화합물 2>와 동일한 방법을 사용하여 <화합물 172> 5.0g (수율 71%) 을 얻었다.5.0 g (Yield 71%) of <Compound 172> was obtained in the same manner as in <
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.02/d, 7.40/m, 7.37/m, 7.30/d, 7.26/d, 7.00/d, 6.60/s) 2H(7.79/d, 1.72/s) 3H(7.51/m) 4H(7.52/d) 6H(7.54/d, 7.51/m, 6.69/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.02 / d, 7.40 / m, 7.37 / m, 7.30 / d, 7.26 / d, 7.00 / d, 6.60 / s) 2H (7.79 / d, 1.72 / s) 3H (7.51 / m) 4H (7.52 / d) 6H (7.54 / d, 7.51 /
LC/MS: m/z=705[(M+1)+]
LC / MS: m / z = 705 [(M + 1) < + &
실시예Example 60 : 화합물 183의 합성 60: Synthesis of Compound 183
(1) (One) 제조예Manufacturing example 1 : 중간체 60-1의 합성 1: Synthesis of intermediate 60-1
5-chloro-2-iodo-1H-benzo[d]imidazole(3.0 g, 0.011 mol)에 methyl 2-iodobenzoate(4.2 g, 0.016 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 60-1> 2.6g (수율 58%)을 얻었다.(m/z=412)
The same procedure as in Example 1-Preparation Example (2) was repeated except that methyl 2-iodobenzoate (4.2 g, 0.016 mol) was added to 5-chloro-2-iodo-1H- benzo [d] imidazole (3.0 g, To obtain 2.6 g (yield: 58%) of Intermediate 60-1 (m / z = 412)
(2) (2) 제조예Manufacturing example 2 : 중간체 60-2의 합성 2: Synthesis of intermediate 60-2
중간체 60-1(3.0 g, 0.007 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 60-2> 1.8 g (수율 64%)을 얻었다.(m/z=412)
1.8 g (yield 64%) of Intermediate 60-2 (3.0 g, 0.007 mol) was obtained in the same manner as in Example 1- (3) = 412)
(3) (3) 제조예Manufacturing example 3 : 중간체 60-3의 합성 3: Synthesis of intermediate 60-3
중간체 60-2(3.0 g, 0.008 mol)을 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <중간체 60-3> 1.6g (수율 51%)을 얻었다.(m/z=394)
1.6 g (51%) of Intermediate 60-3 was obtained in the same manner as in Example 1 (4), except that Intermediate 60-2 (3.0 g, 0.008 mol) was added. M / z = 394)
(4) (4) 제조예Manufacturing example 4 : 중간체 60-4의 합성 4: Synthesis of intermediate 60-4
중간체 60-3(3.0 g, 0.008 mol)에 phenyl boronic acid(1.2 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 60-4> 2.0g (수율 72%)을 얻었다.(m/z=344)
Intermediate 60-4 (2.0 g, 0.010 mol) was synthesized in the same manner as in Example 1- (6) except that phenyl boronic acid (1.2 g, 0.010 mol) was added to Intermediate 60-3 Yield: 72%). (M / z = 344)
(5) (5) 제조예Manufacturing example 5 : 중간체 60-4-1의 합성 5: Synthesis of intermediate 60-4-1
중간체 60-4(3.0 g, 0.009 mol)에 bis(pinacolato)dibron(2.8 g, 0.011 mol)를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 60-4-1> 2.8g (수율 72%)을 얻었다.(m/z=436)
Synthesis was conducted in the same manner as in Example 1-Preparation Example (5), except that bis (pinacolato) dibron (2.8 g, 0.011 mol) was added to Intermediate 60-4 (3.0 g, 0.009 mol) > 2.8 g (yield: 72%) was obtained. (M / z = 436)
(6) (6) 제조예Manufacturing example 6 : 중간체 60-5의 합성 6: Synthesis of intermediate 60-5
중간체 60-4-1(3.9 g, 0.009 mol)에 1,4-dibromobenzene(1.9 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 60-5> 2.7 g (수율 72%)을 얻었다.(m/z=465)
Synthesis was conducted in the same manner as in Example 1 (6), except that 1,4-dibromobenzene (1.9 g, 0.008 mol) was added to Intermediate 60-4-1 (3.9 g, 0.009 mol) > 2.7 g (yield 72%). (M / z = 465)
(7) (7) 제조예Manufacturing example 7 : 화합물 183의 합성 7: Synthesis of Compound 183
중간체 60-5(3.0 g, 0.006 mol)에 bis(9,9-dimethyl-9H-fluoren-2-yl)amine(2.6 g, 0.006 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 183> 3.5g (수율 75%)을 얻었다.To the intermediate 60-5 (3.0 g, 0.006 mol) was added bis (9,9-dimethyl-9H-fluoren-2-yl) amine (2.6 g, 0.006 mol) Synthesis was conducted in the same manner to obtain 3.5 g (yield 75%) of <Compound 183>.
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.74/s, 7.41/m, 7.40/m, 7.37/m, 7.35/s, 7.30/d, 7.26/d) 2H(8.28/d, 7.87/d, 7.62/d, 7.55/d, 7.54/d, 7.51/m, 7.38/m, 7.28/m, 6.75/s, 6.69/d, 6.58/d) 6H(1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.74 / s, 7.41 / m, 7.40 / m, 7.37 / m, 7.35 / s, 7.30 / d, 7.26 / d) 2H (8.28 / d, 7.87 7.58 / d, 7.54 / d, 7.51 / m, 7.38 / m, 7.28 / m, 6.75 / s, 6.69 / d, 6.58 / d)
LC/MS: m/z=787[(M+1)+]
LC / MS: m / z = 787 [(M + 1) < + &
실시예Example 61 : 화합물 184의 합성 61: Synthesis of compound 184
(1) (One) 제조예Manufacturing example 1 : 화합물 184의 합성 1: Synthesis of Compound 184
중간체 60-5(3.0 g, 0.006 mol)에 N-(biphenyl-4-yl)-9,9-dimethyl-9H-fluoren-2-amine(2.2 g, 0.006 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 184> 3.4g (수율 77%)을 얻었다.(Biphenyl-4-yl) -9,9-dimethyl-9H-fluoren-2-amine (2.2 g, 0.006 mol) was added to Intermediate 60-5 (3.0 g, 0.006 mol) (2) to obtain 3.4 g (yield 77%) of < Compound 184 >.
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.87/d, 7.74/s, 7.62/d, 7.55/d, 7.40/m, 7.38/m, 7.37/m, 7.35/s, 7.30/d, 7.28/m, 6.75/s, 6.58/d) 2H(8.28/d, 7.52/d, 7.41/m) 4H(7.54/d, 7.51/m, 6.69/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.87 / d, 7.74 / s, 7.62 / d, 7.55 / d, 7.40 / m, 7.38 / m, 7.37 / m, 7.35 / s, 7.30 / d (7.58 / d, 7.51 / m, 6.69 / d, 1.72 / s), 7.28 /
LC/MS: m/z=746[(M+1)+]
LC / MS: m / z = 746 [(M + 1) < + &
실시예Example 62 : 화합물 186의 합성 62: Synthesis of compound 186
(1) (One) 제조예Manufacturing example 1 : 중간체 62-1의 합성 1: Synthesis of intermediate 62-1
4-chloro-2-iodo-1H-benzo[d]imidazole(3.0 g, 0.011 mol)에 phenyl boronic acid(1.6 g, 0.013 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 62-1> 1.5g (수율 61%)을 얻었다.(m/z=228)
Phenyl boronic acid (1.6 g, 0.013 mol) was added to 4-chloro-2-iodo-1H-benzo [d] imidazole (3.0 g, 0.011 mol) in the same manner as in Example 1- 1.5 g (yield: 61%) of Intermediate 62-1 (m / z = 228) was obtained.
(2) (2) 제조예Manufacturing example 2 : 중간체 62-2의 합성 2: Synthesis of intermediate 62-2
중간체 62-1(2.5 g, 0.011 mol)에 methyl 2-iodobenzoate(2.9 g, 0.011 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 62-2> 3.0g (수율 61%)을 얻었다.(m/z=362)
(2.9 g, 0.011 mol) was added to Intermediate 62-1 (2.5 g, 0.011 mol) and the same procedure as in Example 1 (2) was used to synthesize 3.0 g of Intermediate 62-2 (Yield: 61%). (M / z = 362)
(3) (3) 제조예Manufacturing example 3 : 중간체 62-3의 합성 3: Synthesis of intermediate 62-3
중간체 62-2(2.5 g, 0.007 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 62-3> 1.6g (수율 64%)을 얻었다.(m/z=362)
1.6 g (yield: 64%) of <Intermediate 62-3> was obtained by adding the intermediate 62-2 (2.5 g, 0.007 mol) in the same manner as in Example 1- (3) = 362)
(4) (4) 제조예Manufacturing example 4 : 중간체 62-4의 합성 4: Synthesis of intermediate 62-4
중간체 62-3(2.5 g, 0.007 mol)을 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <중간체 62-4> 1.7g (수율 70%)을 얻었다.(m/z=344)
1.7 g (yield 70%) of Intermediate 62-4 was obtained in the same manner as in Example 1 (4) except that Intermediate 62-3 (2.5 g, 0.007 mol) was added. M / z = 344)
(5) (5) 제조예Manufacturing example 5 : 중간체 62-5의 합성 5: Synthesis of intermediate 62-5
중간체 62-4(3.0 g, 0.008 mol)에 bis(pinacolato)dibron(2.5 g, 0.010 mol)를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 62-5> 2.5g (수율 73%)을 얻었다.(m/z=436)
(Intermediate 62-5) 2.5 (2.5 g, 0.010 mol) was added to Intermediate 62-4 (3.0 g, 0.008 mol) in the same manner as in Example 1- g (yield: 73%). (m / z = 436)
(6) (6) 제조예Manufacturing example 6 : 중간체 62-6의 합성 6: Synthesis of intermediate 62-6
중간체 62-5(3.0 g, 0.007 mol)에 1,4-dibromobenzene(1.3 g, 0.006 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 62-6> 2.1g (수율 75%)을 얻었다.(m/z=465)
Intermediate 62-6> 2.1 (4-aminopyridine) was synthesized in the same manner as in Example 1 (6), except that 1,4-dibromobenzene (1.3 g, 0.006 mol) g (yield: 75%). (m / z = 465)
(7) (7) 제조예Manufacturing example 7 : 화합물 186의 합성 7: Synthesis of Compound 186
중간체 62-6(3.0 g, 0.006 mol)에 dibiphenyl-4-ylamine(2.1 g, 0.006 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 186> 3.0 g (수율 71%)을 얻었다.3.0 g (186) of compound 186 was synthesized in the same manner as in Example 1 (2) except that dibiphenyl-4-ylamine (2.1 g, 0.006 mol) was added to Intermediate 62-6 (3.0 g, 0.006 mol) Yield: 71%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.99/d, 7.67/d, 7.40/m, 7.37/m, 7.30/d, 7.26/d) 2H(8.28/d, 1.72/s) 3H(7.41/m) 4H(7.52/d) 6H(7.54/d, 7.51/m, 6.69/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.99 / d, 7.67 / d, 7.40 / m, 7.37 / m, 7.30 / d, 7.26 / d) 2H (8.28 / d, 1.72 / s) 3H (7.41 / m) 4H (7.52 / d) 6H (7.54 / d, 7.51 / m, 6.69 / d)
LC/MS: m/z=706[(M+1)+]
LC / MS: m / z = 706 [(M + 1) < + &
실시예Example 63 : 화합물 193의 합성 63: Synthesis of Compound 193
(1) (One) 제조예Manufacturing example 1 : 중간체 63-1의 합성 1: Synthesis of intermediate 63-1
중간체 60-4-1(3.0 g, 0.011 mol)에 1,4-dibromo-2,5-dimethylbenzene(2.2 g, 0.009 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 63-1> 3.2g (수율 71%)을 얻었다.(m/z=493)
Synthesis was conducted in the same manner as in Example 1 (6) except that 1,4-dibromo-2,5-dimethylbenzene (2.2 g, 0.009 mol) was added to Intermediate 60-4-1 (3.0 g, 0.011 mol) 3.2 g (yield: 71%) of Intermediate 63-1 (m / z = 493) was obtained.
(2) (2) 제조예Manufacturing example 2 : 화합물 193의 합성 2: Synthesis of Compound 193
중간체 63-1(5.0 g, 0.010 mol)에 bis(9,9-dimethyl-9H-fluoren-2-yl)amine(4.0 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 193> 6.3 g (수율 77%)을 얻었다.To the intermediate 63-1 (5.0 g, 0.010 mol) was added bis (9,9-dimethyl-9H-fluoren-2-yl) amine (4.0 g, 0.010 mol) Synthesis was conducted in the same manner to obtain 6.3 g (yield 77%) of <Compound 193>.
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.74/s, 7.42/s, 7.41/m, 7.40/m, 7.37/m, 7.35/s, 7.30/d, 7.26/d, 6.75/s, 6.49/s) 2H(8.28/d, 7.87/d, 7.62/d, 7.55/d, 7.51/m, 7.38/m, 7.28/m, 6.75/s, 6.58/d, 2.59/s) 6H(1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.74 / s, 7.42 / s, 7.41 / m, 7.40 / m, 7.37 / m, 7.35 / s, 7.30 / d, 7.26 / d, 6.75 / s , 6.49 / s) 2H (8.28 / d, 7.87 / d, 7.62 / d, 7.55 / d, 7.51 / m, 7.38 / / s)
LC/MS: m/z=815[(M+1)+]
LC / MS: m / z = 815 [(M + 1) < + &
실시예Example 64 : 화합물 194의 합성 64: Synthesis of compound 194
(1) (One) 제조예Manufacturing example 1 : 중간체 64-1의 합성 1: Synthesis of intermediate 64-1
중간체 60-4-1(3.0 g, 0.011 mol)에 2,6-dibromonaphthalene(2.6 g, 0.009 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 64-1> 3.4g (수율 73%)을 얻었다.(m/z=515)
2,6-dibromonaphthalene (2.6 g, 0.009 mol) was added to Intermediate 60-4-1 (3.0 g, 0.011 mol) and synthesized in the same manner as in Example 1-Preparation Example (6) (M / z = 515) was obtained in an amount of 3.4 g (yield: 73%).
(2) (2) 제조예Manufacturing example 2 : 화합물 194의 합성 2: Synthesis of Compound 194
중간체 64-1(3.0 g, 0.008 mol)에 N-(biphenyl-4-yl)-9,9-dimethyl-9H-fluoren-2-amine(2.9 g, 0.008 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 194> 3.1g (수율 80%)을 얻었다.(Biphenyl-4-yl) -9,9-dimethyl-9H-fluoren-2-amine (2.9 g, 0.008 mol) was added to Intermediate 64-1 (3.0 g, 0.008 mol) (2) to obtain 3.1 g (yield 80%) of < Compound 194 >.
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.87/d, 7.84/d, 7.74/s, 7.69/d, 7.64/d, 7.62/d, 7.55/d, 7.49/d, 7.46/s, 7.40/m, 7.38/m, 7.37/m, 7.35/s, 7.30/d, 7.28/m, 7.26/d, 6.75/s, 6.58/d) 2H(8.28/d, 7.54/d, 7.52/d, 7.41/m, 6.69/d) 4H(7.51/m, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.87 / d, 7.84 / d, 7.74 / s, 7.69 / d, 7.64 / d, 7.62 / d, 7.55 / d, 7.49 / d, 7.46 / s D, 7.54 / d, 7.52 / d, 7.28 / d, 7.75 / d, 7.38 / , 7.41 / m, 6.69 / d) 4H (7.51 / m, 1.72 / s)
LC/MS: m/z=797[(M+1)+]
LC / MS: m / z = 797 [(M + 1) < + &
실시예Example 65 : 화합물 212의 합성 65: Synthesis of Compound 212
(1)(One) 제조예Manufacturing example 1 : 중간체 65-1의 합성 1: Synthesis of intermediate 65-1
2-bromo-9,9-dimethyl-9H-fluorene(3.0 g, 0.0011 mol)에 4'-tert-butylbiphenyl-4-amine(2.5 g, 0.011 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 65-1> 3.5g (수율 77%)을 얻었다.(m/z=417)
Tert-butylbiphenyl-4-amine (2.5 g, 0.011 mol) was added to 2-bromo-9,9-dimethyl-9H-fluorene (3.0 g, 0.0011 mol) (M / z = 417) of <Intermediate 65-1> (yield: 77%) was obtained by the same method as used
(2) (2) 제조예Manufacturing example 2 : 화합물 212의 합성 2: Synthesis of Compound 212
중간체 63-1(5.0 g, 0.0010 mol)에 중간체 65-1(4.2 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 212> 6.1g (수율 74%)을 얻었다.(m/z=417)Synthesis was conducted in the same manner as in Example 1 (2) to give Intermediate 65-1 (4.2 g, 0.010 mol) and Intermediate 63-1 (5.0 g, 0.0010 mol) 74%). (M / z = 417)
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.87/d, 7.74/s, 7.62/d, 7.55/d, 7.42/s, 7.41/m, 7.40/m, 7.38/m, 7.37/m, 7.35/s, 7.30/d, 7.28/m, 7.26/d, 6.75/s, 6.58/d, 6.49/s) 2H(8.28/d, 7.54/d, 7.51/m, 7.38/d, 7.37/d, 6.69/d, 2.59/s) 3H(1.35/s) 4H(1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.87 / d, 7.74 / s, 7.62 / d, 7.55 / d, 7.42 / s, 7.41 / m, 7.40 / m, 7.38 / m, 7.37 / m 7.58 / d, 7.58 / d, 7.38 / d, 7.38 / d, 7.28 / , 6.69 / d, 2.59 / s) 3H (1.35 / s) 4H (1.72 / s)
LC/MS: m/z=831[(M+1)+]
LC / MS: m / z = 831 [(M + 1) < + &
실시예Example 66 : 화합물 215의 합성 66: Synthesis of compound 215
(1) (One) 제조예Manufacturing example 1 : 중간체 66-1의 합성 1: Synthesis of intermediate 66-1
3,3'-dibromobiphenyl(3.0 g, 0.0010 mol)에 N-(biphenyl-4-yl)-9,9-dimethyl-9H-fluoren-2-amine(3.6 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 66-1> 4.4g (수율 75%)을 얻었다.(m/z=592)
(Biphenyl-4-yl) -9,9-dimethyl-9H-fluoren-2-amine (3.6 g, 0.010 mol) was added to 3,3'-dibromobiphenyl (3.0 g, 0.0010 mol) (M / z = 592) (4.4 g, yield 75%) was synthesized in the same manner as in Preparation Example (2)
(2) (2) 제조예Manufacturing example 2 : 화합물 215의 합성 2: Synthesis of Compound 215
중간체 60-4-1(3.0 g, 0.011 mol)에 중간체 66-1(5.3 g, 0.009 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 215> 5.4g (수율 73%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (2), except that Intermediate 66-1 (5.3 g, 0.009 mol) was added to Intermediate 60-4-1 (3.0 g, 0.011 mol) (Yield: 73%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.99/d, 7.87/d, 7.70/s, 7.62/d, 7.57/m, 7.55/d, 7.47/d, 7.44/m, 7.40/m, 7.38/m, 7.37/m, 7.30/d, 7.28/m, 7.26/d, 6.89/s, 6.88/d, 6.75/d, 6.59/d, 6.58/d) 2H(8.28/d, 7.54/d, 7.52/d, 7.48/d, 7.41/m, 6.69/d) 4H(7.51/m, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.99 / d, 7.87 / d, 7.70 / s, 7.62 / d, 7.57 / m, 7.55 / d, 7.47 / d, 7.44 / m, 7.40 / m , 7.38 / m, 7.30 / d, 7.28 / m, 7.26 / d, 6.89 / s, 6.88 / d, 6.75 / d, 6.59 / d, 6.58 / , 7.52 / d, 7.48 / d, 7.41 / m, 6.69 / d) 4H (7.51 / m, 1.72 / s)
LC/MS: m/z=823[(M+1)+]
LC / MS: m / z = 823 [(M + 1) < + &
실시예Example 67 : 화합물 276의 합성 67: Synthesis of Compound 276
(1) (One) 제조예Manufacturing example 1 : 중간체 67-1의 합성 1: Synthesis of intermediate 67-1
중간체 55-3(3.0 g, 0.009 mol)에 4-aminophenylboronic acid(1.5 g, 0.011 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 67-1> 2.0g (수율 63%)을 얻었다.(m/z=358)
4-aminophenylboronic acid (1.5 g, 0.011 mol) was added to Intermediate 55-3 (3.0 g, 0.009 mol), and the title compound was synthesized in the same manner as in Example 1- (M / z = 358) (yield: 63%).
(2) (2) 제조예Manufacturing example 2 : 중간체 67-2의 합성 2: Synthesis of intermediate 67-2
중간체 67-1(3.0 g, 0.008 mol)에 bromobenzene(2.6 g, 0.016 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 67-2> 3.1g (수율 77%)을 얻었다.(m/z=511)
Intermediate 67-2> 3.1 g (Yield 77%) was obtained according to the same method as that employed for the preparation of Example 1- (2) with the introduction of bromobenzene (2.6 g, 0.016 mol) into Intermediate 67-1 (3.0 g, 0.008 mol) %). (M / z = 511)
(3) (3) 제조예Manufacturing example 3 : 중간체 67-3의 합성 3: Synthesis of intermediate 67-3
N-(biphenyl-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine(5.0 g, 0.010 mol)에 bis(pinacolato)dibron(3.0 g, 0.012 mol)를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 67-3> 3.9g (수율 70%)을 얻었다.(m/z=563)
Bis (pinacolato) dibron (3.0 g, 0.012 mol) was added to N- (biphenyl-4-yl) -N- (4- bromophenyl) -9,9-dimethyl-9H- ) Was synthesized in the same manner as in Example 1 (5) to give 3.9 g (yield: 70%) of Intermediate 67-3 (m / z = 563)
(4) (4) 제조예Manufacturing example 4 : 화합물 276의 합성 4: Synthesis of Compound 276
중간체 67-2(5.0 g, 0.010 mol), 중간체 67-3(6.8 g, 0.012 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 276> 6.2g (수율 68%)을 얻었다.Synthesis was conducted in the same manner as in Example 1- (6) to obtain Intermediate 67-2 (5.0 g, 0.010 mol) and Intermediate 67-3 (6.8 g, 0.012 mol) 68%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.63/s, 7.87/d, 7.62/d, 7.55/d, 7.41/m, 7.40/m, 7.38/m, 7.37/m, 7.36/s, 7.30/d, 7.28/m, 7.26/d, 7.21/s, 6.75/s, 6.58/d) 2H(7.52/d, 7.51/m, 6.81/m) 4H(7.20/m, 6.63/d, 1.72/s) 6H(7.54/d, 6.69/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.63 / s, 7.87 / d, 7.62 / d, 7.55 / d, 7.41 / m, 7.40 / m, 7.38 / m, 7.37 / m, 7.36 / s (7.52 / d, 7.51 / m, 6.81 / m) 4H (7.20 / m, 6.63 / d, 1.72 / s) 6H (7.54 / d, 6.69 / d)
LC/MS: m/z=913[(M+1)+]
LC / MS: m / z = 913 [(M + 1) < + &
실시예Example 68 : 화합물 281의 합성 68: Synthesis of Compound 281
(1) (One) 제조예Manufacturing example 1 : 화합물 281의 합성 1: Synthesis of Compound 281
중간체 54-2(6.7 g, 0.010 mol)을 사용하여 <화합물 2>와 동일한 방법을 사용하여 <화합물 281> 6.4g (수율 71%) 을 얻었다.6.4 g (Yield: 71%) of Compound 281 was obtained by using the same method as
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.87/d, 7.62/d, 7.55/d, 7.41/m, 7.38/m, 7.28/m, 7.06/s, 6.75/s, 6.58/d) 2H(7.99/d, 7.54/d, 7.52/d, 7.51/m, 7.40/d, 7.37/m, 7.36/s, 7.34/m, 7.30/d, 7.26/d, 7.04/d, 6.85/s, 6.69/d) 6H(1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.87 / d, 7.62 / d, 7.55 / d, 7.41 / m, 7.38 / m, 7.28 / m, 7.06 / s, 6.75 / s, 6.58 / d 7.36 / s, 7.34 / m, 7.30 / d, 7.26 / d, 7.04 / d, 6.85 / s (7.99 / d, 7.54 / d, 7.52 / d, 7.51 / , 6.69 (d) 6H (1.72 / s)
LC/MS: m/z=901[(M+1)+]
LC / MS: m / z = 901 [(M + 1) < + &
실시예Example 69 : 화합물 283의 합성 69: Synthesis of compound 283
(1) (One) 제조예Manufacturing example 1 : 화합물 283의 합성 1: Synthesis of compound 283
중간체 55-1(5.0 g, 0.011 mol)에 중간체 48-1(4.9 g, 0.009 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 283> 5.0g (수율 71%)을 얻었다.Synthesis was conducted in the same manner as in Example 1-Preparation Example (6), except that Intermediate 48-1 (4.9 g, 0.009 mol) was added to Intermediate 55-1 (5.0 g, 0.011 mol) 71%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.63/s, 7.41/m, 7.40/m, 7.37/m, 7.36/s, 7.30/d, 7.26/d, 7.21/s, 5.73/s) 2H(7.52/d, 7.51/m, 6.25/s, 1.72/s) 4H(2.34/s) 8H(6.98/d, 6.51/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.63 / s, 7.41 / m, 7.40 / m, 7.37 / m, 7.36 / s, 7.30 / d, 7.26 / d, 7.21 / s, 5.73 / s ) 2H (7.52 / d, 7.51 / m, 6.25 / s, 1.72 / s)
LC/MS: m/z=777[(M+1)+]
LC / MS: m / z = 777 [(M + 1) < + &
실시예Example 70 : 화합물 288의 합성 70: Synthesis of compound 288
(1) (One) 제조예Manufacturing example 1 : 화합물 288의 합성 1: Synthesis of Compound 288
중간체 55-5(5.0 g, 0.011 mol)에 중간체 54-1(2.7 g, 0.005 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 288> 3.8g (수율 73%)을 얻었다.(2.7 g, 0.005 mol) was added to Intermediate 55-5 (5.0 g, 0.011 mol), and the compound was synthesized in the same manner as in Example 1- (6) 73%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.63/s, 7.87/d, 7.62/d, 7.55/d, 7.38/m, 7.28/m, 7.06/s, 6.75/s, 6.58/d) 2H(7.54/d, 7.40/m, 7.37/m, 7.36/s, 7.30/d, 7.26/d, 7.21/s, 6.85/s, 6.69/d) 3H(7.41/m) 6H(7.52/d, 7.51/m, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.63 / s, 7.87 / d, 7.62 / d, 7.55 / d, 7.38 / m, 7.28 / m, 7.06 / s, 6.75 / s, 6.58 / d ) 2H (7.54 / d, 7.40 / m, 7.37 / m, 7.36 / s, 7.30 / d, 7.26 / d, 7.21 / s, 6.85 / s, 6.69 / , 7.51 / m, 1.72 / s)
LC/MS: m/z=1053[(M+1)+]
LC / MS: m / z = 1053 [(M + 1) < + &
실시예Example 71 : 화합물 295의 합성 71: Synthesis of compound 295
(1) (One) 제조예Manufacturing example 1 : 중간체 71-1의 합성 1: Synthesis of intermediate 71-1
중간체 55-6(3.0 g, 0.006 mol)에 9,9-dimethyl-9H-fluoren-2-amine(1.3 g, 0.006 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 71-1> 2.6g (수율 74%)을 얻었다.(m/z=592)
Synthesis was carried out in the same manner as in Example 1 (2) except that 9,9-dimethyl-9H-fluoren-2-amine (1.3 g, 0.006 mol) was added to Intermediate 55-6 (3.0 g, 0.006 mol) 2.6 g (yield: 74%) of Intermediate 71-1 (m / z = 592) was obtained.
(2) (2) 제조예Manufacturing example 2 : 중간체 71-2의 합성 2: Synthesis of intermediate 71-2
중간체 71-1(5.0 g, 0.008 mol)에 1,4-dibromobenzene(1.9 g, 0.008 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 71-2> 4.2g (수율 74%)을 얻었다.(m/z=712)
Synthesis was conducted in the same manner as in Example 1 (2) except that 1,4-dibromobenzene (1.9 g, 0.008 mol) was added to Intermediate 71-1 (5.0 g, 0.008 mol) g (yield: 74%). (m / z = 712)
(3) (3) 제조예Manufacturing example 3 : 화합물 295의 합성 3: Synthesis of compound 295
중간체 71-2(5.0 g, 0.007 mol), phenyl boronic acid(1.0 g, 0.008 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 295> 3.7g (수율 70%)을 얻었다.Compound 295 (3.7 g, Yield: 70%) was synthesized in the same manner as in Example 1- (6) except that Intermediate 71-2 (5.0 g, 0.007 mol) and phenyl boronic acid %).
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.87/d, 7.62/d, 7.55/d, 7.41/m, 7.40/m, 7.38/m, 7.37/m, 7.30/d, 7.28/m, 7.26/d, 7.21/s, 6.75/s, 6.58/d) 2H(7.52/d, 7.51/m) 4H(7.54/d, 6.69/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.87 / d, 7.62 / d, 7.55 / d, 7.41 / m, 7.40 / m, 7.38 / m, 7.37 / m, 7.30 / d, 7.28 / m 7.56 / d, 7.21 / s, 6.75 / s, 6.58 / d) 2H (7.52 / d, 7.51 /
LC/MS: m/z=750[(M+1)+]
LC / MS: m / z = 750 [(M + 1) < + &
실시예Example 72 : 화합물 298의 합성 72: Synthesis of compound 298
(1) (One) 제조예Manufacturing example 1 : 중간체 72-1의 합성 1: Synthesis of intermediate 72-1
1-phenyl-6,10b-dihydropyrrolo[2,3,4-kl]acridine(3.0 g, 0.011 mol), 1,4-dibromobenzene(2.6 g, 0.011 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 72-1> 3.5g (수율 72%)을 얻었다.(m/z=437)
(6) was prepared by adding 1-phenyl-6,10b-dihydropyrrolo [2,3,4-kl] acridine (3.0 g, 0.011 mol) and 1,4- dibromobenzene (2.6 g, 0.011 mol) (M / z = 437) (intermediate 72-1) (yield: 72%).
(2) (2) 제조예Manufacturing example 2 : 화합물 298의 합성 2: Synthesis of compound 298
중간체 72-1(3.0 g, 0.007 mol), N-(biphenyl-4-yl)-9,9-dimethyl-9H-fluoren-2-amine(2.5 g, 0.007 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 298> 3.6g (수율 72%)을 얻었다.To a solution of the intermediate 72-1 (3.0 g, 0.007 mol) and N- (biphenyl-4-yl) -9,9-dimethyl-9H- fluoren- (6), 3.6 g (yield 72%) of Compound 298 was obtained.
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.87/d, 7.62/s, 7.55/d, 7.41/m, 7.38/m, 7.28/m, 4.10/s) 2H(7.51/m, 1.72/s) 4H(7.94/d, 7.01/m, 6.38/m) 5H(7.52/d) 6H(6.69/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.87 / d, 7.62 / s, 7.55 / d, 7.41 / m, 7.38 / m, 7.28 / m, 4.10 / s) 2H (7.51 / m, 1.72 / s) 4H (7.94 / d, 7.01 / m, 6.38 / m) 5H (7.52 / d)
LC/MS: m/z=718[(M+1)+]
LC / MS: m / z = 718 [(M + 1) < + &
실시예Example 73 : 화합물 302의 합성 73: Synthesis of compound 302
(1) (One) 제조예Manufacturing example 1 : 중간체 73-1의 합성 1: Synthesis of intermediate 73-1
2-iodo-3H-indole(3.0 g, 0.012 mol)에 methyl 2-iodobenzoate(4.7 g, 0.018 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 73-1> 3.1g (수율 68%)을 얻었다.(m/z=377)
Was synthesized in the same manner as in Example 1 (2) to give methyl 2-iodobenzoate (4.7 g, 0.018 mol) in the presence of 2-iodo-3H-indole (3.0 g, 0.012 mol) > 3.1 g (yield: 68%). (M / z = 377)
(2) (2) 제조예Manufacturing example 2 : 중간체 73-2의 합성 2: Synthesis of Intermediate 73-2
중간체 73-1(3.0 g, 0.008 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 73-2> 1.8 g (수율 61%)을 얻었다.(m/z=377)
1.8 g (yield: 61%) of Intermediate 73-2 (3.0 g, 0.008 mol) was synthesized in the same manner as in Example 1- (3) = 377)
(3) (3) 제조예Manufacturing example 3 : 중간체 73-3의 합성 3: Synthesis of Intermediate 73-3
중간체 73-2(3.0 g, 0.008 mol)을 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <중간체 73-3> 2.0g (수율 70%)을 얻었다.(m/z=359)
2.0 g (yield 70%) of Intermediate 73-3 was obtained in the same manner as in Example 1- (4), except that Intermediate 73-2 (3.0 g, 0.008 mol) = 359)
(4) (4) 제조예Manufacturing example 4 : 화합물 302의 합성 4: Synthesis of Compound 302
중간체 73-3(3.0 g, 0.008 mol), 중간체 67-3(4.8 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 302> 4.0g (수율 75%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (6), except that Intermediate 73-3 (3.0 g, 0.008 mol) and Intermediate 67-3 (4.8 g, 0.010 mol) 75%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.87/d, 7.62/s, 7.58/d, 7.55/d, 7.38/m, 7.28/m) 2H(7.54/d, 7.52/d, 7.51/m) 4H(7.30/d, 7.20/m, 6.69/d, 6.68/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.87 / d, 7.62 / s, 7.58 / d, 7.55 / d, 7.38 / m, 7.28 / m) 2H (7.54 / d, 7.52 / d, 7.51 / m) 4H (7.30 / d, 7.20 / m, 6.69 / d, 6.68 / d, 1.72 / s)
LC/MS: m/z=669[(M+1)+]
LC / MS: m / z = 669 [(M + 1) < + &
실시예Example 74 : 화합물 306의 합성 74: Synthesis of Compound 306
(1) (One) 제조예Manufacturing example 1 : 중간체 74-1의 합성 1: Synthesis of intermediate 74-1
2-bromo-6-chloroaniline(2.0 g, 0.010 mol)에 4-bromo-3-vinylpyridine(1.8 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 74-1> 1.0g (수율 41%)을 얻었다.(m/z=244)
4-bromo-3-vinylpyridine (1.8 g, 0.010 mol) was added to 2-bromo-6-chloroaniline (2.0 g, 0.010 mol) 74-1> (yield: 41%). (M / z = 244)
(2) (2) 제조예Manufacturing example 2 : 중간체 74-2의 합성 2: Synthesis of intermediate 74-2
중간체 74-1(3.0 g, 0.012 mol)에 (E)-1,2-dibromoethene(2.2 g, 0.012 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 74-2> 1.6g (수율 50%)을 얻었다.(m/z=268)
(E) -1,2-dibromoethene (2.2 g, 0.012 mol) was added to Intermediate 74-1 (3.0 g, 0.012 mol) to obtain Intermediate 74 -2> 1.6 g (yield 50%). (M / z = 268)
(3) (3) 제조예Manufacturing example 3 : 화합물 306의 합성 3: Synthesis of Compound 306
중간체 74-2(3.0 g, 0.011 mol), 중간체 67-3(6.3 g, 0.013 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 306> 4.7g (수율 64%)을 얻었다.This compound was synthesized in the same manner as in Example 1- (6), except that Intermediate 74-2 (3.0 g, 0.011 mol) and Intermediate 67-3 (6.3 g, 0.013 mol) 64%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.43/d, 8.41/s, 7.99/d, 7.87/d, 7.62/d, 7.55/d, 7.41/m, 7.38/m, 7.36/s, 7.34/m, 7.30/d, 7.28/m, 7.04/d, 6.75/s, 6.58/d) 2H(7.52/d, 7.51/m) 4H(7.54/d, 6.69/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.43 / d, 8.41 / s, 7.99 / d, 7.87 / d, 7.62 / d, 7.55 / d, 7.41 / m, 7.38 / m, 7.36 / s (7.54 / d, 6.69 / d, 1.72 / s), 7.34 / m, 7.30 / d, 7.28 / m, 7.04 / d, 6.75 / s, 6.58 /
LC/MS: m/z=670[(M+1)+]
LC / MS: m / z = 670 [(M + 1) < + &
실시예Example 75 : 화합물 307의 합성 75: Synthesis of Compound 307
(1)(One) 제조예Manufacturing example 1 : 중간체 75-1의 합성 1: Synthesis of intermediate 75-1
3-bromobenzene-1,2-diamine(2.0 g, 0.011 mol)에 1,2-dibromobenzene(2.6 g, 0.011 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 75-1> 2.0g (수율 71%)을 얻었다.(m/z=261)
1,2-dibromobenzene (2.6 g, 0.011 mol) was added to 3-bromobenzene-1,2-diamine (2.0 g, 0.011 mol) (Yield: 71%) of the title compound (m / z = 261)
(2) (2) 제조예Manufacturing example 2 : 중간체 75-2의 합성 2: Synthesis of intermediate 75-2
중간체 75-1(3.0 g, 0.011 mol)에 (E)-1,2-dibromoethene(2.0 g, 0.011 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 75-2> 1.6g (수율 50%)을 얻었다.(m/z=285)
(E) -1,2-dibromoethene (2.0 g, 0.011 mol) was added to Intermediate 75-1 (3.0 g, 0.011 mol) to obtain Intermediate 75 -2> 1.6 g (yield: 50%). (M / z = 285)
(3) (3) 제조예Manufacturing example 3 : 중간체 75-3의 합성 3: Synthesis of Intermediate 75-3
중간체 75-2(3.0 g, 0.011 mol), bromobenzene(1.7 g, 0.011 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 75-3> 2.9g (수율 74%)을 얻었다.(m/z=361)
Intermediate 75-3 (2.9 g, yield 74%) was obtained as a white solid from Intermediate 75-2 (3.0 g, 0.011 mol) and bromobenzene (1.7 g, 0.011 mol) %). (M / z = 361)
(4) (4) 제조예Manufacturing example 4 : 중간체 75-4의 합성 4: Synthesis of intermediate 75-4
1,4-dibromobenzene(2.4 g, 0.010 mol), bis(9,9-dimethyl-9H-fluoren-2-yl)amine(4.0 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 75-3-1> 4.1g (수율 74%)을 얻었다.(m/z=556)
Was used in the same manner as in Example 1 (2) except that 1,4-dibromobenzene (2.4 g, 0.010 mol) and bis (9,9-dimethyl-9H- fluoren- (M / z = 556) of <Intermediate 75-3-1> (yield: 74%).
(5) (5) 제조예Manufacturing example 5 : 중간체 75-4의 합성 5: Synthesis of intermediate 75-4
중간체 75-3-1(5.0 g, 0.009 mol), bis(pinacolato)dibron(2.8 g, 0.011 mol)를 넣고 실시예 1-제조예 (5)에서 사용된 동일한 방법으로 합성하여 <중간체 75-4> 3.9g (수율 71%)을 얻었다.(m/z=603)
Intermediate 75-3-1 (5.0 g, 0.009 mol) and bis (pinacolato) dibron (2.8 g, 0.011 mol) were added to the reaction mixture to obtain Intermediate 75-4 > 3.9 g (yield: 71%). (M / z = 603)
(5) (5) 제조예Manufacturing example 5 : 화합물 307의 합성 5: Synthesis of Compound 307
중간체 75-3(3.0 g, 0.008 mol), 중간체 75-4(5.2 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 75-4> 4.3g (수율 71%)을 얻었다.<Intermediate 75-4> was synthesized in the same manner as in Example 1- (6), except that Intermediate 75-3 (3.0 g, 0.008 mol) and Intermediate 75-4 (5.2 g, 0.010 mol) (Yield: 71%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(6.81/m) 2H(7.87/d, 7.62/d, 7.55/d, 7.54/d, 7.38/m, 7.28/m, 6.75/s, 6.69/d, 6.58/d) 4H(7.20/m, 6.81/m, 6.63/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (6.81 / m) 2H (7.87 / d, 7.62 / d, 7.55 / d, 7.54 / d, 7.38 / m, 7.28 / m, 6.75 / s, 6.69 / d, 6.58 / d) 4H (7.20 / m, 6.81 / m, 6.63 / d, 1.72 / s)
LC/MS: m/z=758[(M+1)+]
LC / MS: m / z = 758 [(M + 1) < + &
실시예Example 76 : 화합물 310의 합성 76: Synthesis of Compound 310
(1) (One) 제조예Manufacturing example 1 : 중간체 76-1의 합성 1: Synthesis of intermediate 76-1
2-bromopyrazine(2.0 g, 0.013mol)에 methyl 2-amino-3-bromobenzoate(2.9 g, 0.013 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 76-1> 2.4g (수율 59%)을 얻었다.(m/z=308)
(2.9 g, 0.013 mol) was added to 2-bromopyrazine (2.0 g, 0.013 mol) in the same manner as in Example 1-Preparation Example (2) > 2.4 g (yield: 59%). (M / z = 308)
(2) (2) 제조예Manufacturing example 2 : 중간체 76-2의 합성 2: Synthesis of intermediate 76-2
중간체 76-1(3.0 g, 0.010 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 76-2> 2.0g (수율 64%)을 얻었다.(m/z=308)
2.0 g (yield: 64%) of <Intermediate 76-2> was obtained by the same method as employed in the preparation example (3) of Example 1, with the intermediate 76-1 (3.0 g, 0.010 mol) = 308)
(3) (3) 제조예Manufacturing example 3 : 중간체 76-3의 합성 3: Synthesis of intermediate 76-3
중간체 76-2(3.0 g, 0.010 mol)을 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <중간체 76-3> 2.0g (수율 70%)을 얻었다.(m/z=290)
2.0 g (yield 70%) of Intermediate 76-3 was obtained in the same manner as in Example 1 (4) except that Intermediate 76-2 (3.0 g, 0.010 mol) was added. M / z = 290)
(4) (4) 제조예Manufacturing example 4 : 중간체 76-4의 합성 4: Synthesis of intermediate 76-4
중간체 33-1(3.0 g, 0.010 mol)에 1,1-dibromoethene(1.8 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 76-4> 1.6g (수율 51%)을 얻었다.(m/z=314)
Synthesis was conducted in the same manner as in Example 1 (2), except that 1,1-dibromoethene (1.8 g, 0.010 mol) was added to Intermediate 33-1 (3.0 g, 0.010 mol) g (yield: 51%). (m / z = 314)
(5) (5) 제조예Manufacturing example 5 : 화합물 310의 합성 5: Synthesis of Compound 310
중간체 76-4(3.0 g, 0.010 mol)에 중간체 67-3(4.8 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 76> 4.8 g (수율72%)을 얻었다.(4.8 g, 0.010 mol) was added to Intermediate 76-4 (3.0 g, 0.010 mol) in the same manner as in Example 1- (6) 72%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.58/d, 8.51/d, 7.99/d, 7.87/d, 7.62/d, 7.55/d, 7.41/m, 7.38/m, 7.36/s, 7.34/m, 7.28/m, 7.04/d, 6.75/s, 6.58/d) 2H(7.52/d, 7.51/m) 4H(7.54/d, 6.69/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.58 / d, 8.51 / d, 7.99 / d, 7.87 / d, 7.62 / d, 7.55 / d, 7.41 / m, 7.38 / m, 7.36 / s (7.54 / d, 6.69 / d, 1.72 / s), 7.34 m, 7.28 m, 7.04 d, 6.75 s, 6.58 d)
LC/MS: m/z=671[(M+1)+]
LC / MS: m / z = 671 [(M + 1) < + &
실시예Example 77 : 화합물 311의 합성 77: Synthesis of Compound 311
(1) (One) 제조예Manufacturing example 1 : 중간체 77-1의 합성 1: Synthesis of intermediate 77-1
2-amino-phenol(2.0 g, 0.010 mol)에 1,2,3-tribromobenzene(3.1 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 77-1> 1.1g (수율 41%)을 얻었다.(m/z=262)
Synthesis was conducted in the same manner as in Example 1 (2), except that 1,2,3-tribromobenzene (3.1 g, 0.010 mol) was added to 2-amino-phenol (2.0 g, 0.010 mol) 1> 1.1 g (yield: 41%). (M / z = 262)
(2) (2) 제조예Manufacturing example 2 : 중간체 77-2의 합성 2: Synthesis of Intermediate 77-2
중간체 77-1(3.0 g, 0.011 mol)에 1,2-dibromoethene(1.9 g, 0.0011 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 77-2> 1.6g (수율 51%)을 얻었다.(m/z=286)
Synthesis was conducted in the same manner as in Example 1 (2), except that 1,2-dibromoethene (1.9 g, 0.0011 mol) was added to Intermediate 77-1 (3.0 g, 0.011 mol) g (yield: 51%). (m / z = 286)
(3) (3) 제조예Manufacturing example 3 : 화합물 311의 합성 3: Synthesis of Compound 311
중간체 77-2(3.0 g, 0.010 mol)에 중간체 67-3(4.8 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 311> 4.5g (수율 70%)을 얻었다.Synthesis was conducted in the same manner as in Example 1- (6), except that Intermediate 67-3 (4.8 g, 0.010 mol) was added to Intermediate 77-2 (3.0 g, 0.010 mol) 70%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.89/d, 7.87/d, 7.62/d, 7.58/d, 7.55/d, 7.41/m, 7.36/s, 7.30/m, 7.28/m, 7.14/d, 6.88/d, 6.75/s, 6.58/d) 2H(7.52/d, 7.51/m, 7.38/m, 1.72/s) 4H(7.54/d, 6.69/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.89 / d, 7.87 / d, 7.62 / d, 7.58 / d, 7.55 / d, 7.41 / m, 7.36 / s, 7.30 / m, 7.28 / m (7.54 / d, 6.69 / d), 7.14 / d, 6.88 / d, 6.75 / s, 6.58 /
LC/MS: m/z=643[(M+1)+]
LC / MS: m / z = 643 [(M + 1) < + &
실시예Example 78 : 화합물 312의 합성 78: Synthesis of Compound 312
(1) (One) 제조예Manufacturing example 1 : 중간체 78-1의 합성 1: Synthesis of intermediate 78-1
2-amino-benzenethiol(2.0 g, 0.010 mol)에 1,2,3-tribromobenzene(3.1 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 78-1> 1.2g (수율 43%)을 얻었다.(m/z=278)
Synthesis was conducted in the same manner as in Example 1 (2), except that 1,2,3-tribromobenzene (3.1 g, 0.010 mol) was added to 2-amino-benzenethiol (2.0 g, 0.010 mol) 1> 1.2 g (yield: 43%). (M / z = 278)
(2) (2) 제조예Manufacturing example 2 : 중간체 78-2의 합성 2: Synthesis of intermediate 78-2
중간체 78-1(3.0 g, 0.010 mol)에 1,2-dibromoethene(1.7 g, 0.0010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 77-2> 1.5g (수율 51%)을 얻었다.(m/z=302)
Synthesis was conducted in the same manner as in Example 1 (2), except that 1,2-dibromoethene (1.7 g, 0.0010 mol) was added to Intermediate 78-1 (3.0 g, 0.010 mol) g (yield: 51%). (m / z = 302)
(3) (3) 제조예Manufacturing example 3 : 화합물 312의 합성 3: Synthesis of Compound 312
중간체 78-2(3.0 g, 0.010 mol)에 중간체 67-3(4.8 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 312> 4.9 g (수율74%)을 얻었다.Synthesis was conducted in the same manner as in Example 1- (6) to obtain Intermediate 67-3 (4.8 g, 0.010 mol) and Intermediate 78-2 (3.0 g, 0.010 mol) 74%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.91/d, 7.87/d, 7.62/d, 7.55/d, 7.42/d, 7.41/d, 7.41/m, 7.38/m, 7.36/s, 7.32/m, 7.28/m, 7.25/m, 7.22/m, 7.11/d, 6.75/s, 6.58/d) 2H(7.52/d, 7.51/m, 1.72/s) 4H(7.54/d, 6.69/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.91 / d, 7.87 / d, 7.62 / d, 7.55 / d, 7.42 / d, 7.41 / d, 7.41 / m, 7.38 / m, 7.36 / s (7.52 / d, 7.51 / m, 1.72 / s) 4H (7.54 / d, 6.69 / d), 7.32 / m, 7.28 / m, 7.25 / / d)
LC/MS: m/z=659[(M+1)+]
LC / MS: m / z = 659 [(M + 1) < + &
실시예Example 79 : 화합물 313의 합성 79: Synthesis of Compound 313
(1) (One) 제조예Manufacturing example 1 : 중간체 79-1의 합성 1: Synthesis of intermediate 79-1
3-bromopyridine(2.0 g, 0.013 mol)에 methyl 2-amino-3-bromobenzoate(2.9 g, 0.013 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 79-1> 1.8g (수율 45%)을 얻었다.(m/z=307)
(2.9 g, 0.013 mol) of methyl 2-amino-3-bromobenzoate was added to 3-bromopyridine (2.0 g, 0.013 mol) > 1.8 g (yield: 45%). (M / z = 307)
(2) (2) 제조예Manufacturing example 2 : 중간체 79-2의 합성 2: Synthesis of intermediate 79-2
중간체 79-1(3.0 g, 0.010 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 79-2> 1.8g (수율 60%)을 얻었다.(m/z=307)
1.8 g (yield: 60%) of <Intermediate 79-2> was obtained in the same manner as in Example 1- (3) except that Intermediate 79-1 (3.0 g, 0.010 mol) = 307)
(3) (3) 제조예Manufacturing example 3 : 중간체 79-3의 합성 3: Synthesis of intermediate 79-3
중간체 79-2(3.0 g, 0.010 mol)을 넣고 실시예 1-제조예(3)에서 사용된 동일한 방법으로 합성하여 <중간체 79-3> 2.0g (수율 70%)을 얻었다.(m/z=289)
2.0 g (yield 70%) of <Intermediate 79-3> was obtained by the same method as in Example 1- (3) except that Intermediate 79-2 (3.0 g, 0.010 mol) = 289)
(4) (4) 제조예Manufacturing example 4 : 중간체 79-4의 합성 4: Synthesis of intermediate 79-4
중간체 79-3(3.0 g, 0.010 mol)에 1,1-dibromoethene(1.8 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 79-4> 1.7g (수율 54%)을 얻었다.(m/z=313)
Intermediate 79-4 was synthesized by the same method as in the preparation example (2) of Example 1, except that 1,1-dibromoethene (1.8 g, 0.010 mol) was added to Intermediate 79-3 (3.0 g, 0.010 mol) g (yield: 54%). (m / z = 313)
(5) (5) 제조예Manufacturing example 5 : 화합물 313의 합성 5: Synthesis of Compound 313
중간체 79-4(3.0 g, 0.010 mol)에 중간체 67-3(4.8 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 313> 4.4g (수율66%)을 얻었다.Synthesis was conducted in the same manner as in Example 1- (6), except that Intermediate 67-3 (4.8 g, 0.010 mol) was added to Intermediate 79-4 (3.0 g, 0.010 mol) 66%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.60/s, 8.10/d, 7.99/d, 7.87/d, 7.62/d, 7.55/d, 7.41/m, 7.38/m, 7.36/s, 7.34/m, 7.28/m, 7.04/d, 6.97/d, 6.75/s, 6.58/d) 2H(7.52/d, 7.51/m) 4H(7.54/d, 6.69/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.60 / s, 8.10 / d, 7.99 / d, 7.87 / d, 7.62 / d, 7.55 / d, 7.41 / m, 7.38 / m, 7.36 / s (7.54 / d, 6.69 / d, 1.72 / s), 7.34 / m, 7.28 / m, 7.04 / d, 6.97 / d, 6.75 / s, 6.58 /
LC/MS: m/z=670[(M+1)+]
LC / MS: m / z = 670 [(M + 1) < + &
실시예Example 80 : 화합물 314의 합성 80: Synthesis of Compound 314
(1) (One) 제조예Manufacturing example 1 : 중간체 80-1의 합성 1: Synthesis of intermediate 80-1
3-bromopyridine(2.0 g, 0.013 mol)에 methyl 2-amino-3-bromobenzoate(2.9 g, 0.013 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 80-1> 1.7g (수율 41%)을 얻었다.(m/z=307)
(2.9 g, 0.013 mol) was added to 3-bromopyridine (2.0 g, 0.013 mol) in the same manner as in Example 1 (2) to obtain Intermediate 80-1 > 1.7 g (yield: 41%). (M / z = 307)
(2) (2) 제조예Manufacturing example 2 : 중간체 80-2의 합성 2: Synthesis of intermediate 80-2
중간체 80-1(3.0 g, 0.010 mol)을 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 80-2> 1.6g (수율 53%)을 얻었다.(m/z=307)
1.6 g (yield 53%) of Intermediate 80-2 (3.0 g, 0.010 mol) was obtained by the same method as in Example 1- (3) = 307)
(3) (3) 제조예Manufacturing example 3 : 중간체 80-3의 합성 3: Synthesis of Intermediate 80-3
중간체 80-2(3.0 g, 0.010 mol)을 넣고 실시예 1-제조예 (4)에서 사용된 동일한 방법으로 합성하여 <중간체 80-3> 1.8g (수율 61%)을 얻었다.(m/z=289)
1.8 g (yield: 61%) of Intermediate 80-3 was obtained in the same manner as in Example 1 (4), except that Intermediate 80-2 (3.0 g, 0.010 mol) = 289)
(4) (4) 제조예Manufacturing example 4 : 중간체 80-4의 합성 4: Synthesis of Intermediate 80-4
중간체 80-3(3.0 g, 0.010 mol)에 1,1-dibromoethene(1.8 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 80-4> 1.4g (수율 44%)을 얻었다.(m/z=313)
Intermediate 80-4> 1.4 (1) Synthesis was conducted in the same manner as in Example 1 (2) except that 1,1-dibromoethene (1.8 g, 0.010 mol) was added to Intermediate 80-3 (3.0 g, 0.010 mol) g (yield: 44%). (m / z = 313)
(5) (5) 제조예Manufacturing example 5 : 화합물 314의 합성 5: Synthesis of Compound 314
중간체 80-4(3.0 g, 0.010 mol)에 중간체 67-3(4.8 g, 0.010 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <화합물 314> 4.0g (수율60%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (6) to give Intermediate 67-3 (4.8 g, 0.010 mol) and Intermediate 80-4 (3.0 g, 0.010 mol) 60%).
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.43/d, 8.10/d, 7.99/d, 7.87/d, 7.62/d, 7.55/d, 7.41/m, 7.38/m, 7.36/s, 7.34/m, 7.28/m, 7.20/m, 7.04/d, 6.75/s, 6.58/d) 2H(7.52/d, 7.51/m) 4H(7.54/d, 6.69/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.43 / d, 8.10 / d, 7.99 / d, 7.87 / d, 7.62 / d, 7.55 / d, 7.41 / m, 7.38 / m, 7.36 / s (7.54 / d, 6.69 / d, 1.72 / s), 7.34 m, 7.28 m, 7.20 m, 7.04 d, 6.75 s, 6.58 d)
LC/MS: m/z=670[(M+1)+]
LC / MS: m / z = 670 [(M + 1) < + &
실시예Example 81 : 화합물 315의 합성 81: Synthesis of Compound 315
(1) (One) 제조예Manufacturing example 1 : 중간체 81-1의 합성 1: Synthesis of intermediate 81-1
2-bromo-1H-indol-3-ylboronic acid(2.4 g, 0.010 mol)에 phenyl boronic acid(1.4 g, 0.012 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 81-1> 1.7g (수율 72%)을 얻었다.(m/z=237)
The title compound was synthesized in the same manner as in Example 1 (6), except that phenyl boronic acid (1.4 g, 0.012 mol) was added to 2-bromo-1H-indol-3-ylboronic acid (2.4 g, 0.010 mol) 1.7 g (yield: 72%) of Intermediate 81-1 was obtained. (M / z = 237)
(2) (2) 제조예Manufacturing example 2 : 중간체 81-2의 합성 2: Synthesis of Intermediate 81-2
2,5-dibromothiophene(3.0 g, 0.012 mol)에 중간체 67-3(7.9 g, 0.014 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 81-2> 5.0g (수율 70%)을 얻었다.(m/z=598)
Synthesis was conducted in the same manner as in Example 1 (6), except that Intermediate 67-3 (7.9 g, 0.014 mol) was added to 2,5-dibromothiophene (3.0 g, 0.012 mol) g (yield 70%). (m / z = 598)
(3) (3) 제조예Manufacturing example 3 : 중간체 81-3의 합성 3: Synthesis of intermediate 81-3
중간체 81-1(3.0 g, 0.013 mol)에 중간체 81-2(7.8 g, 0.011 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 81-3> 5.0g (수율 64%)을 얻었다.(m/z=710)
Intermediate 81-3 (5.0 g, 0.011 mol) was added to Intermediate 81-1 (3.0 g, 0.013 mol) to obtain Intermediate 81-2 (7.8 g, 0.011 mol) (Yield: 64%). (M / z = 710)
(4) (4) 제조예Manufacturing example 4 : 화합물 315의 합성 4: Synthesis of Compound 315
중간체 81-3(7.1 g, 0.010 mol)을 사용하여 <화합물 2>와 동일한 방법을 사용하여 <화합물 315> 6.2g (수율 75%) 을 얻었다.6.2 g (yield 75%) of <compound 315> was obtained in the same manner as in <
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.37/d, 7.87/d, 7.55/d, 7.62/d, 7.40/m, 7.38/m, 7.37/m, 7.30/d, 7.28/m, 7.27/d, 7.17/m, 7.00/d, 6.75/s, 6.58/d) 2H(7.73/d, 7.41/m) 4H(7.54/d, 7.52/d, 7.51/m, 6.69/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.37 / d, 7.87 / d, 7.55 / d, 7.62 / d, 7.40 / m, 7.38 / m, 7.37 / m, 7.30 / d, 7.28 / m D, 7.57 / d, 7.17 / m, 7.00 / d, 6.75 / s, 6.58 / d) 2H (7.73 / d, 7.41 / / s)
LC/MS: m/z=828[(M+1)+]
LC / MS: m / z = 828 [(M + 1) < + &
실시예Example 82 : 화합물 316의 합성 82: Synthesis of Compound 316
(1) (One) 제조예Manufacturing example 1 : 중간체 82-1의 합성 1: Synthesis of intermediate 82-1
2,5-dibromofuran(3.0 g, 0.012 mol)에 중간체 67-3(7.9 g, 0.014 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 82-1> 4.5g (수율 65%)을 얻었다.(m/z=582)
Synthesis was conducted in the same manner as in Example 1 (6), except that Intermediate 67-3 (7.9 g, 0.014 mol) was added to 2,5-dibromofuran (3.0 g, 0.012 mol) g (yield: 65%). (m / z = 582)
(2) (2) 제조예Manufacturing example 2 : 중간체 82-2의 합성 2: Synthesis of intermediate 82-2
중간체 81-1(3.0 g, 0.013 mol)에 중간체 82-1(6.8 g, 0.011 mol)를 넣고 실시예 1-제조예 (6)에서 사용된 동일한 방법으로 합성하여 <중간체 82-2> 4.6g (수율 60%)을 얻었다.(m/z=694)
Intermediate 82-1 (6.8 g, 0.011 mol) was added to Intermediate 81-1 (3.0 g, 0.013 mol), and the reaction was conducted in the same manner as in Example 1- (6) (Yield: 60%). (M / z = 694)
(3) (3) 제조예Manufacturing example 3 : 화합물 316의 합성 3: Synthesis of Compound 316
중간체 82-2(6.9 g, 0.010 mol)을 사용하여 <화합물 2>와 동일한 방법을 사용하여 <화합물 316> 5.8g (수율 71%) 을 얻었다.Using the intermediate 82-2 (6.9 g, 0.010 mol), 5.8 g (Yield 71%) of <Compound 316> was obtained in the same manner as in <
H-NMR (200MHz, CDCl3):δ ppm, 1H(8.37/d, 7.87/d, 7.55/d, 7.62/d, 7.40/m, 7.38/m, 7.37/m, 7.30/d, 7.28/m, 7.27/d, 7.17/m, 7.00/d, 6.75/s, 6.58/d) 2H(7.41/m, 7.07/d) 4H(7.54/d, 7.52/d, 7.51/m, 6.69/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.37 / d, 7.87 / d, 7.55 / d, 7.62 / d, 7.40 / m, 7.38 / m, 7.37 / m, 7.30 / d, 7.28 / m M, 7.07 / d) 4H (7.54 / d, 7.52 / d, 7.51 / m, 6.69 / d, 1.72 / s)
LC/MS: m/z=812[(M+1)+]
LC / MS: m / z = 812 [(M + 1) < + &
실시예Example 83 : 화합물 317의 합성 83: Synthesis of Compound 317
(1) (One) 제조예Manufacturing example 1 : 화합물 317의 합성 1: Synthesis of Compound 317
중간체 40-1(3.0 g, 0.009 mol)에 N-(biphenyl-4-yl)-9,9-dimethyl-9H-fluoren-2-amine(3.2 g, 0.009 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <화합물 317> 6.0g (수율 77%)을 얻었다.(Biphenyl-4-yl) -9,9-dimethyl-9H-fluoren-2-amine (3.2 g, 0.009 mol) was added to Intermediate 40-1 (3.0 g, 0.009 mol) (2) to obtain 6.0 g (yield: 77%) of < Compound 317 >.
H-NMR (200MHz, CDCl3):δ ppm, 1H(7.87/d, 7.83/m, 7.62/d, 7.55/d, 7.41/m, 7.38/m, 7.28/m, 7.08/d, 7.05/m, 6.75/s, 6.58/d, 6.52/d, 5.04/s) 2H(7.33/m, 7.26/m) 6H(7.54/d, 7.51/m, 6.69/d, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.87 / d, 7.83 / m, 7.62 / d, 7.55 / d, 7.41 / m, 7.38 / m, 7.28 / m, 7.08 / d, 7.05 / m (7.54 / d, 7.51 / m, 6.69 / d, 1.72 / s), 6.75 / s, 6.58 / d, 6.52 /
LC/MS: m/z=865[(M+1)+]
LC / MS: m / z = 865 [(M + 1) < + &
소자 device
실시예Example
1 : 화합물 1을 1:
ITO로 코팅된 유리기판 위에 NPB를 증착하여 120 nm의 정공수송층을 형성하였으며, 이어서 Ir(ppy)3을 도펀트로 하여 화합물 1의 증착속도를 0.1 nm/sec, Ir(ppy)3 증착속도를 0.009 nm/sec로 증착하고, 증착속도 비율이 9%가 되도록 Ir(ppy)3을 도핑하여 정공수송층 상에 발광층을 30 nm 두께로 형성하였다.Depositing NPB on a glass substrates, coated with ITO, and was to form a hole transport layer of 120 nm, followed by Ir (ppy) the deposition rate of the
그 위에 Balq를 10 nm 두께로 증착하여 정공이 발광층을 지나 전자수송층으로 이동하는 것을 방지하는 정공차단층을 형성하고, 그 위에 Alq3를 증착하여 40 nm의 전자수송층을 형성하였으며, 그 위에 불화리튬을 증착하여 1 nm의 전자주입층을 형성하였다. 전자주입층 상에 알루미늄을 증착하여 120 nm의 음극을 형성하여 유기전계발광소자를 제조하였다.Balq was deposited thereon to a thickness of 10 nm to form a hole blocking layer for preventing holes from moving to the electron transporting layer through the light emitting layer, and Alq 3 was deposited thereon to form an electron transporting layer of 40 nm. Lithium fluoride To form a 1 nm electron injection layer. Aluminum was deposited on the electron injection layer to form a 120 nm negative electrode, thereby fabricating an organic electroluminescent device.
이때, 각 물질의 증착속도는 유기물질인, 화합물 1, NPB, Alq3, Balq는 0.1 nm/sec, 불화리튬은 0.01 nm/sec, 알루미늄은 0.5 nm/sec로 하였다.
At this time, the deposition rate of each material was set to 0.1 nm / sec for
소자 device 실시예Example 2 내지 43 2 to 43
상기 화합물 1 대신 하기 [표 1]에 기재된 화합물을 사용한 것을 제외하고는 소자실시예 1와 동일한 방법으로 소자 실시예 2 내지 43의 유기전계발광소자를 제조하였다.
An organic electroluminescent device of each of the
소자 device 비교예Comparative Example 1 One
비교예 1을 위한 유기발광다이오드 소자는 상기 실시예의 소자구조에서 발명에 의해 제조된 화합물 1 대신 일반적으로 인광호스트 물질로 많이 사용되고 있는 CBP를 사용한 점을 제외하고 동일하게 제작하였다.
The organic light emitting diode device for Comparative Example 1 was fabricated in the same manner except that CBP, which is generally used as a phosphorescent host material, was used instead of the
소자실시예Device Example 44: 화합물 44를 44: Compound 44 정공수송재료로With hole transport material 하여 So 유기전계발광소자Organic electroluminescent device 제조 Produce
ITO로 코팅된 유리기판 위에 화합물 44를 증착하여 120 nm의 정공수송층을 형성하였으며, 이어서 Ir(ppy)3을 도펀트로 하여 CBP를 호스트로 하여 증착속도를 0.1 nm/sec, Ir(ppy)3 증착속도를 0.009 nm/sec로 증착하고, 증착속도 비율이 9%가 되도록 Ir(ppy)3을 도핑하여 정공수송층 상에 발광층을 30 nm 두께로 형성하였다.Compound 44 was deposited on ITO-coated glass substrate to form a 120 nm hole transport layer. Subsequently, Ir (ppy) 3 was used as a dopant to deposit CBP at 0.1 nm / sec and Ir (ppy) 3 And the Ir (ppy) 3 was doped so that the deposition rate ratio was 9% to form a light emitting layer with a thickness of 30 nm on the hole transport layer.
그 위에 Balq를 10 nm 두께로 증착하여 정공이 발광층을 지나 전자수송층으로 이동하는 것을 방지하는 정공차단층을 형성하고, 그 위에 Alq3를 증착하여 40 nm의 전자수송층을 형성하였으며, 그 위에 불화리튬을 증착하여 1 nm의 전자주입층을 형성하였다. 전자주입층 상에 알루미늄을 증착하여 120 nm의 음극을 형성하여 유기전계발광소자를 제조하였다.Balq was deposited thereon to a thickness of 10 nm to form a hole blocking layer for preventing holes from moving to the electron transporting layer through the light emitting layer, and Alq 3 was deposited thereon to form an electron transporting layer of 40 nm. Lithium fluoride To form a 1 nm electron injection layer. Aluminum was deposited on the electron injection layer to form a 120 nm negative electrode, thereby fabricating an organic electroluminescent device.
이때, 각 물질의 증착속도는 유기물질인, 화합물 1, CBP, Alq3, Balq는 0.1 nm/sec, 불화리튬은 0.01 nm/sec, 알루미늄은 0.5 nm/sec로 하였다.
At this time, the deposition rate of each material was set to 0.1 nm / sec for
소자 device 실시예Example 45 내지 83 45 to 83
화합물 44 대신에 하기 [표 2]에 기재된 화합물을 사용한 것을 제외하고는 소자실시예 44과 동일한 방법으로 소자 실시예 45 내지 83의 유기전계발광소자를 제조하였다.
Organic electroluminescent devices of Device Examples 45 to 83 were fabricated in the same manner as in Example 44 except that the compound described in [Table 2] was used instead of Compound 44.
소자 device 비교예Comparative Example 2 2
비교예2를 위한 유기발광다이오드 소자는 상기 실시예의 소자구조에서 발명에 의해 제조된 화합물1 대신 일반적으로 정공수송물질로 많이 사용되고 있는 NPB를 사용한 점을 제외하고 동일하게 제작하였다.The organic light emitting diode device for Comparative Example 2 was fabricated in the same manner except that NPB, which is generally used as a hole transport material, was used instead of the
상기에서 사용된 Ir(ppy)3, CBP, NPB의 구조는 다음과 같다.The structures of Ir (ppy) 3 , CBP and NPB used in the above are as follows.
[표 1][Table 1]
[표 2][Table 2]
구동전압 및 발광효율 측정Measurement of driving voltage and luminous efficiency
상기 유기발광소자(기판크기 : 25 × 25 ㎟ / 증착면적 : 2 × 2 ㎟)를 IVL 측정셋트(CS-2000+지그+IVL프로그램)에 고정한 후 전류를 1 mA/㎡씩 상승시키며 증착면의 발광 휘도(cd/㎡), 구동전압(V), 전류밀도(A/㎡), 발광효율(cd/A)을 측정하여 휘도가 1000 cd/㎡ 일 때 구동전압과 발광효율을 상기 [표 1] 및 [표 2]에 나타내었다.After fixing the organic light emitting device (substrate size: 25 × 25
[표 1]과 [표 2]에 따르면, 본 발명에 따른 유기전계발광소자용 화합물이 유기전계발광소자의 발광층의 호스트 물이나, 정공수송물질로 사용될 때 종래의 CBP(호스트재료), NPB(정공수송재료)를 사용할 때보다 구동전압은 낮아지고, 발광효율은 증가됨을 볼 수 있다.According to [Table 1] and [Table 2], when the compound for an organic electroluminescent device according to the present invention is used as a host material or a hole transport material of the light emitting layer of an organic electroluminescent device, conventional CBP (host material), NPB Hole transporting material), the driving voltage is lowered and the luminous efficiency is increased.
Claims (12)
[화학식 1]
상기 [화학식 1]에서,
X1 내지 X10은 각각 독립적으로 N 또는 CR1이고, X11은 단일결합이거나, CR2R3, CR4, NR5, PR6, SiR7R8, O 및 S 중에서 선택되고,
상기 R1 내지 R8은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 비치환된 탄소수 2 내지 30의 알케닐기, 치환 또는 비치환된 탄소수 2 내지 30의 알키닐기, 치환 또는 비치환된 탄소수 3 내지30의 시클로알킬기, 치환 또는 비치환된 탄소수 2 내지 30의 헤테로시클로알킬기, 치환 또는 비치환된 탄소수 5 내지 30의 시클로알케닐기, 치환 또는 비치환된 탄소수 1 내지 30의 알콕시기, 치환 또는 비치환된 탄소수 6 내지 30의 아릴옥시기, 치환 또는 비치환된 탄소수 1 내지 30의 알킬티옥시기, 치환 또는 비치환된 탄소수 5 내지 30의 아릴티옥시기, 치환 또는 비치환된 탄소수 1 내지 30의 알킬아민기, 치환 또는 비치환된 탄소수 5 내지 30의 아릴아민기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환된 탄소수 3 내지 50의 헤테로아릴기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기, 치환 또는 비치환된 실릴기, 아미노기, 싸이올기, 시아노기, 히드록시기, 니트로기 및 할로겐기로 이루어진 군에서 선택되고,
상기 R1 내지 R8 중 인접한 치환기는 서로 연결되어 지환족, 방향족의 단일환 또는 다환 고리를 형성할 수 있으며, 상기 형성된 지환족, 방향족의 단일환 또는 다환 고리의 탄소원자는 N, S 및 O 중에서 선택되는 어느 하나 이상의 헤테로원자로 치환될 수 있고,
상기 R1 내지 R8은 각각 1종 이상의 치환기로 더 치환될 수 있고, 상기 1종 이상의 치환기는 중수소, 시아노기, 할로겐기, 히드록시기, 니트로기, 탄소수 1 내지 24의 알킬기, 탄소수 1 내지 24의 할로겐화된 알킬기, 탄소수 1 내지 24의 알케닐기, 탄소수 1 내지 24의 알키닐기, 탄소수 1 내지 24의 헤테로알킬기, 탄소수 6 내지 24의 아릴기, 탄소수 6 내지 24의 아릴알킬기, 탄소수 2 내지 24의 헤테로아릴기, 또는 탄소수 2 내지 24의 헤테로아릴알킬기, 탄소수 1 내기 24의 알콕시기, 탄소수 1 내지 24의 알킬아미노기, 탄소수 1 내지 24의 아릴아미노기, 탄소수 1 내지 24의 헤테로아릴아미노기, 탄소수 1 내지 24의 알킬실릴기, 탄소수 1 내지 24의 아릴실릴기 및 탄소수 1 내지 24의 아릴옥시기로 이루어진 군에서 선택된다.An organic light-emitting compound represented by the following Formula 1:
[Chemical Formula 1]
In the above formula (1)
X 1 to X 10 are each independently N or CR 1 and X 11 is a single bond or is selected from CR 2 R 3 , CR 4 , NR 5 , PR 6 , SiR 7 R 8 , O and S,
Each of R 1 to R 8 is independently selected from the group consisting of hydrogen, deuterium, a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 30 carbon atoms, a substituted or unsubstituted alkoxy group having 2 to 30 carbon atoms A substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms, a substituted or unsubstituted heterocycloalkyl group having 2 to 30 carbon atoms, a substituted or unsubstituted cycloalkenyl group having 5 to 30 carbon atoms, a substituted or unsubstituted C1- A substituted or unsubstituted C1 to C30 alkoxy group, a substituted or unsubstituted C6 to C30 aryloxy group, a substituted or unsubstituted C1 to C30 alkylthio group, a substituted or unsubstituted C1 to C30 arylthio group, An unsubstituted alkylamine group having 1 to 30 carbon atoms, a substituted or unsubstituted arylamine group having 5 to 30 carbon atoms, a substituted or unsubstituted aryl group having 5 to 50 carbon atoms, A substituted or unsubstituted aryl group having 5 to 50 carbon atoms, a substituted or unsubstituted C3 to C30 cycloalkyl having 3 to 30 carbon atoms, a substituted or unsubstituted C3 to C30 heteroaryl group, a substituted or unsubstituted C3 to C30 cycloalkyl, A substituted or unsubstituted aryl group having 2 to 50 carbon atoms, a substituted or unsubstituted silyl group, an amino group, a thiol group, a cyano group, a hydroxyl group, a nitro group and a halogen group,
The adjacent substituents of R 1 to R 8 may be connected to form a single alicyclic or aromatic ring or polycyclic ring. The carbon atom of the alicyclic or aromatic monocyclic or polycyclic ring may be substituted with N, S and O Which may be substituted with any one or more hetero atoms selected,
Each of R 1 to R 8 may be further substituted with at least one substituent, and the at least one substituent may be one selected from the group consisting of deuterium, cyano, halogen, hydroxy, nitro, alkyl having 1 to 24 carbon atoms, A halogenated alkyl group, an alkenyl group having 1 to 24 carbon atoms, an alkynyl group having 1 to 24 carbon atoms, a heteroalkyl group having 1 to 24 carbon atoms, an aryl group having 6 to 24 carbon atoms, an arylalkyl group having 6 to 24 carbon atoms, An aryl group or a heteroarylalkyl group having 2 to 24 carbon atoms, an alkoxy group having 24 carbon atoms, an alkylamino group having 1 to 24 carbon atoms, an arylamino group having 1 to 24 carbon atoms, a heteroarylamino group having 1 to 24 carbon atoms, An alkylsilyl group of 1 to 24 carbon atoms, an arylsilyl group of 1 to 24 carbon atoms, and an aryloxy group of 1 to 24 carbon atoms.
상기 [화학식 1]은 하기 [화학식 2] 내지 [화학식 17] 중에서 선택되는 어느 하나인 것을 특징으로 하는 유기발광 화합물:
상기 [화학식 2] 내지 [화학식 17]에서,
X1 내지 X11의 정의는 상기 [화학식 1]에서의 정의와 동일하고, 상기 X1 내지 X11의 각 치환기는 인접한 치환기와 서로 연결되어 지환족, 방향족의 단일환 또는 다환 고리를 형성할 수 있으며, 상기 형성된 지환족, 방향족의 단일환 또는 다환 고리의 탄소원자는 N, S 및 O 중에서 선택되는 어느 하나 이상의 헤테로원자로 치환될 수 있다.The method according to claim 1,
The organic electroluminescent compound according to claim 1, wherein the compound represented by Formula 1 is any one selected from the following Formulas (2) to (17):
In the above Chemical Formulas 2 to 17,
X 1 to X 11 are the same as defined in the above formula (1), and each of the substituents of X 1 to X 11 is linked to adjacent substituents to form a monocyclic or polycyclic ring of alicyclic or aromatic And the carbon atom of the formed alicyclic or aromatic monocyclic or polycyclic ring may be substituted with any one or more heteroatoms selected from N, S and O.
상기 X2 내지 X6 중 하나 이상은 CR3이고, 상기 *-R3는 하기 [구조식 1]인 것을 특징으로 하는 유기발광 화합물:
[구조식 1]
[구조식 1]에서,
L1은 치환 또는 비치환된 탄소수 1 내지 30의 알킬렌기, 치환 또는 비치환된 탄소수 2 내지 30의 알케닐렌기, 치환 또는 비치환된 탄소수 2 내지 30의 알키닐렌기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬렌기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴렌기, 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴렌기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 5 내지 50의 아릴렌기 및 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴렌기 중에서 선택되며,
n은 0 내지 4의 정수이고, n이 2 이상인 경우, 복수 개의 L1은 서로 동일하거나 상이하며,
Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 5 내지 50의 아릴기 및 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기 중에서 선택되며,
상기 Ar1 및 Ar2는 서로 결합하거나 인접한 치환기와 연결되어 지환족, 방향족의 단일환 또는 다환 고리를 형성할 수 있으며, 상기 형성된 지환족, 방향족의 단일환 또는 다환 고리의 탄소원자는 N, S 및 O 중에서 선택되는 어느 하나 이상의 헤테로원자로 치환될 수 있으며,
p는 0 내지 3이 정수이고, 상기 p가 2 이상인 경우 복수의 *-( )는 서로 동일하거나 상이할 수 있고,
상기 L1, Ar1 및 Ar2는 각각 1종 이상의 치환기로 더 치환될 수 있고, 상기 1종 이상의 치환기는 중수소, 시아노기, 할로겐기, 히드록시기, 니트로기, 탄소수 1 내지 24의 알킬기, 탄소수 1 내지 24의 할로겐화된 알킬기, 탄소수 1 내지 24의 알케닐기, 탄소수 1 내지 24의 알키닐기, 탄소수 1 내지 24의 헤테로알킬기, 탄소수 6 내지 24의 아릴기, 탄소수 6 내지 24의 아릴알킬기, 탄소수 2 내지 24의 헤테로아릴기, 또는 탄소수 2 내지 24의 헤테로아릴알킬기, 탄소수 1 내기 24의 알콕시기, 탄소수 1 내지 24의 알킬아미노기, 탄소수 1 내지 24의 아릴아미노기, 탄소수 1 내지 24의 헤테로아릴아미노기, 탄소수 1 내지 24의 알킬실릴기, 탄소수 1 내지 24의 아릴실릴기 및 탄소수 1 내지 24의 아릴옥시기로 이루어진 군에서 선택된다.The method according to claim 1,
At least one of X 2 to X 6 is CR 3 , and * -R 3 is represented by the following formula 1:
[Structural formula 1]
In the structural formula 1,
L 1 is a substituted or unsubstituted alkylene group having 1 to 30 carbon atoms, a substituted or unsubstituted aliphatic hydrocarbon group having 2 to 30 carbon atoms A substituted or unsubstituted C2-C30 alkynylene group, a substituted or unsubstituted C3-C30 A substituted or unsubstituted C2 to C30 heteroarylene group, a substituted or unsubstituted C3 to C30 cycloalkyl, a substituted or unsubstituted C1 to C50 arylene group, a substituted or unsubstituted C2 to C30 heteroarylene group, A substituted or unsubstituted C2 to C50 heteroarylene group in which one or more substituted or unsubstituted C 3 -C 30 cycloalkyl is fused,
n is an integer of 0 to 4, and when n is 2 or more, a plurality of L < 1 > s are the same as or different from each other,
Ar 1 and Ar 2 are the same or different and each independently represents a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms, a substituted or unsubstituted group having 5 to 50 carbon atoms A substituted or unsubstituted aryl group, a substituted or unsubstituted C2 to C50 heteroaryl group, a substituted or unsubstituted C3 to C30 cycloalkyl substituted or unsubstituted aryl group having 5 to 50 carbon atoms, A substituted or unsubstituted C2 to C50 heteroaryl group in which one or more ring-opened cycloalkyls having 3 to 30 carbon atoms is fused,
Ar 1 and Ar 2 may be bonded to each other or may be connected to adjacent substituents to form a single alicyclic or aromatic ring or polycyclic ring, and the carbon atom of the alicyclic or aromatic monocyclic or polycyclic ring may be N, S, O, < / RTI >< RTI ID = 0.0 >
p is an integer of 0 to 3, and when p is 2 or more, a plurality of * - () may be the same or different from each other,
Wherein L 1, Ar 1 and Ar 2 each may be further substituted with one or more substituents, the one or more substituents are deuterium, a cyano group, a halogen group, a hydroxyl group, a nitro group, an alkyl group having 1 to 24 carbon atoms, having a carbon number of 1 A halogenated alkyl group having 1 to 24 carbon atoms, an alkenyl group having 1 to 24 carbon atoms, an alkynyl group having 1 to 24 carbon atoms, a heteroalkyl group having 1 to 24 carbon atoms, an aryl group having 6 to 24 carbon atoms, an arylalkyl group having 6 to 24 carbon atoms, A heteroaryl group having 2 to 24 carbon atoms, a heteroarylalkyl group having 2 to 24 carbon atoms, an alkoxy group having 24 carbon atoms, an alkylamino group having 1 to 24 carbon atoms, an arylamino group having 1 to 24 carbon atoms, a heteroarylamino group having 1 to 24 carbon atoms, An alkylsilyl group having 1 to 24 carbon atoms, an arylsilyl group having 1 to 24 carbon atoms, and an aryloxy group having 1 to 24 carbon atoms.
상기 X2 내지 X10 중 하나 이상은 CR3이고, 상기 *-R3는 하기 [구조식 2]인 것을 특징으로 하는 유기발광 화합물:
[구조식 2]
상기 [구조식 2]에서,
L2는 치환 또는 비치환된 탄소수 1 내지 30의 알킬렌기, 치환 또는 비치환된 탄소수 2 내지 30의 알케닐렌기, 치환 또는 비치환된 탄소수 2 내지 30의 알키닐렌기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬렌기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴렌기, 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴렌기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 5 내지 50의 아릴렌기 및 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴렌기 중에서 선택되며,
m은 0 내지 4의 정수이고, m이 2 이상인 경우, 복수 개의 L2는 서로 동일하거나 상이하며,
Ar3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 5 내지 50의 아릴기 및 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기 중에서 선택되며,
q는 0 내지 3이 정수이고, 상기 q가 2 이상인 경우 복수의 Ar3는 서로 동일하거나 상이할 수 있고,
상기 복수의 Ar3 및 이의 치환기는 인접한 치환기와 연결되어 지환족, 방향족의 단일환 또는 다환 고리를 형성할 수 있으며, 상기 형성된 지환족, 방향족의 단일환 또는 다환 고리의 탄소원자는 N, S 및 O 중에서 선택되는 어느 하나 이상의 헤테로원자로 치환될 수 있고,
상기 L2 및 Ar3는 각각 1종 이상의 치환기로 더 치환될 수 있고, 상기 1종 이상의 치환기는 중수소, 시아노기, 할로겐기, 히드록시기, 니트로기, 탄소수 1 내지 24의 알킬기, 탄소수 1 내지 24의 할로겐화된 알킬기, 탄소수 1 내지 24의 알케닐기, 탄소수 1 내지 24의 알키닐기, 탄소수 1 내지 24의 헤테로알킬기, 탄소수 6 내지 24의 아릴기, 탄소수 6 내지 24의 아릴알킬기, 탄소수 2 내지 24의 헤테로아릴기, 또는 탄소수 2 내지 24의 헤테로아릴알킬기, 탄소수 1 내기 24의 알콕시기, 탄소수 1 내지 24의 알킬아미노기, 탄소수 1 내지 24의 아릴아미노기, 탄소수 1 내지 24의 헤테로아릴아미노기, 탄소수 1 내지 24의 알킬실릴기, 탄소수 1 내지 24의 아릴실릴기 및 탄소수 1 내지 24의 아릴옥시기로 이루어진 군에서 선택된다.The method according to claim 1,
Wherein at least one of X 2 to X 10 is CR 3 , and * -R 3 is represented by the following formula 2:
[Structural formula 2]
In the above formula 2,
L 2 is a substituted or unsubstituted alkylene group having 1 to 30 carbon atoms, a substituted or unsubstituted alkylene group having 2 to 30 carbon atoms A substituted or unsubstituted C2-C30 alkynylene group, a substituted or unsubstituted C3-C30 A substituted or unsubstituted C2 to C30 heteroarylene group, a substituted or unsubstituted C3 to C30 cycloalkyl, a substituted or unsubstituted C1 to C50 arylene group, a substituted or unsubstituted C2 to C30 heteroarylene group, A substituted or unsubstituted C2 to C50 heteroarylene group in which one or more substituted or unsubstituted C 3 -C 30 cycloalkyl is fused,
m is an integer of 0 to 4, and when m is 2 or more, a plurality of L 2 are the same or different from each other,
And Ar 3 are the same or different and each independently represents a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms, a substituted or unsubstituted aryl group having 5 to 50 carbon atoms, A substituted or unsubstituted C2 to C50 heteroaryl group, a substituted or unsubstituted C3 to C30 heteroaryl group, a substituted or unsubstituted C6 to C30 heteroaryl group, a substituted or unsubstituted C3 to C30 cycloalkyl, Substituted or unsubstituted heteroaryl group having 2 to 50 carbon atoms in which at least one of 3 to 30 cycloalkyls is fused,
q is an integer of 0 to 3, and when q is 2 or more, a plurality of Ar 3 may be the same or different,
The plurality of Ar 3 and substituents thereof may be connected to adjacent substituents to form a single alicyclic or aromatic ring or polycyclic ring, and the carbon atoms of the formed alicyclic or aromatic monocyclic or polycyclic ring may be N, S, and O ≪ / RTI > and < RTI ID = 0.0 >
Each of L 2 and Ar 3 may be further substituted with one or more substituents each of which may be substituted with one or more substituents selected from the group consisting of deuterium, cyano, halogen, hydroxy, nitro, alkyl having 1 to 24 carbon atoms, A halogenated alkyl group, an alkenyl group having 1 to 24 carbon atoms, an alkynyl group having 1 to 24 carbon atoms, a heteroalkyl group having 1 to 24 carbon atoms, an aryl group having 6 to 24 carbon atoms, an arylalkyl group having 6 to 24 carbon atoms, An aryl group or a heteroarylalkyl group having 2 to 24 carbon atoms, an alkoxy group having 24 carbon atoms, an alkylamino group having 1 to 24 carbon atoms, an arylamino group having 1 to 24 carbon atoms, a heteroarylamino group having 1 to 24 carbon atoms, An alkylsilyl group of 1 to 24 carbon atoms, an arylsilyl group of 1 to 24 carbon atoms, and an aryloxy group of 1 to 24 carbon atoms.
상기 [화학식 1]은 하기 [화합물 1] 내지 [화합물 324] 중에서 선택되는 것을 특징으로 하는 유기발광 화합물:
The method according to claim 1,
The organic electroluminescent compound according to claim 1, wherein the organic electroluminescent compound is selected from the following compounds [1] to [324]:
상기 [화학식 1]은 하기 [화합물 325] 내지 [화합물 700] 중에서 선택되는 것을 특징으로 하는 유기발광 화합물:
The method according to claim 1,
Wherein the compound represented by Formula 1 is selected from the following compounds 325 to 700:
상기 유기물층 중 1 층 이상은 청구항 1 내지 6 중 어느 한 항에 따른 [화학식 1]의 유기발광 화합물을 포함하는 것인 유기전계발광소자.1. An organic electroluminescent device comprising a first electrode, a second electrode, and at least one organic material layer disposed between the first electrode and the second electrode,
Wherein at least one of the organic material layers contains an organic light emitting compound of Formula 1 according to any one of claims 1 to 6.
상기 유기물층은 정공 주입층, 정공 수송층, 정공 주입 및 정공 수송을 동시에 하는 층, 전자 수송층, 전자 주입층, 전자 수송 및 전자 주입을 동시에 하는 층 및 발광층 중 1층 이상을 포함하고, 상기 층들 중 1층 이상이 상기 [화학식 1]로 표시되는 유기발광 화합물을 포함하는 것을 특징으로 하는 유기전계발광소자.8. The method of claim 7,
Wherein the organic material layer includes at least one of a hole injecting layer, a hole transporting layer, a hole injecting and transporting layer, an electron transporting layer, an electron injecting layer, a layer simultaneously performing electron transport and electron injection, and a light emitting layer, Wherein at least one layer comprises an organic light-emitting compound represented by the above formula (1).
상기 발광층이 상기 [화학식 1]로 표시되는 유기발광 화합물을 포함하는 것을 특징으로 하는 유기전계발광소자.9. The method of claim 8,
Wherein the light emitting layer comprises an organic light emitting compound represented by the following formula (1).
상기 [화학식 1]로 표시되는 유기발광 화합물은 상기 발광층 내의 호스트 화합물로 사용되고, 상기 발광층은 도판트 화합물을 1종 이상 더 포함하는 것을 특징으로 하는 유기전계발광소자.10. The method of claim 9,
The organic electroluminescent compound represented by Formula 1 is used as a host compound in the light emitting layer, and the light emitting layer further includes at least one dopant compound.
상기 정공수송층 또는 정공 주입 및 정공 수송을 동시에 하는 층이 상기 [화학식 1]로 표시되는 유기발광 화합물을 포함하는 것을 특징으로 하는 유기전계발광소자.9. The method of claim 8,
Wherein the hole transport layer or the layer simultaneously injecting holes and transporting holes comprises an organic light emitting compound represented by the following formula (1).
상기 유기물층에 적색, 녹색 또는 청색 발광을 하는 유기 발광층을 하나 이상을 더 포함하여 백색 발광을 하는 것을 특징으로 하는 유기전계발광소자.8. The method of claim 7,
Wherein at least one of the organic light emitting layers emitting red, green or blue light is further included in the organic material layer to emit white light.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140059983A KR20150133097A (en) | 2014-05-19 | 2014-05-19 | An electroluminescent compound and an electroluminescent device comprising the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140059983A KR20150133097A (en) | 2014-05-19 | 2014-05-19 | An electroluminescent compound and an electroluminescent device comprising the same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20150133097A true KR20150133097A (en) | 2015-11-27 |
Family
ID=54847659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140059983A KR20150133097A (en) | 2014-05-19 | 2014-05-19 | An electroluminescent compound and an electroluminescent device comprising the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20150133097A (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016101865A1 (en) * | 2014-12-26 | 2016-06-30 | Dow Global Technologies Llc | Organic compounds and electronic device comprising organic layer comprising organic compounds |
CN106189363A (en) * | 2016-07-01 | 2016-12-07 | 湘潭大学 | One class closes polymer-metal complex dye sensitizing agent of Cd (II) and its production and use containing 2 (2 ' hydroxy phenyl) benzimidizole derivatives |
WO2017105106A1 (en) * | 2015-12-18 | 2017-06-22 | 주식회사 두산 | Organic compound, and organic electroluminescent element including same |
CN107325103A (en) * | 2017-07-07 | 2017-11-07 | 中节能万润股份有限公司 | A kind of electroluminescent organic material, its preparation method and application |
WO2018058497A1 (en) * | 2016-09-30 | 2018-04-05 | Dow Global Technologies Llc | Organic compound and electronic device comprising organic layer comprising organic compound |
CN107915748A (en) * | 2017-11-14 | 2018-04-17 | 华东师范大学 | A kind of preparation method of 4 (tert-butyl group) 1 phenylimidazoles simultaneously [4,5,1 kl] phenoxazine |
CN111170956A (en) * | 2020-01-10 | 2020-05-19 | 黄锦海 | Hole transport material composition containing benzoxazole and thiazole group and application thereof |
CN111170957A (en) * | 2020-01-10 | 2020-05-19 | 上海百豪新材料有限公司 | Preparation method of hole transport material composition containing benzoxazole and thiazole group |
CN113121493A (en) * | 2021-04-13 | 2021-07-16 | 吉林奥来德光电材料股份有限公司 | Arylamine compound, preparation method thereof, organic electroluminescent device and display device |
WO2023011581A1 (en) * | 2021-08-04 | 2023-02-09 | 江苏恒瑞医药股份有限公司 | Nitrogen-containing heterocyclic compound, preparation method therefor, and pharmaceutical application thereof |
CN115947698A (en) * | 2022-12-26 | 2023-04-11 | 郑州海阔光电材料有限公司 | Synthesis method of phenoxazine |
CN116554154A (en) * | 2023-05-25 | 2023-08-08 | 中国科学院长春应用化学研究所 | Thermal-induction delayed fluorescence compound, preparation method thereof and organic electroluminescent device |
CN118084927A (en) * | 2024-04-19 | 2024-05-28 | 季华恒烨(佛山)电子材料有限公司 | Indolocarbazole compound and application thereof |
-
2014
- 2014-05-19 KR KR1020140059983A patent/KR20150133097A/en not_active Application Discontinuation
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016101865A1 (en) * | 2014-12-26 | 2016-06-30 | Dow Global Technologies Llc | Organic compounds and electronic device comprising organic layer comprising organic compounds |
US10005729B2 (en) | 2014-12-26 | 2018-06-26 | Rohm And Haas Electronic Materials Korea Ltd | Organic compounds and electronic device comprising an organic layer comprising the organic compounds |
WO2017105106A1 (en) * | 2015-12-18 | 2017-06-22 | 주식회사 두산 | Organic compound, and organic electroluminescent element including same |
KR20170073122A (en) * | 2015-12-18 | 2017-06-28 | 주식회사 두산 | Organic compounds and organic electro luminescence device comprising the same |
CN106189363A (en) * | 2016-07-01 | 2016-12-07 | 湘潭大学 | One class closes polymer-metal complex dye sensitizing agent of Cd (II) and its production and use containing 2 (2 ' hydroxy phenyl) benzimidizole derivatives |
WO2018058497A1 (en) * | 2016-09-30 | 2018-04-05 | Dow Global Technologies Llc | Organic compound and electronic device comprising organic layer comprising organic compound |
CN107325103A (en) * | 2017-07-07 | 2017-11-07 | 中节能万润股份有限公司 | A kind of electroluminescent organic material, its preparation method and application |
CN107915748A (en) * | 2017-11-14 | 2018-04-17 | 华东师范大学 | A kind of preparation method of 4 (tert-butyl group) 1 phenylimidazoles simultaneously [4,5,1 kl] phenoxazine |
CN111170956A (en) * | 2020-01-10 | 2020-05-19 | 黄锦海 | Hole transport material composition containing benzoxazole and thiazole group and application thereof |
CN111170957A (en) * | 2020-01-10 | 2020-05-19 | 上海百豪新材料有限公司 | Preparation method of hole transport material composition containing benzoxazole and thiazole group |
CN111170957B (en) * | 2020-01-10 | 2023-03-21 | 上海百豪新材料有限公司 | Preparation method of hole transport material composition containing benzoxazole and thiazole groups |
CN113121493A (en) * | 2021-04-13 | 2021-07-16 | 吉林奥来德光电材料股份有限公司 | Arylamine compound, preparation method thereof, organic electroluminescent device and display device |
WO2023011581A1 (en) * | 2021-08-04 | 2023-02-09 | 江苏恒瑞医药股份有限公司 | Nitrogen-containing heterocyclic compound, preparation method therefor, and pharmaceutical application thereof |
CN115947698A (en) * | 2022-12-26 | 2023-04-11 | 郑州海阔光电材料有限公司 | Synthesis method of phenoxazine |
CN115947698B (en) * | 2022-12-26 | 2024-05-03 | 郑州海阔光电材料有限公司 | Synthesis method of phenoxazine |
CN116554154A (en) * | 2023-05-25 | 2023-08-08 | 中国科学院长春应用化学研究所 | Thermal-induction delayed fluorescence compound, preparation method thereof and organic electroluminescent device |
CN118084927A (en) * | 2024-04-19 | 2024-05-28 | 季华恒烨(佛山)电子材料有限公司 | Indolocarbazole compound and application thereof |
CN118084927B (en) * | 2024-04-19 | 2024-08-23 | 季华恒烨(佛山)电子材料有限公司 | Indolocarbazole compound and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101825405B1 (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR101627691B1 (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR101852926B1 (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR101530266B1 (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR20150133097A (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR20160066308A (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR101842013B1 (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR101790550B1 (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR20170082459A (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR20160127429A (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR101626524B1 (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR20150037623A (en) | Heterocyclic compound and organic light emitting device using the same | |
KR101837048B1 (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR101913628B1 (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR20150110101A (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR101713530B1 (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR20160054870A (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR101666826B1 (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR101627695B1 (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR20160040826A (en) | Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same | |
JP6766303B2 (en) | Nitrogen-containing polycyclic compound and organic light emitting device using it | |
KR101816810B1 (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR101638073B1 (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR101640478B1 (en) | Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same | |
KR20170003470A (en) | An electroluminescent compound and an electroluminescent device comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |